,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,Platelet Degranulation R-HSA-114608,0.46945444029908906,4.215942508047793,0.0,0.0,0.0,46/65,27.35%,ALB;LGALS3BP;FN1;AHSG;FGB;FGA;APOA1;CLU;QSOX1;PFN1;PLG;ITIH3;F5;F13A1;ITIH4;TLN1;PROS1;TF;APOH;TUBA4A;PPIA;TGFB1;FLNA;HSPA5;THBS1;A1BG;FGG;SERPINF2;CAP1;SERPINA1;WDR1;IGF2;CLEC3B;VWF;RARRES2;ACTN1;APP;FERMT3;SERPINE1;TAGLN2;APLP2;OLA1;SERPING1;ANXA5;CALM1;ACTN4
1,prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.46945444029908906,4.215942508047793,0.0,0.0,0.0,46/65,27.35%,ALB;LGALS3BP;FN1;AHSG;FGB;FGA;APOA1;CLU;QSOX1;PFN1;PLG;ITIH3;F5;F13A1;ITIH4;TLN1;PROS1;TF;APOH;TUBA4A;PPIA;TGFB1;FLNA;HSPA5;THBS1;A1BG;FGG;SERPINF2;CAP1;SERPINA1;WDR1;IGF2;CLEC3B;VWF;RARRES2;ACTN1;APP;FERMT3;SERPINE1;TAGLN2;APLP2;OLA1;SERPING1;ANXA5;CALM1;ACTN4
2,prerank,Hemostasis R-HSA-109582,0.3073381204829149,3.6570415637175016,0.0,0.0,0.0,66/125,26.24%,ALB;LGALS3BP;APOB;FN1;AHSG;FGB;FGA;APOA1;CLU;QSOX1;PFN1;PLG;TFPI;ITIH3;F5;SERPIND1;F13A1;ITIH4;TLN1;PROS1;TF;SDC1;IGLL5;APOH;TUBA4A;PPIA;TGFB1;FLNA;HSPA5;RAP1B;THBS1;A1BG;FGG;SERPINC1;SERPINF2;CAP1;SERPINA1;F9;SDC4;GRB7;HBE1;WDR1;PPP2CA;F13B;IGF2;CLEC3B;YWHAZ;VWF;JCHAIN;RARRES2;ACTN1;EHD3;SERPINA5;APP;FERMT3;SERPINE1;TAGLN2;APLP2;CD74;OLA1;SERPING1;C1QBP;ANXA5;CAPZA1;CALM1;PPP2R1A
3,prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",0.37162402797951644,3.6508444379577716,0.0,0.0,0.0,48/79,27.35%,ALB;LGALS3BP;FN1;AHSG;FGB;FGA;APOA1;CLU;QSOX1;PFN1;PLG;ITIH3;F5;F13A1;ITIH4;TLN1;PROS1;TF;APOH;TUBA4A;PPIA;TGFB1;FLNA;HSPA5;RAP1B;THBS1;A1BG;FGG;SERPINF2;CAP1;SERPINA1;WDR1;IGF2;CLEC3B;YWHAZ;VWF;RARRES2;ACTN1;APP;FERMT3;SERPINE1;TAGLN2;APLP2;OLA1;SERPING1;ANXA5;CALM1;ACTN4
4,prerank,Common Pathway Of Fibrin Clot Formation R-HSA-140875,0.8336272780717227,3.1808792452947388,0.0,0.0,0.0,10/10,17.12%,FGB;FGA;F5;SERPIND1;F13A1;PROS1;FGG;SERPINC1;F13B;SERPINA5
5,prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.6510698915912877,3.1291914381692822,0.0,0.0,0.0,15/17,24.43%,FGB;FGA;TFPI;F5;SERPIND1;F13A1;PROS1;FGG;SERPINC1;F9;F13B;VWF;SERPINA5;SERPING1;C1QBP
6,prerank,Post-translational Protein Phosphorylation R-HSA-8957275,0.37505372352289196,3.100947216381962,0.0,0.0,0.0,24/56,8.77%,ALB;C3;APOB;FN1;AHSG;ITIH2;APOE;FGA;MATN3;C4A;APOA1;QSOX1;GPC3;F5;SERPIND1;TF;LAMB1;PDIA6;LAMC1;HSP90B1;NOTUM;FGG;SERPINC1;SERPINA1
7,prerank,Innate Immune System R-HSA-168249,0.1989491000080246,3.0878423743002754,0.0,0.0,0.0,137/251,38.98%,C3;APOB;VTN;AHSG;FGB;FGA;C4A;C5;CLU;LTF;C4BPA;POLR3B;PKM;GSN;QSOX1;HSPA1A;IGF2R;VCP;HSP90AB1;PROS1;HSP90AA1;IGLL5;KRT1;TUBB4B;PPIA;CFI;EEF1A1;RAP1B;EEF2;HSP90B1;RPS27A;A1BG;C1R;FGG;CAP1;LYZ;SERPINA1;PSMD14;CTSB;PPP2CA;PYGB;CFHR5;XRCC5;C4B;TUBB;COLEC10;C8B;XRCC6;CTSD;MASP1;ACLY;HSPA8;DHX9;ALDOC;C1S;MYH9;HNRNPC;PIGR;PSMC5;HEXB;CCT8;PA2G4;DYNC1H1;PSMC3;CST3;SPTAN1;APP;BPIFB2;CCT2;PSMC4;CAND1;CFH;IDH1;PPIE;PSMD13;PLA2G2A;PSMC1;HLA-A;GDI2;APRT;CPB2;FTH1;PSMC2;PSMC6;MAN2B1;KPNB1;PYGL;LBP;ACTR3;PSME2;B4GALT1;SERPING1;PSMB2;PSMA6;COPB1;VAT1;CAPZA1;DCD;GLB1;CALM1;PPP2R1A;COTL1;CYB5R3;REG3A;RAB14;PSMA7;PGM1;IQGAP1;CTSH;PSMD12;PRKDC;HUWE1;GSTP1;ARPC2;PSMD11;S100P;CFB;DIAPH1;PSMA1;RAB18;PSMA4;PSMD8;RAB7A;RAB5C;UBE2V1;ARPC5;PSMB3;TKFC;C4BPB;PSMA3;CTSZ;PSMA2;PSMD3;GGH;ILF2;DNM2;PSMB1
8,prerank,Complement Cascade R-HSA-166658,0.5218397538538094,3.0716557771202293,0.0,0.0,0.0,20/27,24.14%,C3;VTN;C4A;C5;CLU;C4BPA;PROS1;IGLL5;CFI;C1R;CFHR5;C4B;COLEC10;C8B;MASP1;C1S;HNRNPC;CFH;CPB2;SERPING1
9,prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.3561068926281106,3.0209983595896737,0.0,0.0,0.0,25/61,8.77%,ALB;C3;APOB;FN1;AHSG;ITIH2;APOE;FGA;MATN3;C4A;APOA1;QSOX1;GPC3;PLG;F5;SERPIND1;TF;LAMB1;PDIA6;LAMC1;HSP90B1;NOTUM;FGG;SERPINC1;SERPINA1
10,prerank,Regulation Of Complement Cascade R-HSA-977606,0.5351048676522813,2.9638348532201624,0.0,0.0,0.0,19/24,27.76%,C3;VTN;C4A;C5;CLU;C4BPA;PROS1;IGLL5;CFI;C1R;CFHR5;C4B;C8B;C1S;HNRNPC;CFH;CPB2;SERPING1;PSMA7
11,prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.5861891461818047,2.7807538616292082,0.0,0.0005035402185291039,0.004,13/16,23.90%,TUBA1C;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;TUBB3;CCT6B
12,prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.2593703646478108,2.7673829762571027,0.0,0.0006507288977914574,0.006,88/103,61.72%,RPS27A;PSMD14;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;PSMC5;PSMC3;RPS25;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;RPL12;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;PSMD12;RPS5;PSMD11;RPL18;RPS11;RPL11;PSMA1;RPS3A;PSMA4;PSMD8;RPL5;PSMB3;PSMA3;PSMA2;PSMD3;RPS15A;PSMB1;RPS7;ETF1;RPL14;PSMD6;PSMD2;RPL9;PSMA5;ELOB;PSMB4;RPS8;RPL15;RPL27;RPL4;MAGOH;PSMD5;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;DAG1;RPS6;PABPC1;RPS17;RPS27;RPS20;PSMD7;RPS12;PSME3;RPL23;RPS19;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1
13,prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.5676163053352952,2.755381296228744,0.0,0.0005639650447525964,0.006,14/17,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;TUBB3;CCT6B;TUBA8
14,prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.5676163053352952,2.755381296228744,0.0,0.0005639650447525964,0.006,14/17,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;TUBB3;CCT6B;TUBA8
15,prerank,Immune System R-HSA-168256,0.15377482871657544,2.705663565314488,0.0,0.0006797792950142903,0.007,214/354,49.50%,C3;APOB;VTN;FN1;AHSG;FGB;FGA;C4A;C5;CLU;LTF;C4BPA;POLR3B;PKM;GSN;QSOX1;HSPA1A;F13A1;IGF2R;VCP;HSP90AB1;PROS1;HSP90AA1;CLSTN1;SDC1;IGLL5;KRT1;TUBB4B;PPIA;CFI;EEF1A1;TGFB1;FLNA;HSPA5;RAP1B;EEF2;HSP90B1;RPS27A;A1BG;C1R;UBA1;FGG;CAP1;LYZ;SERPINA1;LAMA5;PSMD14;CTSB;PPP2CA;PYGB;CFHR5;XRCC5;C4B;YWHAZ;PDIA3;TUBB;COLEC10;C8B;XRCC6;CTSD;CLTC;GSTO1;MASP1;ACLY;HSPA8;DHX9;TCP1;ALDOC;C1S;MYH9;HNRNPC;EIF4A1;PIGR;PSMC5;HEXB;CCT8;PA2G4;DYNC1H1;PSMC3;CRLF1;FLNB;CST3;SPTAN1;RPLP0;SEC23A;APP;BPIFB2;AP1B1;CCT2;PSMC4;CAND1;CFH;IDH1;PPIE;PSMD13;PLA2G2A;PSMC1;HLA-A;GDI2;APRT;CPB2;FTH1;P4HB;HSPA9;PSMC2;PSMC6;MAN2B1;KPNB1;PYGL;LBP;ACTR3;PSME2;B4GALT1;CD74;SERPING1;PSMB2;PSMA6;COPB1;VAT1;CAPZA1;DCD;GLB1;CALM1;PPP2R1A;COTL1;CYB5R3;MRC2;REG3A;RAB14;PSMA7;EIF4A3;FSCN1;PGM1;CAPZB;IQGAP1;CTSH;PSMD12;PRKDC;HUWE1;CCL20;AP2M1;GSTP1;ARPC2;PSMD11;S100P;CFB;HNRNPA2B1;DIAPH1;ACTR1A;PSMA1;RAB18;PSMA4;AP2B1;PSMD8;RAB7A;RAB5C;UBE2V1;AP2A1;YWHAB;ARPC5;PSMB3;TKFC;MSN;SEC24C;C4BPB;PSMA3;CTSZ;PSMA2;PSMD3;TIMP1;KIF5B;GGH;ILF2;DNM2;PSMB1;EIF4A2;FUCA1;AP1M1;PSMD6;CHI3L1;SEC31A;NIT2;VASP;LMNB1;PSMD2;DCTN1;CDC42;PRDX4;PSMA5;HNRNPF;AP1G1;TPR;NPEPPS;CLTA;ICOSLG;ELOB;SRP14;CD81;PSMB4;PFKL;IMPDH2;TALDO1;UBE2N;COL1A2;PCBP2;AGL;TTR;PSMD5;CTSV;VCL;FTL;FUCA2;ARPC3;ADAM10
16,prerank,Amyloid Fiber Formation R-HSA-977225,0.47988133921634674,2.6518791265214965,0.0,0.0009241444010651789,0.009,14/22,18.29%,APOE;FGA;APOA1;LTF;H2BC11;H2BC12;TGFBI;GSN;H2AZ1;RPS27A;LYZ;HSPG2;CST3;APP
17,prerank,Signaling By ROBO Receptors R-HSA-376176,0.2401719089054107,2.648979902074864,0.0,0.0010070804370582076,0.011,95/114,61.72%,PFN1;RPS27A;CAP1;PSMD14;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;PSMC5;PSMC3;RPS25;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;RPL12;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;PSMD12;RPS5;PSMD11;RPL18;RPS11;RPL11;PSMA1;RPS3A;PSMA4;PSMD8;RPL5;PSMB3;PSMA3;PSMA2;PSMD3;NRP1;PFN2;RPS15A;PRKAR2A;PSMB1;RPS7;ETF1;RPL14;PSMD6;VASP;PSMD2;CDC42;RPL9;PSMA5;ELOB;PSMB4;RPS8;RPL15;RPL27;RPL4;MAGOH;PSMD5;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;DAG1;RPS6;PABPC1;RPS17;RPS27;RPS20;PSMD7;RPS12;PSME3;RPL23;RPS19;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1
18,prerank,Initial Triggering Of Complement R-HSA-166663,0.6696805410116541,2.6363448328317025,0.0,0.001144891444234594,0.013,9/11,16.13%,C3;C4A;IGLL5;C1R;C4B;COLEC10;MASP1;C1S;HNRNPC
19,prerank,Metabolism Of Proteins R-HSA-392499,0.13257093269419545,2.4937349065127297,0.0,0.004531861966761935,0.028,318/451,61.72%,ALB;C3;H2AC21;APOB;FN1;AHSG;ITIH2;APOE;FGA;MATN3;C4A;APOA1;LTF;H2BC11;H2BC12;TGFBI;GSN;QSOX1;GPC3;MAN1A1;PLG;NPM1;F5;SERPIND1;TUBA1C;VCP;PROS1;TF;TUBB4B;LAMB1;PDIA6;TUBA4A;EEF1A1;TGFB1;H2AC11;EIF5;LAMC1;EEF2;H2AZ1;HSP90B1;RPS27A;THBS1;EEF1G;UBA1;NOTUM;FGG;SERPINC1;LYZ;SERPINA1;F9;PSMD14;ADAMTS13;RPSA;GANAB;DMBT1;HSPG2;RPS10;ALG1;B4GAT1;IGF2;RPL22;PDIA3;IGFALS;TUBB;VARS1;CTSD;CCT3;KCTD11;RPLP1;RARS1;HSPA8;SPTBN1;RPS9;TCP1;RPS16;RPS3;CCT4;NANS;HNRNPC;EIF4A1;COPA;PSMC5;CCT7;CCT8;DYNC1H1;PSMC3;RPS25;CST3;SPTAN1;RPLP0;SEC23A;RPS13;APP;BPIFB2;RPL10A;CCT2;USO1;RPL30;PSMC4;CAND1;CCT5;PSMD13;PSMC1;ETFB;HLA-A;HNRNPK;CPB2;P4HB;TUBB3;AARS1;PSMC2;PSMC6;MAN2A1;APLP2;RPS14;LMAN2;PSME2;B4GALT1;CCT6B;PSMB2;PSMA6;RPS2;PCNA;RPL12;COPB1;CAPZA1;ARF4;GLB1;CALM1;HARS1;TUBA8;ARF5;EIF3C;RPL27A;EIF3A;RPS4X;RAB14;RPLP2;PSMA7;CAPZB;PARP1;PPA2;DARS1;RUVBL1;CTSH;PSMD12;PRKDC;RPS5;PPA1;NSF;SARS1;PSMD11;RPL18;RPS11;VCAN;DDB1;RPL11;ACTR1A;TARS1;EIF3K;PSMA1;RPS3A;RAB18;PSMA4;GFPT1;PLA2G7;PSMD8;RAB7A;RPL5;RAB5C;EIF3F;LMNB2;CCT6A;COPB2;PSMB3;SEC24C;EIF3L;ARCN1;PSMA3;IARS1;CTSZ;PSMA2;PSMD3;TIMP1;KIF5B;EIF3B;RPS15A;EIF3E;PSMB1;COPG1;RPS7;ETF1;EIF4A2;NARS1;KTN1;FUCA1;QARS1;RPL14;CPE;COPS8;ACHE;HDAC1;EEF1B2;PSMD6;APOA4;APOA5;TOP1;SEC31A;MFGE8;STC2;DDX5;IGFBP7;GARS1;PSMD2;DCTN1;GPS1;DDX17;EIF2S1;RPL9;PSMA5;TPR;RAB1B;TUBB2A;ELOB;FARSB;RAB5A;SRP14;PSMB4;TTLL12;RPS8;RPL15;GNB1;RPL27;FBN1;RPL4;UBE2N;GMDS;VWA1;KARS1;CD109;NOP56;EIF2S3;NOP58;TTR;PSMD5;USP5;DTD1;FUCA2;ADAM10;USP14;RPS23;RPL7;OTUB1;EPRS1;WARS1;KNG1;PMM2;RPL29;UGGT1;RPL28;RPL26;USP7;RPL8;FN3K;DAG1;COPS3;CTSC;RAB6A;EIF3D;RPS6;PABPC1;SPON2;UBA2;RPS17;EIF4E;RPS27;PRSS23;FBXO2;RPS20;PSMD7;MARS1;DNAJC3;COPS6;IARS2;SEC24A;LARS1;IGFBP2;OS9;RPS12;PSME3;SORL1;TBCB;USP9X;EEF1D;RAB1A;RPL23;INHBE;EIF3I;CALR;RPS19;PCSK9;MAT2B;TRIM28;FBXO22;NUCB1;RAB2A;TUFM;PSMB5;ERO1A;RPL35A;RPL7A;RAB5B;PSMB6;RBX1;PSMB9;CAPZA2;MUC6;PSME1
20,prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.3454442452953549,2.4879541479848357,0.0016778523489932886,0.004603796283694664,0.031,39/41,61.72%,HSPA1A;RPS27A;PSMD14;HSPA8;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;HNRNPD;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;HSPB1;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PABPC1;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
21,prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,0.3440855789473716,2.4730481945851124,0.001639344262295082,0.004724122777473048,0.035,38/40,61.72%,VCP;RPS27A;NOTUM;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;P4HB;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
22,prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,0.34422296194274027,2.470210973178419,0.0016556291390728477,0.004431153923056114,0.036,38/40,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
23,prerank,DNA Replication Pre-Initiation R-HSA-69002,0.34422296194274027,2.470210973178419,0.0016556291390728477,0.004431153923056114,0.036,38/40,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
24,prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.45245859740356387,2.465882111933972,0.0,0.004276218471201006,0.036,12/22,11.51%,APOB;APOE;APOA1;GPC3;APOM;SDC1;AGRN;AKR1C3;SDC4;HSPG2;APOC3;RBP4
25,prerank,Retinoid Metabolism And Transport R-HSA-975634,0.45245859740356387,2.465882111933972,0.0,0.004276218471201006,0.036,12/22,11.51%,APOB;APOE;APOA1;GPC3;APOM;SDC1;AGRN;AKR1C3;SDC4;HSPG2;APOC3;RBP4
26,prerank,Neutrophil Degranulation R-HSA-6798695,0.1956128333270087,2.4628213697545323,0.0,0.004117840009304672,0.036,104/144,55.58%,C3;AHSG;LTF;PKM;GSN;QSOX1;HSPA1A;IGF2R;VCP;HSP90AB1;HSP90AA1;KRT1;TUBB4B;PPIA;EEF1A1;RAP1B;EEF2;A1BG;CAP1;LYZ;SERPINA1;PSMD14;CTSB;PYGB;XRCC5;TUBB;XRCC6;CTSD;ACLY;HSPA8;ALDOC;PIGR;HEXB;CCT8;PA2G4;DYNC1H1;PSMC3;CST3;SPTAN1;CCT2;CAND1;IDH1;PPIE;PSMD13;HLA-A;GDI2;APRT;FTH1;PSMC2;MAN2B1;KPNB1;PYGL;B4GALT1;COPB1;VAT1;GLB1;COTL1;CYB5R3;RAB14;PGM1;IQGAP1;CTSH;PSMD12;HUWE1;GSTP1;PSMD11;S100P;DIAPH1;RAB18;RAB7A;RAB5C;ARPC5;CTSZ;PSMA2;PSMD3;GGH;ILF2;PSMB1;FUCA1;AP1M1;PSMD6;CHI3L1;NIT2;PSMD2;PRDX4;PSMA5;SRP14;PFKL;IMPDH2;AGL;TTR;VCL;FTL;FUCA2;ADAM10;PRCP;CTSC;RAB6A;GAA;RNASET2;NBEAL2;PSMD7;MANBA;DNAJC3
27,prerank,GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.6734797195845995,2.4468220509316354,0.0,0.0042922462765653275,0.04,7/9,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;VWF
28,prerank,p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.6734797195845995,2.4468220509316354,0.0,0.0042922462765653275,0.04,7/9,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;VWF
29,prerank,ABC Transporter Disorders R-HSA-5619084,0.34268557844351916,2.429264467978266,0.003316749585406302,0.004511720358020771,0.045,37/39,61.72%,APOA1;VCP;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
30,prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.3427830036660176,2.4244573253902764,0.001669449081803005,0.004522116027048468,0.047,37/39,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
31,prerank,HDL Remodeling R-HSA-8964058,0.7699530516431922,2.4227774212293487,0.0,0.004418565417592887,0.047,7/7,23.32%,ALB;APOE;APOA1;APOC3;APOC2;PLTP;LCAT
32,prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.19323431885820355,2.4221129379185142,0.0,0.004284669495847647,0.047,120/153,61.72%,GLUD1;AHCY;RPS27A;PSMD14;RPSA;RPS10;HGD;RPL22;OAT;RPLP1;RARS1;RPS9;RPS16;RPS3;PSMC5;PSMC3;RPS25;ASS1;RPLP0;PHGDH;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;TYRP1;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;PSAT1;RPL12;PYCR1;HAAO;ALDH9A1;CKB;RPL27A;RPS4X;RPLP2;PSMA7;BHMT;DARS1;MAT1A;PSMD12;RPS5;SARS1;PSMD11;ALDH7A1;RPL18;RPS11;RPL11;PSMA1;RPS3A;ECHS1;PSMA4;PSMD8;RPL5;PSMB3;PSMA3;IARS1;PSMA2;PSMD3;QDPR;RPS15A;SHMT1;PSMB1;ASL;RPS7;QARS1;DLST;ACADSB;RPL14;PSMD6;PSMD2;NQO1;RPL9;PSMA5;PSMB4;RPS8;RPL15;RPL27;NNMT;RPL4;KARS1;GSR;PSMD5;SLC45A2;RPS23;RPL7;EPRS1;RPL29;RPL28;SERINC5;RPL26;RPL8;RPS6;HPD;RPS17;RPS27;RPS20;PSMD7;MARS1;LARS1;RPS12;SLC3A2;PYCR2;PSME3;RPL23;MPST;RPS19;PSMB5;RPL35A;RPL7A;PSMB6;PSMB9;PSME1
33,prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.8058651026392961,2.4215994026952576,0.0,0.004158649804793304,0.047,6/6,19.70%,CCT3;TCP1;CCT4;CCT8;CCT2;CCT5
34,prerank,Axon Guidance R-HSA-422475,0.17739035537400194,2.4068916441970463,0.002797202797202797,0.0045232298487300066,0.051,139/181,61.89%,RELN;PFN1;HSP90AB1;TLN1;HSP90AA1;CLSTN1;AGRN;LAMB1;COL6A1;LAMC1;RPS27A;CAP1;CNTN1;DPYSL5;PSMD14;GRB7;RPSA;RPS10;RPL22;CLTC;COL6A3;RPLP1;HSPA8;SPTBN1;RPS9;DPYSL2;RPS16;MYH9;RPS3;EZR;PSMC5;PSMC3;RPS25;SPTAN1;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;PSMC2;MYL6;PSMC6;RPS14;ACTR3;PSME2;PSMB2;PSMA6;RPS2;RPL12;COL6A2;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;PSMD12;RPS5;AP2M1;ARPC2;PSMD11;RPL18;RPS11;ROCK2;RPL11;PSMA1;RPS3A;MYH10;PSMA4;AP2B1;PSMD8;RHOC;RPL5;AP2A1;ARPC5;PSMB3;MSN;PSMA3;PSMA2;PSMD3;NRP1;PFN2;RPS15A;DNM2;PRKAR2A;PSMB1;RPS7;ETF1;RPL14;NEO1;PSMD6;VASP;MYH14;PSMD2;CDC42;NRP2;RPL9;PSMA5;CLTA;ELOB;PSMB4;RPS8;RPL15;RPL27;RPL4;MAGOH;PSMD5;ARPC3;ADAM10;RPS23;RPL7;RPL29;MAPK3;RPL28;RPL26;RPL8;DAG1;RPS6;PABPC1;RPS17;RPS27;RPS20;PSMD7;SDCBP;RPS12;PSME3;SEMA3A;RPL23;RPS19;ARPC1B;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
35,prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.34108785965138855,2.40205831001424,0.0016313213703099511,0.004325145455997355,0.054,36/38,61.72%,VCP;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
36,prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.34108785965138855,2.40205831001424,0.0016313213703099511,0.004325145455997355,0.054,36/38,61.72%,VCP;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
37,prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.34108785965138855,2.40205831001424,0.0016313213703099511,0.004325145455997355,0.054,36/38,61.72%,VCP;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
38,prerank,G2/M Checkpoints R-HSA-69481,0.3027513338468655,2.398384898253778,0.001594896331738437,0.004338192651943049,0.057,37/48,48.57%,H2BC11;H2BC12;RPS27A;PSMD14;YWHAZ;PSMC5;PSMC3;PSMC4;YWHAQ;PSMD13;PSMC1;YWHAE;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;YWHAG;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;YWHAH;PSMD5
39,prerank,Protein Methylation R-HSA-8876725,0.7411971830985917,2.377170045884555,0.0,0.0050756854027733675,0.067,7/7,26.18%,VCP;EEF1A1;EEF2;HSPA8;ETFB;RPS2;CALM1
40,prerank,Folding Of Actin By CCT/TriC R-HSA-390450,0.6553878273818108,2.3609812322703267,0.0,0.005364545547646648,0.077,8/9,23.90%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;CCT6B
41,prerank,Ub-specific Processing Proteases R-HSA-5689880,0.2972973603221636,2.3539335127247867,0.0,0.005697197901072146,0.083,45/50,61.72%,H2AC21;H2BC11;H2BC12;H2AC11;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;RUVBL1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;USP5;USP14;OTUB1;USP7;PSMD7;PSME3;USP9X;MAT2B;PSMB5;PSMB6;PSMB9;PSME1
42,prerank,DNA Replication R-HSA-69306,0.30709021485288845,2.333983397140256,0.0016286644951140066,0.00643594660706036,0.093,41/45,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;PSMD14;FEN1;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PCNA;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
43,prerank,Nervous System Development R-HSA-9675108,0.17015035854838803,2.31807902190875,0.0028328611898017,0.0068939233554984585,0.101,140/184,61.89%,RELN;PFN1;HSP90AB1;TLN1;HSP90AA1;CLSTN1;AGRN;LAMB1;COL6A1;LAMC1;RPS27A;CAP1;CNTN1;DPYSL5;PSMD14;GRB7;RPSA;RPS10;RPL22;CLTC;COL6A3;RPLP1;HSPA8;SPTBN1;RPS9;DPYSL2;RPS16;MYH9;RPS3;EZR;PSMC5;PSMC3;RPS25;SPTAN1;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;PSMC2;MYL6;PSMC6;RPS14;ACTR3;PSME2;PSMB2;PSMA6;RPS2;RPL12;COL6A2;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;PSMD12;RPS5;AP2M1;ARPC2;PSMD11;RPL18;RPS11;ROCK2;RPL11;PSMA1;RPS3A;MYH10;PSMA4;AP2B1;PSMD8;RHOC;RPL5;AP2A1;ARPC5;PSMB3;MSN;PSMA3;PSMA2;PSMD3;NRP1;PFN2;RPS15A;DNM2;PRKAR2A;PSMB1;RPS7;ETF1;RPL14;NEO1;PSMD6;VASP;MYH14;PSMD2;CDC42;NRP2;RPL9;PSMA5;CLTA;ELOB;PSMB4;RPS8;RPL15;RPL27;RPL4;MAGOH;LAMA2;PSMD5;ARPC3;ADAM10;RPS23;RPL7;RPL29;MAPK3;RPL28;RPL26;RPL8;DAG1;RPS6;PABPC1;RPS17;RPS27;RPS20;PSMD7;SDCBP;RPS12;PSME3;SEMA3A;RPL23;RPS19;ARPC1B;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
44,prerank,Translation R-HSA-72766,0.20203695881394176,2.3085319869422083,0.0015290519877675841,0.007492678451713065,0.113,93/118,60.84%,EEF1A1;EIF5;EEF2;RPS27A;EEF1G;RPSA;RPS10;RPL22;VARS1;RPLP1;RARS1;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPLP0;RPS13;RPL10A;RPL30;AARS1;RPS14;RPS2;RPL12;HARS1;EIF3C;RPL27A;EIF3A;RPS4X;RPLP2;PPA2;DARS1;RPS5;PPA1;SARS1;RPL18;RPS11;RPL11;TARS1;EIF3K;RPS3A;RPL5;EIF3F;EIF3L;IARS1;EIF3B;RPS15A;EIF3E;RPS7;ETF1;EIF4A2;NARS1;QARS1;RPL14;EEF1B2;GARS1;EIF2S1;RPL9;FARSB;SRP14;RPS8;RPL15;RPL27;RPL4;KARS1;EIF2S3;DTD1;RPS23;RPL7;EPRS1;WARS1;RPL29;RPL28;RPL26;RPL8;EIF3D;RPS6;PABPC1;RPS17;EIF4E;RPS27;RPS20;MARS1;IARS2;LARS1;RPS12;EEF1D;RPL23;EIF3I;RPS19;TUFM;RPL35A;RPL7A
45,prerank,Sensory Perception R-HSA-9709957,0.3317253908388579,2.308152643692745,0.0,0.007382337464696255,0.114,26/38,37.46%,APOB;APOE;APOA1;GSN;GPC3;APOM;SDC1;AGRN;AKR1C3;SDC4;HSPG2;APOC3;RBP4;SPTBN1;MYH9;EZR;SPTAN1;APOC2;CAPZA1;CALM1;CAPZB;LPL;LDLR;OR1D4;MSN;GPC6
46,prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.3377777587488935,2.30189765900489,0.0016666666666666668,0.007508106066919064,0.117,34/36,61.72%,PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;MRC2;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
47,prerank,PCP/CE Pathway R-HSA-4086400,0.30979595796690274,2.298326888854884,0.0016207455429497568,0.007402041212377828,0.118,33/44,45.65%,PFN1;RPS27A;PSMD14;CLTC;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;AP2M1;PSMD11;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;CLTA;PSMB4
48,prerank,Metabolism Of Polyamines R-HSA-351202,0.3377532661455217,2.2973527366645863,0.0016474464579901153,0.007178469355350905,0.12,34/36,61.72%,PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;NQO1;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
49,prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.3377532661455217,2.2973527366645863,0.0016474464579901153,0.007178469355350905,0.12,34/36,61.72%,PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;NQO1;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
50,prerank,Regulation Of Apoptosis R-HSA-169911,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
51,prerank,Stabilization Of P53 R-HSA-69541,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
52,prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
53,prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
54,prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
55,prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
56,prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
57,prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
58,prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
59,prerank,G1/S DNA Damage Checkpoints R-HSA-69615,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
60,prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
61,prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
62,prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
63,prerank,Degradation Of AXIN R-HSA-4641257,0.3378277978509021,2.29190886415935,0.001669449081803005,0.0057403584912317845,0.125,34/36,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
64,prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,0.313934958105972,2.2809936693769477,0.0,0.006116851639239699,0.138,21/43,19.93%,APOB;APOE;APOA1;GPC3;APOM;MOCS3;HSP90AA1;SDC1;AGRN;AKR1C3;SDC4;SHMT2;HSPG2;FASN;APOC3;RBP4;GSTO1;SLC2A1;APOC2;ALDH1L1;IDH1
65,prerank,Integrin Signaling R-HSA-354192,0.6013004011033234,2.2730856897861904,0.0,0.00633107880729727,0.146,7/10,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;VWF
66,prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,0.6013004011033234,2.2730856897861904,0.0,0.00633107880729727,0.146,7/10,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;VWF
67,prerank,Early Phase Of HIV Life Cycle R-HSA-162594,0.8036342321219225,2.2723730996930795,0.0,0.006255746714902749,0.147,5/5,19.87%,PPIA;XRCC5;XRCC6;FEN1;HMGA1
68,prerank,ABC-family Proteins Mediated Transport R-HSA-382556,0.302611637577947,2.2716274351639076,0.00322061191626409,0.006252655930952698,0.149,39/43,61.72%,APOA1;VCP;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;EIF2S1;PSMA5;PSMB4;EIF2S3;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;PSMB9;PSME1
69,prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.5655686989913624,2.2648075061621054,0.0018281535648994515,0.006905694425541996,0.158,9/11,26.77%,H2BC11;H2BC12;H1-2;H1-1;H2AZ1;H1-0;H1-5;HMGA1;HMGA2
70,prerank,Extracellular Matrix Organization R-HSA-1474244,0.21179866865642288,2.26212457282525,0.001567398119122257,0.006842473279392668,0.159,33/96,16.07%,VTN;FN1;FGB;FGA;MATN3;FBLN1;LUM;PLG;PPIB;COMP;SDC1;AGRN;PLOD1;LAMB1;TGFB1;EFEMP1;COL6A1;LAMC1;THBS1;FMOD;FGG;LAMA5;SDC4;CTSB;HSPG2;FBLN5;NID1;CTSD;PLOD2;COL6A3;LTBP4;ACTN1;COL18A1
71,prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.29177293369381846,2.2485846752324976,0.0,0.007267763820770066,0.172,43/48,61.72%,RPS27A;PSMD14;TKT;PRDX1;PSMC5;PSMC3;PHGDH;PSMC4;IDH1;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;GSTA1;PSMD6;PSMD2;NQO1;PSMA5;PSMB4;TALDO1;GSR;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
72,prerank,"Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",0.6607149969998958,2.247798857330274,0.0,0.007168205412266366,0.172,6/8,10.46%,GPC3;SDC1;AGRN;EXT1;SDC4;HSPG2
73,prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.2797718444556083,2.2453745487712298,0.003401360544217687,0.0071856550103612665,0.174,45/51,61.72%,HSPA1A;RPS27A;PSMD14;YWHAZ;HSPA8;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;HNRNPD;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;HSPB1;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;XPO1;PSMD5;PABPC1;PSMD7;ENPP2;PSME3;PSMB5;TNPO1;PSMB6;ELAVL1;PSMB9;PSME1
74,prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.31971870095703103,2.243557756613683,0.003316749585406302,0.007138186137868576,0.175,37/40,61.72%,HSP90AB1;HSP90AA1;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;MAPRE1;PSME3;PSMB5;PSMB6;PSMB9;PSME1
75,prerank,Integrin Cell Surface Interactions R-HSA-216083,0.42468378585872857,2.217117953795724,0.0017793594306049821,0.008507179481465387,0.207,10/20,10.46%,VTN;FN1;FGB;FGA;LUM;COMP;AGRN;THBS1;FGG;HSPG2
76,prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.317317073496226,2.2067535704139787,0.0016750418760469012,0.009197129394017295,0.224,36/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;ELOB;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
77,prerank,Visual Phototransduction R-HSA-2187338,0.3870671475321056,2.197291892966387,0.00530035335689046,0.009807414102428393,0.244,12/25,11.51%,APOB;APOE;APOA1;GPC3;APOM;SDC1;AGRN;AKR1C3;SDC4;HSPG2;APOC3;RBP4
78,prerank,Apoptosis R-HSA-109581,0.24691970779028768,2.1952354259131113,0.001607717041800643,0.010004515531687108,0.251,47/66,48.57%,GSN;H1-2;H1-1;RPS27A;H1-0;PSMD14;FASN;LMNA;H1-5;YWHAZ;PSMC5;PSMC3;SPTAN1;PSMC4;YWHAQ;PSMD13;PSMC1;YWHAE;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;C1QBP;YWHAG;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;DNM1L;PSMB1;PSMD6;PLEC;LMNB1;PSMD2;PSMA5;PSMB4;YWHAH;PSMD5
79,prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.4907052516243605,2.193490608439484,0.0,0.00998520253343213,0.254,11/14,30.98%,H2BC11;H2BC12;H2AZ1;LMNA;PRDX1;PRDX2;APP;RBBP4;YWHAE;C1QBP;CAPN2
80,prerank,Eukaryotic Translation Elongation R-HSA-156842,0.24969558104482456,2.1908215232976116,0.0031397174254317113,0.009996205819688877,0.259,53/63,60.84%,EEF1A1;EEF2;RPS27A;EEF1G;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;EEF1B2;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;EEF1D;RPL23;RPS19;RPL35A;RPL7A
81,prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,0.2873979578115607,2.1871902518722184,0.003316749585406302,0.010110105070564836,0.264,41/46,61.72%,APOA1;VCP;RPS27A;PSMD14;SLC2A1;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;TPR;PSMB4;PSMD5;BSG;PSMD7;OS9;SLC3A2;PSME3;PSMB5;PSMB6;PSMB9;PSME1
82,prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,0.4188830546090533,2.1866583566876074,0.0,0.010002856774828752,0.264,10/20,10.46%,VTN;SDC1;AGRN;LAMB1;TGFB1;LAMC1;THBS1;LAMA5;SDC4;HSPG2
83,prerank,Programmed Cell Death R-HSA-5357801,0.23387981613259773,2.1806037630214488,0.0030911901081916537,0.010185899277674444,0.27,47/72,44.07%,GSN;H1-2;H1-1;HSP90AA1;RPS27A;H1-0;PSMD14;FASN;LMNA;H1-5;YWHAZ;PSMC5;PSMC3;SPTAN1;PSMC4;YWHAQ;PSMD13;PSMC1;YWHAE;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;C1QBP;YWHAG;PSMA7;PSMD12;PSMD11;PDCD6IP;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;DNM1L;PSMB1;PSMD6;PLEC;CDC37;LMNB1;PSMD2;PSMA5
84,prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.3155321897405164,2.179416454493964,0.003305785123966942,0.0101371531993765,0.272,35/38,61.72%,TGFB1;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
85,prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.3153118123582386,2.1710215954667373,0.003316749585406302,0.010156802250600531,0.285,35/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
86,prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.3153118123582386,2.1710215954667373,0.003316749585406302,0.010156802250600531,0.285,35/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
87,prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.3153118123582386,2.1710215954667373,0.003316749585406302,0.010156802250600531,0.285,35/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
88,prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.3153118123582386,2.1710215954667373,0.003316749585406302,0.010156802250600531,0.285,35/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
89,prerank,Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,0.5669432931621511,2.168054608792374,0.0,0.01027222045799372,0.291,8/10,24.43%,SERPIND1;PROS1;SERPINC1;F9;VWF;SERPINA5;SERPING1;C1QBP
90,prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,0.3132244418395144,2.16318613724265,0.0033500837520938024,0.010557744362126706,0.301,34/37,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
91,prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.6277058676626373,2.1616877291691288,0.0018148820326678765,0.01054807292553575,0.306,7/8,25.66%,CCT3;TCP1;CCT4;CCT8;CCT2;CCT5;ARF4
92,prerank,Degradation Of DVL R-HSA-4641258,0.3151715733327238,2.1598508635613403,0.0016611295681063123,0.010564598649397716,0.309,35/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
93,prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.47915991728970986,-2.1555158930415392,0.006772009029345372,0.513215592845798,0.313,11/13,36.41%,GPD1L;CPNE1;STARD10;HADHB;PLD3;PCYT1A;CSNK2B;PLA1A;CPNE3;PCYT2;HADHA
94,prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.38021422916500985,2.1434852358617817,0.001639344262295082,0.01194354543864351,0.338,13/23,21.39%,ALB;APOB;APOE;APOA1;HSP90AA1;IGLL5;HSP90B1;HYOU1;AMBP;MASP1;JCHAIN;COL1A1;FTH1
95,prerank,Chaperone Mediated Autophagy R-HSA-9613829,0.7025255367980896,2.13519384410135,0.0019193857965451055,0.012415711661921819,0.349,5/6,14.55%,HSP90AB1;HSP90AA1;EEF1A1;RPS27A;HSPA8
96,prerank,Developmental Biology R-HSA-1266738,0.14685866577119114,2.1331693188848178,0.004273504273504274,0.012399677881279183,0.354,162/220,61.89%,RELN;H2BC11;H2BC12;KRT8;PFN1;KRT18;HSP90AB1;TLN1;HSP90AA1;CLSTN1;AGRN;KRT1;LAMB1;KRT9;TGFB1;COL6A1;LAMC1;H2AZ1;RPS27A;CAP1;CNTN1;DPYSL5;PSMD14;KRT19;GRB7;RPSA;RPS10;RPL22;CLTC;COL6A3;RPLP1;HSPA8;SPTBN1;RPS9;DPYSL2;KRT10;KRT2;RPS16;MYH9;RPS3;EZR;PSMC5;PSMC3;RPS25;SPTAN1;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;MYL6;PSMC6;RPS14;ACTR3;PSME2;PSMB2;PSMA6;RPS2;RPL12;COL6A2;PCSK6;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;PSMD12;RPS5;AP2M1;ARPC2;LPL;PSMD11;RPL18;RPS11;ROCK2;RPL11;PSMA1;RPS3A;MYH10;PSMA4;AP2B1;PSMD8;RHOC;RPL5;AP2A1;ARPC5;PSMB3;MSN;KRT13;KRT5;PSMA3;PSMA2;PSMD3;NRP1;PFN2;RPS15A;DNM2;PRKAR2A;PSMB1;RPS7;ETF1;PKLR;RPL14;NEO1;PSMD6;KRT74;VASP;MYH14;PSMD2;CDC42;NRP2;RPL9;PSMA5;CLTA;ELOB;PSMB4;RPS8;RPL15;ANGPTL4;RPL27;RPL4;MAGOH;KRT14;LAMA2;PSMD5;ARPC3;ADAM10;RPS23;RPL7;RPL29;MAPK3;RPL28;RPL26;RPL8;DAG1;RPS6;PABPC1;DKK1;RPS17;RPS27;RPS20;PSMD7;SDCBP;RPS12;DRAP1;PSME3;SEMA3A;RPL23;RPS19;ARPC1B;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
97,prerank,G1/S Transition R-HSA-69206,0.28721813964385456,2.129421772407946,0.0,0.012695442870461612,0.365,32/44,45.65%,RPS27A;PSMD14;PPP2CA;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PCNA;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4
98,prerank,Synthesis Of DNA R-HSA-69239,0.29751986333573155,2.1280893561833554,0.0033444816053511705,0.01267688190974495,0.37,37/41,61.72%,RPS27A;PSMD14;FEN1;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PCNA;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
99,prerank,Signaling By KIT In Disease R-HSA-9669938,-0.701466275659824,-2.117397675261183,0.004629629629629629,0.32394459406578735,0.376,6/6,30.16%,JAK2;SRC;STAT5B;STAT1;STAT3;NRAS
100,prerank,Base Excision Repair R-HSA-73884,0.6525821596244131,2.0793855108873194,0.0036900369003690036,0.01658936138135884,0.464,7/7,35.01%,H2BC11;H2BC12;H2AZ1;FEN1;PCNA;PARP1;APEX1
101,prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.294317903885997,2.0776428972210224,0.005025125628140704,0.016556402385236937,0.468,36/40,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;ELOB;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
102,prerank,Disease R-HSA-1643685,0.11597712303657262,2.0711265869273223,0.0013422818791946308,0.01706253508805946,0.481,205/373,47.11%,C3;H2AC21;FN1;FGB;FGA;APOA1;LTF;H2BC11;H2BC12;GPC3;HSPA1A;LUM;PGK1;NPM1;ENO1;AHCY;VCP;HSP90AB1;TLN1;HSP90AA1;CLSTN1;SDC1;IGLL5;AGRN;PPIA;TGFB1;H2AC11;RAP1B;EEF2;H2AZ1;RPS27A;OGN;THBS1;EEF1G;FMOD;FGG;ATIC;RAN;F9;EXT1;PSMD14;ADAMTS13;SDC4;RPSA;GANAB;HSPG2;PPP2CA;PEBP1;RPS10;GALK1;LMNA;RBP4;ALG1;SNRPD3;B4GAT1;XRCC5;YWHAZ;RPL22;TUBB;VWF;XRCC6;CLTC;RPLP1;MASP1;DCXR;EML4;FEN1;SLC2A1;SPTBN1;RPS9;PRDX1;RPS16;MYH9;RPS3;PRDX2;PSMC5;HEXB;DYNC1H1;PSMC3;RPS25;RPLP0;SEC23A;RPS13;APP;AP1B1;RPL10A;RPL30;PSMC4;YWHAQ;HMGA1;IDH1;PSMD13;PSMC1;HLA-A;HNRNPK;APRT;RBBP4;YWHAE;RRBP1;PSMC2;PSMC6;KPNB1;MAN2A1;HSD17B4;RPS14;NOTCH3;ACTR3;PSME2;B4GALT1;SERPING1;PSMB2;PSMA6;RPS2;C1QBP;RPL12;YWHAG;CORO1A;GLB1;FDXR;CALM1;PPP2R1A;SSRP1;RPL27A;RPS4X;RPLP2;PSMA7;PTGES3;OMD;PGM1;PARP1;SND1;IQGAP1;MSH3;SNRPD2;MAT1A;PSMD12;RPS5;AP2M1;CAPN2;ARPC2;PSMD11;RPL18;RPS11;VCAN;ROCK2;PDCD6IP;RPL11;PSMA1;RPS3A;PSMA4;GFPT1;AP2B1;PSMD8;RAB7A;RPL5;UBE2V1;AP2A1;YWHAB;ARPC5;PSMB3;TKFC;MSN;SEC24C;RCC1;PSMA3;PSMA2;GPC6;PSMD3;NRP1;KIF5B;SUPT16H;RPS15A;PRKAR2A;PSMB1;RPS7;RPL14;HDAC1;AP1M1;PSMD6;SEC31A;DDX5;CDC37;LMNB1;PSMD2;DCTN1;CDC42;RPL9;PSMA5;AP1G1;TPR;CLTA;ELOB;AP3B1;RAB5A;PSMB4;RBP1;IMPDH2;RPS8;RPL15;GNB1;RPL27;TALDO1;RPL4;UBE2N;XPO1
103,prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,0.2507204030254659,2.070863242429384,0.0016129032258064516,0.01690710333743603,0.481,46/54,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;PSMD14;PPP2CA;YWHAZ;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PPP2R1A;PSMA7;RUVBL1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;XPO1;PSMD5;DKK4;DKK1;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
104,prerank,Peptide Chain Elongation R-HSA-156902,0.24134098971484969,2.0656421738417987,0.011075949367088608,0.017235741693652513,0.49,50/60,60.84%,EEF1A1;EEF2;RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
105,prerank,Chromosome Maintenance R-HSA-73886,0.5173511844449993,2.0555441220581057,0.0037243947858473,0.01823202929704994,0.515,9/11,31.79%,H2BC11;H2BC12;NPM1;H2AZ1;FEN1;RBBP4;PCNA;RUVBL1;RUVBL2
106,prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.217291181671401,2.0552048976865676,0.003179650238473768,0.018081409904210793,0.516,63/78,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;EIF3C;RPL27A;EIF3A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;EIF3K;RPS3A;RPL5;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;RPL14;EIF2S1;RPL9;RPS8;RPL15;RPL27;RPL4;EIF2S3;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;EIF3D;RPS6;PABPC1;RPS17;EIF4E;RPS27;RPS20;RPS12;RPL23;EIF3I;RPS19;RPL35A;RPL7A
107,prerank,Creation Of C4 And C2 Activators R-HSA-166786,0.6880844008152149,2.055158153789234,0.0,0.01794503329731644,0.518,5/6,15.49%,IGLL5;C1R;COLEC10;MASP1;C1S
108,prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.29231070032220546,2.054732971730252,0.0067226890756302525,0.017635097431152616,0.518,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
109,prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.29231070032220546,2.054732971730252,0.0067226890756302525,0.017635097431152616,0.518,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
110,prerank,Hedgehog On State R-HSA-5632684,0.29212039874609774,2.052165028174851,0.003236245954692557,0.017717224276172654,0.523,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
111,prerank,S Phase R-HSA-69242,0.2795691430932995,2.045316711861616,0.0033222591362126247,0.01817139319521028,0.536,38/43,61.72%,RPS27A;PSMD14;FEN1;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PCNA;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
112,prerank,Activation Of C3 And C5 R-HSA-174577,0.6840768024210122,2.044604961452585,0.0,0.01806212373058991,0.537,5/6,16.13%,C3;C4A;C5;C4B;HNRNPC
113,prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
114,prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
115,prerank,Orc1 Removal From Chromatin R-HSA-68949,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
116,prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
117,prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
118,prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
119,prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.29220488233225866,2.0388035840745973,0.006666666666666667,0.017666580548393984,0.549,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
120,prerank,Host Interactions Of HIV Factors R-HSA-162909,0.2324317664387867,2.0289069364772163,0.006369426751592357,0.018543820619176005,0.569,44/63,48.57%,NPM1;PPIA;RPS27A;RAN;PSMD14;PSMC5;PSMC3;AP1B1;PSMC4;HMGA1;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;AP2M1;PSMD11;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;AP1M1;PSMD6;PSMD2;PSMA5;AP1G1;TPR;ELOB;PSMB4;XPO1;PSMD5
121,prerank,Regulation Of RAS By GAPs R-HSA-5658442,0.29182037394412935,2.028708402545072,0.0033222591362126247,0.018389288780682873,0.569,35/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
122,prerank,Signaling By NOTCH4 R-HSA-9013694,0.2772219205989461,2.0285800640934086,0.006578947368421052,0.018247298762036485,0.569,37/42,61.72%,RPS27A;PSMD14;YWHAZ;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;ADAM10;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
123,prerank,Metalloprotease DUBs R-HSA-5689901,0.7265024232498778,2.027318840912008,0.0,0.018266127796085264,0.574,4/5,9.47%,H2AC21;H2AC11;RPS27A;PSMD14
124,prerank,Selenoamino Acid Metabolism R-HSA-2408522,0.21456944589622984,2.0239349990405127,0.006134969325153374,0.018540105216866713,0.585,63/76,63.18%,AHCY;RPS27A;RPSA;RPS10;RPL22;RPLP1;RARS1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;DARS1;MAT1A;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;IARS1;RPS15A;RPS7;QARS1;RPL14;RPL9;RPS8;RPL15;RPL27;NNMT;RPL4;KARS1;GSR;RPS23;RPL7;EPRS1;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;MARS1;LARS1;RPS12;RPL23;RPS19;RPL35A;RPL7A;AIMP1;RPL18A
125,prerank,Gene Silencing By RNA R-HSA-211000,0.5371928518508322,2.018723492773117,0.0035842293906810036,0.019033820260400125,0.6,6/10,9.06%,H2BC11;H2BC12;HSP90AA1;H2AZ1;RAN;ANG
126,prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,0.28953616080270456,2.0141710534255206,0.0033500837520938024,0.019490631946649732,0.611,34/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
127,prerank,Viral mRNA Translation R-HSA-192823,0.2380837510236748,2.0122737666537525,0.012841091492776886,0.019556542963444626,0.613,49/59,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;DNAJC3;RPS12;RPL23;RPS19;RPL35A;RPL7A
128,prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.22305976731463956,2.01225592769943,0.004792332268370607,0.01940255443617341,0.613,57/70,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;EIF3C;RPL27A;EIF3A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;EIF3K;RPS3A;RPL5;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;EIF3D;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;EIF3I;RPS19;RPL35A;RPL7A
129,prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,0.2894749595116711,2.006148656876059,0.006700167504187605,0.019605532077745482,0.629,34/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
130,prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.2894749595116711,2.006148656876059,0.006700167504187605,0.019605532077745482,0.629,34/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
131,prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.2894749595116711,2.006148656876059,0.006700167504187605,0.019605532077745482,0.629,34/38,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
132,prerank,Antigen processing-Cross Presentation R-HSA-1236975,0.2549598273386524,2.006034678095421,0.003305785123966942,0.01947432185615154,0.629,43/50,62.01%,FGB;FGA;RPS27A;FGG;PSMD14;PDIA3;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;MRC2;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;CTSV;PSMD7;PSME3;CALR;PSMB5;PSMB6;PSMB9;PSME1;HLA-C
133,prerank,Selenocysteine Synthesis R-HSA-2408557,0.23815051522757397,2.0055411036080466,0.012718600953895072,0.0195282052022287,0.63,49/59,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;SARS1;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
134,prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.27427344056133,2.001602065182501,0.0065040650406504065,0.019890217233567667,0.642,36/41,61.72%,RPS27A;PSMD14;YWHAZ;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
135,prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,0.2763433602671878,2.000480430759659,0.0049504950495049506,0.01985902497673588,0.644,37/42,61.72%,IGLL5;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
136,prerank,Cellular Responses To Stimuli R-HSA-8953897,0.13653144136495418,1.994788237132665,0.005961251862891207,0.020180114757875206,0.655,154/212,61.72%,ALB;APOB;APOA1;H2BC11;H2BC12;HSPA1A;H1-2;VCP;HSP90AB1;TLN1;H1-1;HSP90AA1;PDIA6;EEF1A1;HSPA5;H2AZ1;HSP90B1;RPS27A;HYOU1;BLVRB;H1-0;PSMD14;RPSA;RPS10;LMNA;H1-5;RPL22;TKT;RPLP1;HSPA8;RPS9;BLVRA;PRDX1;RPS16;RPS3;PRDX2;PSMC5;DYNC1H1;PSMC3;RPS25;RPLP0;PHGDH;RPS13;RPL10A;RPL30;PSMC4;HMGA1;IDH1;PSMD13;HSPA13;PSMC1;P4HB;RBBP4;YWHAE;HSPA9;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;RPL12;CAPZA1;HSPA4;HMGA2;SERPINH1;RPL27A;RPS4X;RPLP2;PSMA7;PTGES3;DNAJB11;CAPZB;GPX3;ACADVL;PSMD12;ST13;RPS5;GSTP1;PSMD11;RPL18;RPS11;RPL11;ACTR1A;PSMA1;RPS3A;PSMA4;GFPT1;PSMD8;RPL5;PSMB3;PSMA3;PSMA2;PSMD3;RPS15A;PSMB1;RPS7;ETF1;RPL14;GSTA1;PSMD6;SEC31A;IGFBP7;LMNB1;PSMD2;DCTN1;NQO1;EIF2S1;RPL9;PSMA5;STIP1;TPR;ELOB;PSMB4;RPS8;RPL15;RPL27;TALDO1;RPL4;XPO1;EIF2S3;GSR;PSMD5;RPS23;RPL7;RPL29;MAPK3;PRDX3;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;PSMD7;DNAJC3;RPS12;PSME3;RPL23;CALR;RPS19;ATP6V1A;PSMB5;ERO1A;RPL35A;RPL7A;DNAJA2;PSMB6;RBX1;PSMB9;CAPZA2;PSME1
137,prerank,Cellular Responses To Stress R-HSA-2262752,0.13653144136495418,1.994788237132665,0.005961251862891207,0.020180114757875206,0.655,154/212,61.72%,ALB;APOB;APOA1;H2BC11;H2BC12;HSPA1A;H1-2;VCP;HSP90AB1;TLN1;H1-1;HSP90AA1;PDIA6;EEF1A1;HSPA5;H2AZ1;HSP90B1;RPS27A;HYOU1;BLVRB;H1-0;PSMD14;RPSA;RPS10;LMNA;H1-5;RPL22;TKT;RPLP1;HSPA8;RPS9;BLVRA;PRDX1;RPS16;RPS3;PRDX2;PSMC5;DYNC1H1;PSMC3;RPS25;RPLP0;PHGDH;RPS13;RPL10A;RPL30;PSMC4;HMGA1;IDH1;PSMD13;HSPA13;PSMC1;P4HB;RBBP4;YWHAE;HSPA9;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;RPL12;CAPZA1;HSPA4;HMGA2;SERPINH1;RPL27A;RPS4X;RPLP2;PSMA7;PTGES3;DNAJB11;CAPZB;GPX3;ACADVL;PSMD12;ST13;RPS5;GSTP1;PSMD11;RPL18;RPS11;RPL11;ACTR1A;PSMA1;RPS3A;PSMA4;GFPT1;PSMD8;RPL5;PSMB3;PSMA3;PSMA2;PSMD3;RPS15A;PSMB1;RPS7;ETF1;RPL14;GSTA1;PSMD6;SEC31A;IGFBP7;LMNB1;PSMD2;DCTN1;NQO1;EIF2S1;RPL9;PSMA5;STIP1;TPR;ELOB;PSMB4;RPS8;RPL15;RPL27;TALDO1;RPL4;XPO1;EIF2S3;GSR;PSMD5;RPS23;RPL7;RPL29;MAPK3;PRDX3;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;PSMD7;DNAJC3;RPS12;PSME3;RPL23;CALR;RPS19;ATP6V1A;PSMB5;ERO1A;RPL35A;RPL7A;DNAJA2;PSMB6;RBX1;PSMB9;CAPZA2;PSME1
138,prerank,Telomere Maintenance R-HSA-157579,0.5720500411412137,1.9934387560299445,0.009057971014492754,0.02024452207049857,0.658,7/8,31.79%,H2BC11;H2BC12;H2AZ1;FEN1;PCNA;RUVBL1;RUVBL2
139,prerank,Plasma Lipoprotein Remodeling R-HSA-8963899,0.4000267914890315,1.992840235301528,0.0036101083032490976,0.020159123183547772,0.66,17/19,50.56%,ALB;APOB;APOE;APOA1;ANGPTL8;APOC3;APOC2;PLTP;P4HB;LCAT;PCSK6;LPL;APOA4;APOA5;ANGPTL4;ANGPTL3;PCSK5
140,prerank,HIV Infection R-HSA-162906,0.21378565295143548,1.991125077872768,0.004658385093167702,0.02023144901036935,0.663,48/74,45.65%,NPM1;PPIA;RPS27A;RAN;PSMD14;XRCC5;XRCC6;FEN1;PSMC5;PSMC3;AP1B1;PSMC4;HMGA1;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;SSRP1;PSMA7;PSMD12;AP2M1;PSMD11;PDCD6IP;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;SUPT16H;PSMB1;AP1M1;PSMD6;PSMD2;PSMA5;AP1G1;TPR;ELOB;PSMB4
141,prerank,Influenza Infection R-HSA-168255,0.21060321953967226,1.9816380508520903,0.012539184952978056,0.02132133153886091,0.688,60/75,60.84%,HSPA1A;HSP90AA1;TGFB1;RPS27A;RAN;RPSA;RPS10;RPL22;CLTC;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;KPNB1;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;PARP1;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;TPR;CLTA;RPS8;RPL15;RPL27;RPL4;XPO1;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;DNAJC3;RPS12;RPL23;CALR;RPS19;RPL35A;RPL7A
142,prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.20702975862008147,1.975270512768828,0.009508716323296355,0.021890071797843937,0.703,63/79,60.84%,EIF5;RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;EIF3C;RPL27A;EIF3A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;EIF3K;RPS3A;RPL5;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;RPL14;EIF2S1;RPL9;RPS8;RPL15;RPL27;RPL4;EIF2S3;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;EIF3D;RPS6;RPS17;EIF4E;RPS27;RPS20;RPS12;RPL23;EIF3I;RPS19;RPL35A;RPL7A
143,prerank,Metabolism Of Carbohydrates R-HSA-71387,0.19389076369773695,1.9724125199230953,0.009230769230769232,0.022084848457741262,0.709,38/84,28.40%,PKM;GPC3;LUM;PGK1;ENO1;SDC1;AGRN;CEMIP;RPS27A;OGN;FMOD;EXT1;SDC4;HSPG2;PPP2CA;PYGB;GALK1;B4GAT1;ALDH1A1;UGP2;TKT;DCXR;SLC2A1;ALDOC;AKR1A1;TPI1;HEXB;MDH2;PHGDH;MAN2B1;PYGL;PCK2;B4GALT1;GLB1;CALM1;PPP2R1A;OMD;PGM1
144,prerank,Cellular Response To Hypoxia R-HSA-1234174,0.2728733400491,1.9642317262501972,0.00825082508250825,0.023029042162100277,0.726,36/41,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;ELOB;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
145,prerank,RAC3 GTPase Cycle R-HSA-9013423,-0.43671277017036203,-1.963321914355585,0.011737089201877934,0.5430621734226457,0.681,10/13,32.73%,SRGAP2;FERMT2;ARHGAP17;ABI1;SLC1A5;ESYT1;ARHGAP1;TMPO;NCKAP1;ITGB1
146,prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.5956572769953051,-1.961102826278909,0.015384615384615385,0.41330234445135006,0.686,7/7,40.74%,POLR2H;STAT5B;NCBP1;STAT1;STAT3;NRAS;CPSF6
147,prerank,UCH Proteinases R-HSA-5689603,0.26562906511918766,1.9607101417403947,0.008090614886731391,0.02328873510697105,0.728,31/44,45.65%,H2AC21;TGFB1;H2AC11;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;RUVBL1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4
148,prerank,Hedgehog Off State R-HSA-5610787,0.2730399688613122,1.9552131069357672,0.008333333333333333,0.023794879843871863,0.739,36/41,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PRKAR2A;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
149,prerank,Chylomicron Remodeling R-HSA-8963901,0.5883734586024663,1.9527959087435929,0.0,0.023954718779559892,0.741,8/8,41.44%,APOB;APOE;APOA1;APOC3;APOC2;LPL;APOA4;APOA5
150,prerank,Downstream TCR Signaling R-HSA-202424,0.2731916696182358,1.9527254906491576,0.013266998341625208,0.023799982573742953,0.742,36/41,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
151,prerank,Signaling By NOTCH R-HSA-157118,0.2361138928968708,1.947973340273588,0.004966887417218543,0.024316909796427102,0.753,46/55,61.72%,H2BC11;H2BC12;H2AZ1;RPS27A;CNTN1;PSMD14;YWHAZ;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;NOTCH3;PSME2;B4GALT1;PSMB2;PSMA6;PSMA7;PSMD12;YBX1;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;ADAM10;RAB6A;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
152,prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,0.2430637404833708,1.9453398949503615,0.013050570962479609,0.02454302337614607,0.758,44/52,61.72%,VCP;RPS27A;PSMD14;TKT;PRDX1;PSMC5;PSMC3;PHGDH;PSMC4;IDH1;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;GSTA1;PSMD6;PSMD2;NQO1;PSMA5;PSMB4;TALDO1;GSR;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
153,prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,0.27324829023201647,1.9424978133649051,0.004991680532445923,0.02479834868212131,0.766,36/41,61.72%,TGFB1;RPS27A;PSMD14;CCN2;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
154,prerank,Syndecan Interactions R-HSA-3000170,0.5329643329416737,1.9369555604447921,0.0148975791433892,0.02550647962573119,0.778,6/9,15.72%,VTN;SDC1;TGFB1;THBS1;SDC4;ACTN1
155,prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.2543448949113915,1.9323061333731375,0.005119453924914676,0.02589973924010873,0.783,39/47,59.03%,RPS27A;RPSA;RPS10;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPS13;RPS14;RPS2;EIF3C;EIF3A;RPS4X;RPS5;RPS11;EIF3K;RPS3A;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;EIF2S1;RPS8;EIF2S3;RPS23;EIF3D;RPS6;PABPC1;RPS17;EIF4E;RPS27;RPS20;RPS12;EIF3I;RPS19
156,prerank,Translation Initiation Complex Formation R-HSA-72649,0.2543448949113915,1.9323061333731375,0.005119453924914676,0.02589973924010873,0.783,39/47,59.03%,RPS27A;RPSA;RPS10;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPS13;RPS14;RPS2;EIF3C;EIF3A;RPS4X;RPS5;RPS11;EIF3K;RPS3A;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;EIF2S1;RPS8;EIF2S3;RPS23;EIF3D;RPS6;PABPC1;RPS17;EIF4E;RPS27;RPS20;RPS12;EIF3I;RPS19
157,prerank,Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.5969021327000898,1.9297119423328315,0.0074487895716946,0.02610823335656616,0.787,6/7,26.77%,H1-2;H1-1;H1-0;H1-5;HMGA1;HMGA2
158,prerank,Cap-dependent Translation Initiation R-HSA-72737,0.1999488544564929,1.929113739535646,0.00794912559618442,0.02601776065907024,0.787,64/81,60.84%,EIF5;RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;EIF3C;RPL27A;EIF3A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;EIF3K;RPS3A;RPL5;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;RPL14;EIF2S1;RPL9;RPS8;RPL15;RPL27;RPL4;EIF2S3;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;EIF3D;RPS6;PABPC1;RPS17;EIF4E;RPS27;RPS20;RPS12;RPL23;EIF3I;RPS19;RPL35A;RPL7A
159,prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,0.5132045473404039,1.9286821801262561,0.009398496240601503,0.025889714004988695,0.787,6/10,10.46%,GPC3;VCP;SDC1;AGRN;SDC4;HSPG2
160,prerank,Eukaryotic Translation Termination R-HSA-72764,0.22447176615349376,1.9282784994938191,0.015723270440251572,0.025794088238843726,0.788,49/60,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;ETF1;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
161,prerank,ER-Phagosome Pathway R-HSA-1236974,0.24898667940729996,1.9272208607851604,0.008264462809917356,0.025760862622876284,0.792,41/48,62.01%,FGB;FGA;RPS27A;FGG;PSMD14;PDIA3;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;CALR;PSMB5;PSMB6;PSMB9;PSME1;HLA-C
162,prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3670525859713955,1.9227357968908638,0.010256410256410256,0.026290499862523325,0.801,9/20,10.46%,GPC3;LUM;SDC1;AGRN;OGN;FMOD;EXT1;SDC4;HSPG2
163,prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.2545675590852326,1.9164040793545154,0.007042253521126761,0.027183618697293674,0.812,39/47,59.03%,EIF5;RPS27A;RPSA;RPS10;RPS9;RPS16;RPS3;EIF4A1;RPS25;RPS13;RPS14;RPS2;EIF3C;EIF3A;RPS4X;RPS5;RPS11;EIF3K;RPS3A;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF4A2;EIF2S1;RPS8;EIF2S3;RPS23;EIF3D;RPS6;RPS17;EIF4E;RPS27;RPS20;RPS12;EIF3I;RPS19
164,prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.2703324930213336,1.9154784487119132,0.008237232289950576,0.02695245643771336,0.814,35/40,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
165,prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.2703324930213336,1.9154784487119132,0.008237232289950576,0.02695245643771336,0.814,35/40,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
166,prerank,ECM Proteoglycans R-HSA-3000178,0.3147199189803621,1.9141113555477398,0.015358361774744027,0.026994698439231423,0.817,11/28,10.46%,VTN;MATN3;LUM;COMP;AGRN;LAMB1;TGFB1;LAMC1;FMOD;LAMA5;HSPG2
167,prerank,Prolactin Receptor Signaling R-HSA-1170546,-0.6158357771260997,-1.9035711008773715,0.006535947712418301,0.46313157470708743,0.799,6/6,38.69%,JAK2;SKP1;STAT5B;CUL1;PTPN11;RBX1
168,prerank,RHO GTPases Activate PKNs R-HSA-5625740,0.40964915627771203,1.9031157466638229,0.010752688172043012,0.028797587912366897,0.836,12/16,35.48%,H2BC11;H2BC12;H2AZ1;YWHAZ;MYH9;YWHAQ;YWHAE;MYL6;YWHAG;MYH10;RHOC;YWHAB
169,prerank,Signaling By Hedgehog R-HSA-5358351,0.2474347526536818,1.900246578516895,0.00487012987012987,0.029113779907682737,0.84,40/47,61.72%,VCP;RPS27A;NOTUM;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;P4HB;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PRKAR2A;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;OS9;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
170,prerank,Growth Hormone Receptor Signaling R-HSA-982772,-0.6204177581073846,-1.8963434582274765,0.004210526315789474,0.4034141480407277,0.815,5/6,21.04%,JAK2;STAT5B;STAT1;STAT3;MAPK1
171,prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.22467485025185652,1.8942084985274483,0.01938610662358643,0.03009593151902625,0.846,49/60,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;SRP14;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
172,prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.2702723264040069,1.8927601964672052,0.0068143100511073255,0.030161757568804386,0.849,35/40,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
173,prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,0.24947023843528102,1.8895051200128152,0.004893964110929853,0.030500150379477148,0.851,31/45,45.65%,CLSTN1;IGLL5;PPIA;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4
174,prerank,Infectious Disease R-HSA-5663205,0.1238562518170315,1.887558595762849,0.011283497884344146,0.030698672068337655,0.853,184/253,63.24%,C3;H2AC21;LTF;H2BC11;H2BC12;GPC3;HSPA1A;PGK1;NPM1;ENO1;VCP;HSP90AB1;HSP90AA1;SDC1;IGLL5;AGRN;PPIA;TGFB1;H2AC11;EEF2;RPS27A;RAN;PSMD14;SDC4;RPSA;GANAB;HSPG2;RPS10;SNRPD3;XRCC5;YWHAZ;RPL22;TUBB;XRCC6;CLTC;RPLP1;MASP1;FEN1;RPS9;RPS16;MYH9;RPS3;PSMC5;DYNC1H1;PSMC3;RPS25;RPLP0;SEC23A;RPS13;AP1B1;RPL10A;RPL30;PSMC4;YWHAQ;HMGA1;PSMD13;PSMC1;HLA-A;HNRNPK;RBBP4;YWHAE;PSMC2;PSMC6;KPNB1;MAN2A1;HSD17B4;RPS14;ACTR3;PSME2;PSMB2;PSMA6;RPS2;RPL12;YWHAG;CORO1A;CALM1;SSRP1;RPL27A;RPS4X;RPLP2;PSMA7;PTGES3;PARP1;SNRPD2;PSMD12;RPS5;AP2M1;ARPC2;PSMD11;RPL18;RPS11;ROCK2;PDCD6IP;RPL11;PSMA1;RPS3A;PSMA4;AP2B1;PSMD8;RAB7A;RPL5;UBE2V1;AP2A1;YWHAB;ARPC5;PSMB3;TKFC;SEC24C;RCC1;PSMA3;PSMA2;GPC6;PSMD3;NRP1;SUPT16H;RPS15A;PRKAR2A;PSMB1;RPS7;RPL14;HDAC1;AP1M1;PSMD6;DDX5;PSMD2;CDC42;RPL9;PSMA5;AP1G1;TPR;CLTA;ELOB;RAB5A;PSMB4;IMPDH2;RPS8;RPL15;GNB1;RPL27;RPL4;UBE2N;XPO1;YWHAH;PSMD5;ARPC3;RPS23;RPL7;RPL29;MAPK3;RPL28;RPL26;RPL8;MASP2;RPS6;RPS17;RPS27;RPS20;PSMD7;DNAJC3;SEC24A;RPS12;PSME3;RPL23;CALR;RPS19;ARPC1B;TRIM28;SNRPE;TUFM;PSMB5;RPL35A;RPL7A;PSMB6;RBX1;PSMB9;PSME1;PRMT1;MAP2K1;RRM1;HLA-C;SNRPF;NMT1;RPL18A;CYFIP2
175,prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.6758499413833529,-1.8710547649140685,0.010141987829614604,0.39580517656962655,0.856,5/5,32.67%,EXOSC6;ASNS;EXOSC4;KHSRP;IGFBP1
176,prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.5749076961770389,1.8698275247259921,0.011090573012939002,0.033546441758665994,0.886,6/7,29.46%,H2BC11;H2BC12;NPM1;H2AZ1;RBBP4;RUVBL1
177,prerank,Metabolism R-HSA-1430728,0.10261634858026104,1.8682609856763035,0.01032258064516129,0.03376016314264603,0.887,302/423,64.64%,ALB;APOB;APOE;GLUD1;APOA1;PKM;GPC3;LUM;PGK1;APOM;ENO1;AHCY;MOCS3;HSP90AB1;LDHA;HSP90AA1;CLSTN1;SDC1;AGRN;CEMIP;GSTA5;RPS27A;ATP5F1B;OGN;FMOD;ATIC;GC;RAN;AKR1C3;BLVRB;EXT1;UGDH;PSMD14;SDC4;RPSA;SHMT2;HSPG2;CS;PPP2CA;FASN;RPS10;PYGB;GALK1;APOC3;RBP4;HGD;B4GAT1;RPL22;OAT;ALDH1A1;UGP2;TKT;GSTO1;RPLP1;ACLY;DCXR;RARS1;SLC2A1;RPS9;BLVRA;ALDOC;RPS16;RPS3;AKR1A1;TPI1;LDHB;PSMC5;HEXB;MDH2;PSMC3;RPS25;ASS1;RPLP0;PHGDH;SEC23A;RPS13;PAICS;APOC2;RPL10A;RPL30;ALDH1L1;PSMC4;ADH5;IDH1;PSMD13;PLA2G2A;PSMC1;ETFB;ESD;APRT;TYRP1;ADK;PSMC2;PSMC6;MAN2B1;ACOT13;KPNB1;HSD17B4;RPS14;PYGL;PCK2;PSME2;B4GALT1;PSMB2;PSMA6;RPS2;PSAT1;RPL12;PYCR1;HAAO;ALDH9A1;NDUFA9;ACO2;GLB1;FDXR;CALM1;PPP2R1A;CKB;CYB5R3;MTHFD1;RPL27A;RPS4X;RAB14;RPLP2;PSMA7;PTGES3;BHMT;MAT2A;OMD;PGM1;PPA2;DARS1;IQGAP1;ACADVL;MAT1A;PSMD12;SORD;RPS5;GSTP1;BPGM;PPA1;SARS1;LPL;PSMD11;CNDP2;EPHX1;AKR7A2;ATP5F1A;GMPR2;ALDH7A1;RPL18;RPS11;LDLR;VCAN;AKR1B1;CBR1;RPL11;PSMA1;RPS3A;ECHS1;DECR1;PSMA4;PSMD8;ACSS3;RPL5;CRYL1;ETFA;PSMB3;TKFC;SEC24C;PSMA3;ALDH2;IARS1;PSMA2;GPC6;GMPS;PSMD3;QDPR;RPS15A;DNM2;PRKAR2A;SHMT1;PSMB1;ASL;RPS7;QARS1;PKLR;DLST;ACADSB;RPL14;GSTM3;GSTA1;ACHE;NDUFS1;PSMD6;APOA4;APOA5;ADSL;GSTM2;PSMD2;NQO1;RPL9;PSMA5;TPR;IDH2;AKR1C2;RAB5A;ACOT7;SULT1A1;PSMB4;PFKL;SDHA;RBP1;IMPDH2;RPS8;RPL15;AMPD2;ANGPTL4;GNB1;RPL27;NNMT;TALDO1;RPL4;GART;KARS1;CBR3;GSR;AGL;TTR;PSMD5;SLC45A2;GLO1;RPS23;RPL7;PFAS;FBP1;EPRS1;UROD;DPYD;CHPF;RPL29;ENO3;RPL28;SERINC5;RPL26;RPL8;PPP1CA;RPS6;GAA;BSG;HPD;RPS17;RPS27;HMGCS1;RPS20;PSMD7;MARS1;ENPP2;MANBA;SEC24A;LARS1;ENO2;RPS12;SLC3A2;AK4;PYCR2;PPP1CB;AKR1B10;PSME3;LRP2;NDUFV1;RPL23;LYPLA1;MPST;RPS19;MAT2B;SULT2A1;GYS1;PSMB5;RPL35A;RPL7A;PSMB6;SLC16A3;PSMB9;PSME1;RRM1;NT5C2;DDAH2;CA3;AIMP1;HADH;RPL18A;ALDOB;HADHA;SDHB;CTPS1;GCLC;ADSS1;CTSA;CMPK1;FABP1;GLCE
178,prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.26675659949141156,1.8646818386071284,0.008460236886632826,0.03375455809726131,0.887,34/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
179,prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.26675659949141156,1.8646818386071284,0.008460236886632826,0.03375455809726131,0.887,34/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
180,prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.26675659949141156,1.8646818386071284,0.008460236886632826,0.03375455809726131,0.887,34/39,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
181,prerank,ALK Mutants Bind TKIs R-HSA-9700645,0.6727214270126503,1.8640548335709421,0.0148975791433892,0.03367216601894277,0.887,4/5,14.32%,FN1;NPM1;CLTC;EML4
182,prerank,TCR Signaling R-HSA-202403,0.2565120750851466,1.8614772887812363,0.01001669449081803,0.0340026976657653,0.891,37/43,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;VASP;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
183,prerank,Chylomicron Assembly R-HSA-8963888,0.5523644329489311,1.8563807347724208,0.011009174311926606,0.03478694797838351,0.893,6/8,21.45%,APOB;APOE;APOA1;APOC3;APOC2;P4HB
184,prerank,Interleukin-1 Signaling R-HSA-9020702,0.2450949416011967,1.8530716393227424,0.018363939899833055,0.03508713504752911,0.896,40/47,61.89%,RPS27A;PSMD14;PSMC5;PSMC3;APP;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;USP14;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
185,prerank,Cell Cycle Checkpoints R-HSA-69620,0.20225617063566284,1.8529719129774718,0.017001545595054096,0.03490462028776045,0.896,53/66,61.72%,H2BC11;H2BC12;RPS27A;PSMD14;PPP2CA;YWHAZ;PSMC5;DYNC1H1;PSMC3;PSMC4;YWHAQ;PSMD13;PSMC1;YWHAE;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;YWHAG;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PAFAH1B1;PSMA5;PSMB4;UBE2N;XPO1;YWHAH;PSMD5;RCC2;RPS27;PSMD7;NUDC;MAPRE1;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
186,prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.2574621113944789,1.8423009805670825,0.013793103448275862,0.0369195688225539,0.904,35/42,59.03%,RPS27A;RPSA;RPS10;RPS9;RPS16;RPS3;RPS25;RPS13;RPS14;RPS2;EIF3C;EIF3A;RPS4X;RPS5;RPS11;EIF3K;RPS3A;EIF3F;EIF3L;EIF3B;RPS15A;EIF3E;RPS7;EIF2S1;RPS8;EIF2S3;RPS23;EIF3D;RPS6;RPS17;RPS27;RPS20;RPS12;EIF3I;RPS19
187,prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.46914054957396206,-1.834299841232472,0.017391304347826087,0.43213844865686074,0.898,8/10,32.73%,GNAI2;GNB4;SRC;ARRB1;GNB2;PDE2A;PRKAR1A;ITGB1
188,prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.214607008283125,1.8342746373508922,0.0224,0.03845155516255173,0.912,50/62,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;EIF2S1;RPL9;RPS8;RPL15;RPL27;RPL4;EIF2S3;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
189,prerank,HS-GAG Biosynthesis R-HSA-2022928,0.46462355550238793,1.8304194720760392,0.01971326164874552,0.03911677486621914,0.914,6/11,10.46%,GPC3;SDC1;AGRN;EXT1;SDC4;HSPG2
190,prerank,HSF1 Activation R-HSA-3371511,0.4662978712082384,1.8283910882080379,0.011194029850746268,0.03938509984665673,0.917,8/11,27.82%,HSPA1A;VCP;HSP90AB1;HSP90AA1;EEF1A1;YWHAE;SERPINH1;PTGES3
191,prerank,Cellular Response To Chemical Stress R-HSA-9711123,0.2042531595899894,1.8273381627320422,0.017241379310344827,0.03945347077440427,0.918,55/66,64.47%,ALB;VCP;RPS27A;BLVRB;PSMD14;TKT;BLVRA;PRDX1;PRDX2;PSMC5;PSMC3;PHGDH;PSMC4;IDH1;PSMD13;PSMC1;P4HB;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;GPX3;PSMD12;GSTP1;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;GSTA1;PSMD6;PSMD2;NQO1;PSMA5;PSMB4;TALDO1;GSR;PSMD5;PRDX3;PSMD7;PSME3;PSMB5;ERO1A;PSMB6;RBX1;PSMB9;PSME1;GCLC;FABP1
192,prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,0.2278613153425538,1.826831727060018,0.013050570962479609,0.03933166256125926,0.918,35/52,46.29%,PFN1;RPS27A;PSMD14;CLTC;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;AP2M1;PSMD11;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;CLTA;PSMB4;GNB1
193,prerank,Interferon Gamma Signaling R-HSA-877300,-0.4352674816993154,-1.8224427726461083,0.008714596949891068,0.406851762334809,0.908,11/12,47.98%,B2M;CD44;HLA-G;JAK2;TRIM25;STAT1;NCAM1;PTPN11;HLA-C;ICAM1;VCAM1
194,prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.24149090868368034,1.8183680049727056,0.013179571663920923,0.040874471158278615,0.927,32/47,45.65%,RPS27A;PSMD14;PPP2CA;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PCNA;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4
195,prerank,Interleukin-20 Family Signaling R-HSA-8854691,-0.6500586166471277,-1.8179790678004506,0.0189873417721519,0.3754845429643441,0.911,5/5,35.24%,JAK2;STAT5B;STAT1;STAT3;PTPN11
196,prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.20271398454491324,1.8176498853000973,0.025196850393700787,0.040785142063792613,0.927,54/68,60.84%,RPS27A;RPSA;PPP2CA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;PPP2R1A;RPL27A;RPS4X;RPLP2;EIF4A3;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;ETF1;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;MAGOH;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;PABPC1;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
197,prerank,RAC1 GTPase Cycle R-HSA-9013149,-0.34660328841628024,-1.8079214730283268,0.014319809069212411,0.3589531109729991,0.927,13/18,36.88%,SRGAP2;FERMT2;IQGAP2;ARHGDIA;ARHGAP17;ABI1;SLC1A5;ESYT1;ARHGAP1;TMPO;NCKAP1;ITGB1;CYFIP2
198,prerank,Phospholipid Metabolism R-HSA-1483257,-0.34895199519680686,-1.805466359978195,0.01932367149758454,0.33304416131482634,0.927,13/18,36.41%,RAB4A;GPD1L;PIP4K2A;CPNE1;STARD10;HADHB;PLD3;PCYT1A;CSNK2B;PLA1A;CPNE3;PCYT2;HADHA
199,prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.24158758254929383,1.804118771414341,0.01669449081803005,0.0440844104511395,0.941,38/45,61.72%,RPS27A;PSMD14;PPP2CA;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
200,prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,0.24180437540488095,1.8030807279917198,0.0165016501650165,0.044190050161963645,0.944,32/45,48.57%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;SEPTIN7;PSMB3;PSMA3;PSMA2;HSPB1;PSMD3;PSMB1;PSMD6;PSMD2;CDC42;PSMA5;PSMB4;XPO1;PSMD5
201,prerank,Downstream Signal Transduction R-HSA-186763,-0.5110668012831513,-1.7996470852528546,0.008676789587852495,0.3159929722235502,0.931,7/8,35.77%,SRC;STAT5B;STAT1;STAT3;NRAS;PTPN11;PDGFA
202,prerank,Signaling By SCF-KIT R-HSA-1433557,-0.5157534724094116,-1.79366737345904,0.013333333333333334,0.3030415881565664,0.937,7/8,35.24%,JAK2;SRC;STAT5B;STAT1;STAT3;NRAS;PTPN11
203,prerank,Diseases Of Glycosylation R-HSA-3781865,0.2446655524972287,1.7902075414460374,0.021103896103896104,0.04738578477526514,0.951,14/41,11.81%,GPC3;LUM;SDC1;AGRN;OGN;THBS1;FMOD;EXT1;ADAMTS13;SDC4;HSPG2;GALK1;ALG1;B4GAT1
204,prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.4225484380637359,-1.7610763831918042,0.01643192488262911,0.3406877978040191,0.96,10/11,48.33%,CSTF2;CPSF1;PABPN1;NCBP1;NUDT21;SNRPB;SNRPF;SNRPE;CPSF6;CSTF3
205,prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.2018512457133042,1.757125504313968,0.03189792663476874,0.056951189616508455,0.972,50/63,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;ETF1;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;PABPC1;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;RPL35A;RPL7A
206,prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,0.3191694384887649,1.7568715731271802,0.027522935779816515,0.056786748144619696,0.972,9/23,9.70%,APOB;FN1;PROS1;SDC1;IGLL5;PPIA;TGFB1;SDC4;GRB7
207,prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,0.19700044079499865,1.7550550179086786,0.04285714285714286,0.057068587171078794,0.974,52/66,60.84%,HSP90AA1;RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;PARP1;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;TPR;RPS8;RPL15;RPL27;RPL4;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;DNAJC3;RPS12;RPL23;RPS19;RPL35A;RPL7A
208,prerank,Scavenging By Class A Receptors R-HSA-3000480,0.44245242115841044,1.753000657487124,0.022968197879858657,0.057260309551169356,0.977,7/11,21.39%,APOB;APOE;APOA1;HSP90B1;MASP1;COL1A1;FTH1
209,prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.48638786935390554,1.7484283176018443,0.02490421455938697,0.05831770407826299,0.98,7/9,30.51%,H2BC11;H2BC12;VCP;RPS27A;HLA-A;PCNA;PRKDC
210,prerank,Keratinization R-HSA-6805567,0.38792579567138774,1.743888413983762,0.01971326164874552,0.059462961642791974,0.98,12/14,48.28%,KRT8;KRT18;KRT1;KRT9;KRT19;KRT10;KRT2;PCSK6;KRT13;KRT5;KRT74;KRT14
211,prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.2259180243608342,1.736542706525201,0.02155887230514096,0.06159651574721705,0.981,39/47,61.72%,IGLL5;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;MAPK3;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
212,prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.23401848294252456,1.731563819674762,0.02321724709784411,0.06296388962843923,0.985,29/43,45.65%,PPIA;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4
213,prerank,Signaling By Insulin Receptor R-HSA-74752,-0.5211267605633803,-1.7315165566073116,0.022587268993839837,0.3757211317128191,0.977,7/7,48.16%,ATP6AP1;MAPK1;NRAS;ATP6V1B2;PTPN11;ATP6V1A;MAPK3
214,prerank,RAF/MAP Kinase Cascade R-HSA-5673001,0.18507583706797517,1.726357730437298,0.027331189710610933,0.06448148792372292,0.987,55/70,61.89%,FN1;FGB;FGA;TLN1;RAP1B;RPS27A;FGG;PSMD14;PPP2CA;PEBP1;VWF;SPTBN1;PSMC5;PSMC3;SPTAN1;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;IQGAP1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;VCL;MAPK3;PSMD7;PPP1CB;PSME3;LYPLA1;PSMB5;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
215,prerank,Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) R-HSA-3656244,0.5713836999164862,1.726355927675222,0.022099447513812154,0.0641590804841043,0.987,5/6,28.23%,LUM;OGN;FMOD;B4GALT1;OMD
216,prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,0.21770481510176967,1.7255989031086272,0.018333333333333333,0.06403829095586251,0.987,41/50,61.78%,H2BC11;H2BC12;H2AZ1;RPS27A;THBS1;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;CTSV;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1;PRMT1
217,prerank,Cilium Assembly R-HSA-5617833,0.2741411470442268,1.7237414543063192,0.03152364273204904,0.06433748328786515,0.988,15/29,26.24%,HSP90AA1;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT8;DYNC1H1;CCT2;CCT5;YWHAE;YWHAG;ARF4;PPP2R1A
218,prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.47929897164340596,1.723735211231342,0.025193798449612403,0.06402054987265399,0.988,7/9,30.98%,LMNA;PRDX1;PRDX2;APP;YWHAE;C1QBP;CAPN2
219,prerank,Scavenging Of Heme From Plasma R-HSA-2168880,0.5108272726610958,1.7236005893181534,0.0299625468164794,0.06374226766321363,0.988,5/8,14.38%,ALB;APOA1;IGLL5;AMBP;JCHAIN
220,prerank,Signaling By Interleukins R-HSA-449147,0.15910394991791502,1.720956344241536,0.02511773940345369,0.06452781930169255,0.988,62/102,47.17%,FN1;F13A1;HSP90AA1;CLSTN1;SDC1;PPIA;TGFB1;RAP1B;HSP90B1;RPS27A;LAMA5;PSMD14;PPP2CA;YWHAZ;GSTO1;HSPA8;TCP1;PSMC5;PSMC3;CRLF1;RPLP0;APP;PSMC4;PSMD13;PSMC1;P4HB;HSPA9;PSMC2;PSMC6;LBP;PSME2;PSMB2;PSMA6;CAPZA1;PPP2R1A;PSMA7;FSCN1;PSMD12;CCL20;PSMD11;HNRNPA2B1;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;MSN;PSMA3;PSMA2;PSMD3;TIMP1;PSMB1;PSMD6;LMNB1;PSMD2;CDC42;PSMA5;HNRNPF;PSMB4;TALDO1;UBE2N;COL1A2
221,prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.49604985145500763,1.7172878077725298,0.04,0.06561666808832653,0.99,6/8,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;TUBB3;TUBA8
222,prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.5736070381231672,1.7162418590519732,0.03046594982078853,0.06569667338096238,0.99,6/6,42.84%,MYH9;MYL6;ROCK2;MYH10;RHOC;MYH14
223,prerank,Signal Amplification R-HSA-392518,-0.5554851072165894,-1.7068060953928985,0.026607538802660754,0.40110892433763784,0.986,5/6,27.35%,GNAI2;GNB4;SRC;MAPK14;GNB2
224,prerank,Cellular Response To Heat Stress R-HSA-3371556,0.29679115584694166,1.7053344819124403,0.02491103202846975,0.06912832523145321,0.993,14/24,30.68%,HSPA1A;VCP;HSP90AB1;HSP90AA1;EEF1A1;HSPA5;HSPA8;HSPA13;YWHAE;HSPA9;HSPA4;SERPINH1;PTGES3;ST13
225,prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.33880861861451933,-1.7021755086664443,0.02564102564102564,0.386913599429137,0.988,12/17,36.00%,ST3GAL1;ST3GAL6;CMAS;GNE;GFUS;UAP1;GNPNAT1;NAGK;GMPPB;ST6GAL1;PGM3;CTSA
226,prerank,Chaperonin-mediated Protein Folding R-HSA-390466,0.2911126981032905,1.7008267817939768,0.039586919104991396,0.07026048453987148,0.994,14/26,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;TUBB3;CCT6B;TUBA8
227,prerank,Antimicrobial Peptides R-HSA-6803157,0.45083366284179704,1.6934787814035228,0.02819548872180451,0.07269394331953875,0.995,7/10,27.24%,CLU;LTF;LYZ;BPIFB2;PLA2G2A;DCD;REG3A
228,prerank,PTEN Regulation R-HSA-6807070,0.2236006658914525,1.6934264573467182,0.023450586264656615,0.07238378709123203,0.995,38/46,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;MAPK3;USP7;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1
229,prerank,Nephrin Family Interactions R-HSA-373753,0.5570587308592843,1.688001708630238,0.0300187617260788,0.074282633067767,0.995,5/6,29.11%,SPTBN1;ACTN1;SPTAN1;ACTN4;IQGAP1
230,prerank,HS-GAG Degradation R-HSA-2024096,0.47091685929734495,1.6839882294325752,0.02676864244741874,0.0754260694662074,0.996,5/9,10.46%,GPC3;SDC1;AGRN;SDC4;HSPG2
231,prerank,Mitotic G2-G2/M Phases R-HSA-453274,0.18707023091381228,1.6834715509304141,0.029548989113530325,0.07487619629052494,0.996,54/67,63.53%,HSP90AB1;HSP90AA1;TUBB4B;TUBA4A;RPS27A;PSMD14;PPP2CA;TUBB;PSMC5;DYNC1H1;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;YWHAE;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;YWHAG;PPP2R1A;PSMA7;PSMD12;PSMD11;ACTR1A;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PAFAH1B1;DCTN1;PSMA5;PSMB4;XPO1;PSMD5;PSMD7;MAPRE1;PPP1CB;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1;CDK11A;PPME1
232,prerank,G2/M Transition R-HSA-69275,0.18707023091381228,1.6834715509304141,0.029548989113530325,0.07487619629052494,0.996,54/67,63.53%,HSP90AB1;HSP90AA1;TUBB4B;TUBA4A;RPS27A;PSMD14;PPP2CA;TUBB;PSMC5;DYNC1H1;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;YWHAE;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;YWHAG;PPP2R1A;PSMA7;PSMD12;PSMD11;ACTR1A;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PAFAH1B1;DCTN1;PSMA5;PSMB4;XPO1;PSMD5;PSMD7;MAPRE1;PPP1CB;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1;CDK11A;PPME1
233,prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.5193661971830986,-1.683367067027296,0.03409090909090909,0.4020667735217472,0.99,7/7,48.33%,CSTF2;CPSF1;PABPN1;NCBP1;NUDT21;CPSF6;CSTF3
234,prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.4402094874378592,-1.681986412661422,0.028199566160520606,0.3843657205994061,0.99,8/10,35.24%,JAK2;STAT5B;STAT1;STAT3;CUL5;UBE2D2;NRAS;PTPN11
235,prerank,PRC2 Methylates Histones And DNA R-HSA-212300,0.598845756908833,1.6757955082467413,0.036468330134357005,0.07748857438467044,0.997,4/5,21.68%,H2BC11;H2BC12;H2AZ1;RBBP4
236,prerank,Defective Pyroptosis R-HSA-9710421,0.598845756908833,1.6757955082467413,0.036468330134357005,0.07748857438467044,0.997,4/5,21.68%,H2BC11;H2BC12;H2AZ1;RBBP4
237,prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.3917356747686963,1.6734931532768687,0.02909090909090909,0.07800900501073266,0.998,8/13,23.90%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;CCT6B
238,prerank,Deubiquitination R-HSA-5688426,0.19604129039629106,1.67274221488865,0.024,0.07784593822235691,0.998,47/59,61.72%,H2AC21;H2BC11;H2BC12;VCP;TGFB1;H2AC11;RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;RUVBL1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;USP5;USP14;OTUB1;USP7;PSMD7;PSME3;USP9X;MAT2B;PSMB5;PSMB6;PSMB9;PSME1
239,prerank,Signaling By FGFR1 In Disease R-HSA-5655302,-0.5949589683470106,-1.672704246929762,0.04269662921348315,0.383221775002384,0.991,5/5,40.74%,STAT5B;STAT1;STAT3;NRAS;CPSF6
240,prerank,Cellular Response To Starvation R-HSA-9711097,0.19243916812057318,1.6676725959286318,0.0384,0.07979922277715229,0.998,51/65,60.84%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;EIF2S1;RPL9;RPS8;RPL15;RPL27;RPL4;EIF2S3;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;RPL23;RPS19;ATP6V1A;RPL35A;RPL7A
241,prerank,Interleukin-2 Family Signaling R-HSA-451927,-0.5880126003747043,-1.6658167988369386,0.03655913978494624,0.37718533480652816,0.992,4/5,19.64%,JAK2;STAT5B;STAT1;STAT3
242,prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.2626744260034616,1.6636620072476562,0.035897435897435895,0.0812918974333429,0.998,28/32,62.36%,RPS27A;RPSA;RPS10;SNRPD3;RPS9;RPS16;RPS3;RPS25;RPS13;RPS14;RPS2;RPS4X;SNRPD2;RPS5;RPS11;RPS3A;RPS15A;RPS7;RPS8;RPS23;RPS6;RPS17;RPS27;RPS20;RPS12;RPS19;SNRPE;SNRPF
243,prerank,Transport Of Small Molecules R-HSA-382551,0.14770506594305485,1.6634228932817525,0.028744326777609682,0.08100192920770882,0.998,82/110,61.72%,ALB;APOB;APOE;APOA1;VCP;TF;RPS27A;PSMD14;ANGPTL8;APOC3;CLTC;SLC2A1;PSMC5;PSMC3;APOC2;PLTP;PSMC4;ACO1;CAND1;PSMD13;PSMC1;FTH1;P4HB;PSMC2;PSMC6;LCAT;PSME2;PSMB2;PSMA6;SLC2A14;CALM1;PCSK6;PSMA7;PSMD12;AP2M1;LPL;PSMD11;LDLR;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;PSMA3;PMPCA;PSMA2;PSMD3;PRKAR2A;PSMB1;PSMD6;APOA4;APOA5;APOC1;PSMD2;EIF2S1;PSMA5;CLTA;PSMB4;ANGPTL4;GNB1;EIF2S3;PSMD5;FTL;ANGPTL3;PCSK5;GLRX3;TFRC;BSG;PSMD7;OS9;SLC3A2;PSME3;LCN15;ATP6V1A;PCSK9;SCARB1;PSMB5;PSMB6;SLC16A3;PSMB9;PSME1
244,prerank,Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.5186835464229231,1.6609471460968739,0.02681992337164751,0.0816737718398435,0.998,4/7,8.12%,APOB;FGB;FGA;FGG
245,prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,0.21874376132786427,1.6256314481257998,0.035058430717863104,0.09728397021982288,0.999,37/45,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;COL1A1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;MAPK3;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1
246,prerank,Apoptosis Induced DNA Fragmentation R-HSA-140342,0.5097604384557728,1.6232662645276092,0.0423572744014733,0.09790970286471502,1.0,5/7,22.62%,H1-2;H1-1;H1-0;H1-5;KPNB1
247,prerank,M Phase R-HSA-68886,0.15456787390328922,1.6231853610596665,0.0430622009569378,0.09754064204802886,1.0,73/97,61.72%,H2BC11;H2BC12;TUBA1C;HSP90AA1;TUBB4B;TUBA4A;H2AZ1;RPS27A;RAN;PSMD14;PPP2CA;LMNA;TUBB;EML4;PSMC5;DYNC1H1;PSMC3;USO1;PSMC4;PSMD13;PSMC1;TUBB3;YWHAE;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;YWHAG;PPP2R1A;TUBA8;PSMA7;PSMD12;PSMD11;ACTR1A;PSMA1;PSMA4;PSMD8;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;LMNB1;PSMD2;PAFAH1B1;DCTN1;PSMA5;TPR;RAB1B;TUBB2A;PSMB4;XPO1;PSMD5;RCC2;MAPK3;RPS27;PSMD7;NUDC;MAPRE1;PSME3;RAB1A;BUB3;RAB2A;PSMB5;TNPO1;NUMA1;PSMB6;PSMB9;PSME1
248,prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.2187262867108044,1.6218112171381192,0.045075125208681135,0.0977817430173468,1.0,31/45,48.57%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5
249,prerank,Interleukin-1 Family Signaling R-HSA-446652,0.2104598118517582,1.6204082678076477,0.04666666666666667,0.09789881932876368,1.0,40/49,61.89%,RPS27A;PSMD14;PSMC5;PSMC3;APP;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;USP14;PSMD7;PSME3;PSMB5;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
250,prerank,Separation Of Sister Chromatids R-HSA-2467813,0.19714124504414643,1.619580964216726,0.03114754098360656,0.09788294120465836,1.0,44/55,61.72%,RPS27A;PSMD14;PPP2CA;PSMC5;DYNC1H1;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PAFAH1B1;PSMA5;PSMB4;XPO1;PSMD5;RCC2;RPS27;PSMD7;NUDC;MAPRE1;PSME3;BUB3;PSMB5;PSMB6;PSMB9;PSME1
251,prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.482981220657277,-1.6141796922716378,0.04491725768321513,0.4628277282876413,0.997,7/7,51.96%,AK1;RRM2B;CMPK1;CTPS1;RRM1;AK4;GSR
252,prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.3194353224553207,1.6062508424239117,0.03977272727272727,0.10316165786156259,1.0,8/19,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;PEBP1;VWF
253,prerank,MAP2K And MAPK Activation R-HSA-5674135,0.3194353224553207,1.6062508424239117,0.03977272727272727,0.10316165786156259,1.0,8/19,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;PEBP1;VWF
254,prerank,Post NMDA Receptor Activation Events R-HSA-438064,-0.3954563430379206,-1.6052621690021895,0.0472972972972973,0.4433309163731787,0.998,8/11,32.50%,MPP2;PRKAA1;SRC;PRKAG1;MAPK1;RPS6KA3;NRAS;PRKAR1A
255,prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.3954563430379206,-1.6052621690021895,0.0472972972972973,0.4433309163731787,0.998,8/11,32.50%,MPP2;PRKAA1;SRC;PRKAG1;MAPK1;RPS6KA3;NRAS;PRKAR1A
256,prerank,DNA Double-Strand Break Repair R-HSA-5693532,0.3625332804167851,1.6014781397830644,0.032432432432432434,0.10499334460006157,1.0,9/14,30.51%,H2BC11;H2BC12;RPS27A;XRCC5;XRCC6;FEN1;PCNA;PARP1;PRKDC
257,prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.324077984525104,1.5996405865381735,0.0392156862745098,0.10552819865606676,1.0,14/18,46.70%,PPIA;RAP1B;GSTO1;TCP1;RPLP0;HSPA9;PSME2;CAPZA1;HNRNPA2B1;MSN;LMNB1;CDC42;HNRNPF;TALDO1
258,prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.4543116066480518,-1.5882240459704149,0.05636743215031315,0.46167004421354946,0.999,6/8,28.52%,JAK2;STAT5B;STAT1;STAT3;CUL5;UBE2D2
259,prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,0.16993550849083366,1.5864823586279666,0.05379746835443038,0.11170107662982807,1.0,57/74,61.72%,TUBA1C;TUBB4B;TUBA4A;RPS27A;RAN;PSMD14;PPP2CA;LMNA;TUBB;PSMC5;DYNC1H1;PSMC3;PSMC4;PSMD13;PSMC1;TUBB3;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PPP2R1A;TUBA8;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;LMNB1;PSMD2;PAFAH1B1;PSMA5;TUBB2A;PSMB4;XPO1;PSMD5;RCC2;RPS27;PSMD7;NUDC;MAPRE1;PSME3;BUB3;PSMB5;TNPO1;PSMB6;PSMB9;PSME1
260,prerank,Mitotic Anaphase R-HSA-68882,0.16993550849083366,1.5864823586279666,0.05379746835443038,0.11170107662982807,1.0,57/74,61.72%,TUBA1C;TUBB4B;TUBA4A;RPS27A;RAN;PSMD14;PPP2CA;LMNA;TUBB;PSMC5;DYNC1H1;PSMC3;PSMC4;PSMD13;PSMC1;TUBB3;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PPP2R1A;TUBA8;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;LMNB1;PSMD2;PAFAH1B1;PSMA5;TUBB2A;PSMB4;XPO1;PSMD5;RCC2;RPS27;PSMD7;NUDC;MAPRE1;PSME3;BUB3;PSMB5;TNPO1;PSMB6;PSMB9;PSME1
261,prerank,tRNA Processing R-HSA-72306,-0.341881048948679,-1.5847276912406338,0.04555808656036447,0.4514463822752845,0.999,13/14,58.45%,CSTF2;CPSF1;NUP93;RPP30;OSGEP;FAM98B;SEC13;HSD17B10;XPOT;EPRS1;RTCB;TPR;DDX1
262,prerank,Laminin Interactions R-HSA-3000157,0.4006592633211908,1.5790643396016582,0.04945054945054945,0.1153602106070202,1.0,6/11,16.07%,LAMB1;LAMC1;LAMA5;HSPG2;NID1;COL18A1
263,prerank,Neuronal System R-HSA-112316,-0.21939383844369986,-1.5779528904464106,0.0675990675990676,0.44938862828468173,0.999,31/34,69.26%,FLOT1;MPP2;PDLIM5;GNAI2;NRXN1;GNB4;PRKAA1;SRC;AP2A2;PRKAG1;COMT;MAPK1;RPS6KA3;GNB2;NRAS;PRKAR1A;IL1RAP;MAPK3;GNB1;ACHE;ABAT;CACNA2D1;PRKAR2A;ALDH5A1;ALDH2;AP2A1;PTPRS;AP2B1;NSF;PTPRD;AP2M1
264,prerank,Signaling By WNT R-HSA-195721,0.16748066825555433,1.5758710679185666,0.054773082942097026,0.11666835645514832,1.0,47/73,49.62%,H2BC11;H2BC12;PFN1;H2AZ1;RPS27A;PSMD14;PPP2CA;YWHAZ;CLTC;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;VPS35;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;RUVBL1;PSMD12;AP2M1;PSMD11;PSMA1;PSMA4;AP2B1;PSMD8;AP2A1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;CLTA;PSMB4;GNB1;XPO1;PSMD5;DKK4
265,prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.3510395730761533,1.5633857166559049,0.056896551724137934,0.12342913242358443,1.0,8/14,23.90%,CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;CCT6B
266,prerank,Activation Of BH3-only Proteins R-HSA-114452,0.5178885630498535,1.5612080681905716,0.05075187969924812,0.1232315439371226,1.0,6/6,48.39%,YWHAZ;YWHAQ;YWHAE;YWHAG;YWHAB;YWHAH
267,prerank,SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.5178885630498535,1.5612080681905716,0.05075187969924812,0.1232315439371226,1.0,6/6,48.39%,YWHAZ;YWHAQ;YWHAE;YWHAG;YWHAB;YWHAH
268,prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.5178885630498535,1.5612080681905716,0.05075187969924812,0.1232315439371226,1.0,6/6,48.39%,YWHAZ;YWHAQ;YWHAE;YWHAG;YWHAB;YWHAH
269,prerank,Interleukin-12 Signaling R-HSA-9020591,0.2979862175297561,1.5611620063300167,0.0564373897707231,0.12276227297951366,1.0,15/20,46.70%,PPIA;RAP1B;GSTO1;TCP1;RPLP0;P4HB;HSPA9;PSME2;CAPZA1;HNRNPA2B1;MSN;LMNB1;CDC42;HNRNPF;TALDO1
270,prerank,Metabolism Of RNA R-HSA-8953854,0.107239408305788,1.5600540806730572,0.05374823196605375,0.12296327805562561,1.0,154/217,62.59%,HSPA1A;RPS27A;RAN;PSMD14;RPSA;PPP2CA;RPS10;DDX39B;SNRPD3;IGF2;SRSF1;YWHAZ;RPL22;SRSF3;RPLP1;HSPA8;DHX9;RPS9;RPS16;RPS3;PRPF19;HNRNPC;EIF4A1;PSMC5;PSMC3;RPS25;RPLP0;RPS13;RPL10A;RPL30;PSMC4;PPIE;PSMD13;PSMC1;HNRNPK;PSMC2;PSMC6;RPS14;PSME2;PSMB2;PSMA6;RPS2;RPL12;HNRNPA1;PPP2R1A;SF3B1;RPL27A;RPS4X;RPLP2;PSMA7;EIF4A3;FBL;SNRPD2;SRSF7;PSMD12;RPS5;HNRNPD;YBX1;PSMD11;PRMT5;SRSF2;RPL18;RPS11;HNRNPA2B1;RPL11;PSMA1;RPS3A;PSMA4;PSMD8;RPL5;WDR77;YWHAB;PSMB3;PSMA3;SF3B3;PSMA2;HSPB1;PSMD3;RPS15A;PSMB1;RPS7;ETF1;EIF4A2;SRSF4;RPL14;PSMD6;DDX1;HNRNPU;DDX5;PSMD2;RPL9;PSMA5;HNRNPF;TPR;PSMB4;RPS8;RPL15;RPL27;DDX6;PCBP1;RPL4;XPO1;PCBP2;NOP56;MAGOH;NOP58;SNRNP200;PSMD5;RTCB;RPS23;RPL7;EPRS1;HNRNPR;RPL29;CSTF3;RPL28;RPL26;RPL8;RPS6;PABPC1;PTBP1;RPS17;EIF4E;LSM3;RPS27;RBMX;SNRPA1;RPS20;PSMD7;ENPP2;HNRNPH1;RPS12;SNU13;RRP9;PSME3;SNRPA;U2AF2;RPL23;RPS19;CPSF6;SNRPE;PSMB5;TNPO1;RPL35A;RPL7A;XPOT;ALYREF;PSMB6;ELAVL1;PSMB9;PSME1;HNRNPL;SNRPF;MTREX
271,prerank,HDACs Deacetylate Histones R-HSA-3214815,0.46184015277274215,1.5576891052791477,0.04725897920604915,0.12389070517659348,1.0,4/8,6.66%,H2AC21;H2BC11;H2BC12;H2AC11
272,prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.4579412596403859,1.5567320365341006,0.055776892430278883,0.1240509350771112,1.0,7/8,42.72%,LMNA;PRDX1;PRDX2;APP;YWHAE;CAPN2;LMNB1
273,prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.45226351790022107,1.556196513810206,0.04597701149425287,0.12385615599566602,1.0,4/8,7.60%,H2BC11;H2BC12;H2AZ1;THBS1
274,prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.1712298417937434,1.555985151491888,0.06583072100313479,0.12348681692750822,1.0,55/70,63.18%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;FBL;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;NOP56;NOP58;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;SNU13;RRP9;RPL23;RPS19;RPL35A;RPL7A;MTREX;RPL18A
275,prerank,Meiotic Synapsis R-HSA-1221632,0.4845365339514661,1.5533640102548767,0.05185185185185185,0.12443615826154061,1.0,4/7,11.28%,H2BC11;H2BC12;H2AZ1;LMNA
276,prerank,RNA Polymerase I Promoter Escape R-HSA-73772,0.560220846625977,1.5517920612745544,0.05502846299810247,0.12491194799309444,1.0,3/5,7.07%,H2BC11;H2BC12;H2AZ1
277,prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.2974883534811311,-1.5513571712967151,0.06167400881057269,0.4907239728316216,1.0,12/18,36.00%,ST3GAL1;ST3GAL6;CMAS;GNE;GFUS;UAP1;GNPNAT1;NAGK;GMPPB;ST6GAL1;PGM3;CTSA
278,prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.35967610038247405,1.5505921013767328,0.05,0.12509389224092304,1.0,8/13,28.23%,LUM;OGN;FMOD;B4GAT1;HEXB;B4GALT1;GLB1;OMD
279,prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,0.2044601686927252,1.5452808252867476,0.0651085141903172,0.1275324937854875,1.0,38/47,61.72%,RPS27A;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;UBE2N;PSMD5;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;MUC6;PSME1
280,prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.5208211143695015,-1.5429772245729447,0.05591397849462366,0.4927597656699584,1.0,6/6,48.16%,JAK2;CDK1;MAPK1;PTPN11;MAP2K1;MAPK3
281,prerank,Ca2+ Pathway R-HSA-4086398,-0.4413353832444591,-1.540665540271193,0.05785123966942149,0.48191308150910384,1.0,6/8,30.16%,MOV10;GNB4;PPP3CA;GNB2;CTNNB1;NRAS
282,prerank,Post-translational Protein Modification R-HSA-597592,0.09455336775824046,1.5405266659309578,0.04607046070460705,0.12990858075937994,1.0,234/282,75.92%,ALB;C3;H2AC21;APOB;FN1;AHSG;ITIH2;APOE;FGA;MATN3;C4A;APOA1;H2BC11;H2BC12;QSOX1;GPC3;MAN1A1;NPM1;F5;SERPIND1;TUBA1C;VCP;PROS1;TF;TUBB4B;LAMB1;PDIA6;EEF1A1;TGFB1;H2AC11;LAMC1;EEF2;HSP90B1;RPS27A;THBS1;UBA1;NOTUM;FGG;SERPINC1;SERPINA1;F9;PSMD14;ADAMTS13;GANAB;ALG1;B4GAT1;PDIA3;TUBB;HSPA8;SPTBN1;NANS;HNRNPC;COPA;PSMC5;DYNC1H1;PSMC3;CST3;SPTAN1;SEC23A;APP;BPIFB2;USO1;PSMC4;CAND1;PSMD13;PSMC1;ETFB;HLA-A;HNRNPK;P4HB;TUBB3;PSMC2;PSMC6;MAN2A1;APLP2;LMAN2;PSME2;B4GALT1;PSMB2;PSMA6;RPS2;PCNA;COPB1;CAPZA1;ARF4;GLB1;CALM1;ARF5;RAB14;PSMA7;CAPZB;PARP1;RUVBL1;PSMD12;PRKDC;NSF;PSMD11;VCAN;DDB1;ACTR1A;PSMA1;RAB18;PSMA4;GFPT1;PSMD8;RAB7A;RAB5C;LMNB2;COPB2;PSMB3;SEC24C;ARCN1;PSMA3;CTSZ;PSMA2;PSMD3;TIMP1;PSMB1;COPG1;KTN1;FUCA1;COPS8;HDAC1;PSMD6;APOA5;TOP1;SEC31A;MFGE8;STC2;DDX5;IGFBP7;PSMD2;DCTN1;GPS1;DDX17;PSMA5;TPR;RAB1B;TUBB2A;ELOB;RAB5A;PSMB4;TTLL12;FBN1;UBE2N;GMDS;VWA1;CD109;NOP58;PSMD5;USP5;FUCA2;ADAM10;USP14;OTUB1;KNG1;PMM2;UGGT1;USP7;FN3K;DAG1;COPS3;CTSC;RAB6A;SPON2;UBA2;PRSS23;FBXO2;PSMD7;DNAJC3;COPS6;SEC24A;OS9;PSME3;USP9X;RAB1A;CALR;PCSK9;MAT2B;TRIM28;FBXO22;NUCB1;RAB2A;PSMB5;RAB5B;PSMB6;RBX1;PSMB9;CAPZA2;MUC6;PSME1;RAB21;SPON1;COPS4;CTSA;COPE;SCFD1;MOGS;FUT3;THBS2;MBTPS1;ACTL6A;PGM3;RABGGTA;IGFBP1;DYNC1I2;COPS5;SAR1B;PIGH;CHGB;MXRA8;BMP4;UCHL3;RBBP7;CP;DCTN2;UBE2M;SEC13;SAE1;UBE2D2;CUL2;IDE;ST6GAL1;GMPPB;RAB8B;DYNC1LI1;COPZ1;PPP3CA;NAGK;GALNT2;RANGAP1;CUL1;GNPNAT1;CUL4B
283,prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,0.4284256490507813,1.5375095971455532,0.04158790170132325,0.13120546456180956,1.0,5/9,14.85%,POLR3B;RPS27A;XRCC5;XRCC6;DHX9
284,prerank,IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.5491328588276663,1.536779272055088,0.05027932960893855,0.13004555568787268,1.0,3/5,8.12%,FGB;FGA;FGG
285,prerank,MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.5491328588276663,1.536779272055088,0.05027932960893855,0.13004555568787268,1.0,3/5,8.12%,FGB;FGA;FGG
286,prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.5491328588276663,1.536779272055088,0.05027932960893855,0.13004555568787268,1.0,3/5,8.12%,FGB;FGA;FGG
287,prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.4642018779342723,-1.5352549226066234,0.05627705627705628,0.47881922864443066,1.0,7/7,53.83%,GNB4;SRC;ARRB1;MAPK1;GNB2;MAPK3;GNB1
288,prerank,SARS-CoV-2-host Interactions R-HSA-9705683,0.17933828779962774,1.5351535659232594,0.06188925081433225,0.13046119678946108,1.0,48/61,62.36%,HSP90AB1;HSP90AA1;RPS27A;RPSA;RPS10;SNRPD3;YWHAZ;MASP1;RPS9;RPS16;RPS3;RPS25;SEC23A;RPS13;YWHAQ;HLA-A;YWHAE;RPS14;RPS2;YWHAG;RPS4X;SNRPD2;RPS5;RPS11;RPS3A;UBE2V1;YWHAB;TKFC;SEC24C;RPS15A;RPS7;TPR;RPS8;UBE2N;YWHAH;RPS23;MASP2;RPS6;RPS17;RPS27;RPS20;SEC24A;RPS12;RPS19;SNRPE;TUFM;HLA-C;SNRPF
289,prerank,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.4156788898096135,1.533908916004684,0.064030131826742,0.13021433400918953,1.0,5/10,10.46%,GPC3;SDC1;AGRN;SDC4;HSPG2
290,prerank,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.4156788898096135,1.533908916004684,0.064030131826742,0.13021433400918953,1.0,5/10,10.46%,GPC3;SDC1;AGRN;SDC4;HSPG2
291,prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.144770007434624,-1.5324404128231248,0.04594594594594595,0.47125831549386554,1.0,57/78,58.33%,CSTF2;SRSF10;DDX42;POLR2H;SNRNP70;PRPF8;CPSF1;NUP93;DDX23;CTNNBL1;PABPN1;FUS;HNRNPUL1;NCBP1;HNRNPM;HNRNPA3;PRPF40A;SNRNP40;LSM6;CDC5L;SRRT;SF3B2;SEC13;SF3A3;NUDT21;EFTUD2;TRA2B;SNRPB;HNRNPA0;DHX15;SF3A1;MTREX;SNRPF;HNRNPL;ELAVL1;ALYREF;SNRPE;CPSF6;U2AF2;SNRPA;SNU13;HNRNPH1;SNRPA1;RBMX;LSM3;EIF4E;PTBP1;CSTF3;HNRNPR;SNRNP200;MAGOH;PCBP2;PCBP1;TPR;HNRNPF;DDX5;HNRNPU
292,prerank,Protein Folding R-HSA-391251,0.25230009984827856,1.528410826984675,0.07849829351535836,0.1332042053779113,1.0,14/28,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;CCT3;TCP1;CCT4;CCT7;CCT8;CCT2;CCT5;TUBB3;CCT6B;TUBA8
293,prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,0.16300849108345586,1.5271945928870767,0.0791599353796446,0.13352266006182775,1.0,55/72,61.89%,FN1;FGB;FGA;TLN1;RAP1B;RPS27A;FGG;PSMD14;PPP2CA;PEBP1;VWF;SPTBN1;PSMC5;PSMC3;SPTAN1;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;IQGAP1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;VCL;MAPK3;PSMD7;PPP1CB;PSME3;LYPLA1;PSMB5;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
294,prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.5574648308537319,1.5262635405307925,0.0599250936329588,0.1336218924326987,1.0,3/5,7.07%,H2BC11;H2BC12;H2AZ1
295,prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.5080757005043521,1.5259271103931362,0.06679035250463822,0.1333389815477798,1.0,5/6,33.55%,HSP90AB1;HSP90AA1;EEF2;CALM1;PDCD6IP
296,prerank,IRE1alpha Activates Chaperones R-HSA-381070,0.35108829050320267,1.523276729646044,0.08152173913043478,0.13434910794191518,1.0,10/13,43.19%,TLN1;PDIA6;HSPA5;HYOU1;LMNA;DNAJB11;ACADVL;GFPT1;SEC31A;DCTN1
297,prerank,Diseases Of Metabolism R-HSA-5668914,0.17964693271342766,1.5231793117963361,0.06645056726094004,0.13389229418277276,1.0,26/59,28.40%,GPC3;LUM;AHCY;SDC1;AGRN;RPS27A;OGN;THBS1;FMOD;EXT1;ADAMTS13;SDC4;HSPG2;GALK1;ALG1;B4GAT1;DCXR;HEXB;IDH1;APRT;NOTCH3;B4GALT1;GLB1;FDXR;OMD;PGM1
298,prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.5415040348213838,-1.5228128965167709,0.073558648111332,0.47728836027194527,1.0,4/5,24.61%,EXOSC6;MAPK14;EXOSC4;KHSRP
299,prerank,Suppression Of Phagosomal Maturation R-HSA-9637687,0.5480656506447832,1.5209486107463783,0.06439393939393939,0.13467012773810252,1.0,5/5,45.35%,RPS27A;KPNB1;CORO1A;RAB7A;RAB5A
300,prerank,Glycosaminoglycan Metabolism R-HSA-1630316,0.2281670515437945,1.519994827688719,0.0743801652892562,0.1348446758689354,1.0,11/34,11.81%,GPC3;LUM;SDC1;AGRN;CEMIP;OGN;FMOD;EXT1;SDC4;HSPG2;B4GAT1
301,prerank,Mitochondrial Protein Import R-HSA-1268020,0.4190213867785832,1.5171740901270092,0.06088560885608856,0.13629856697248383,1.0,7/9,37.11%,ATP5F1B;CS;HSPD1;HSPA9;ACO2;ATP5F1A;PMPCA
302,prerank,Molecules Associated With Elastic Fibres R-HSA-2129379,0.3757775025511313,1.5145293723238542,0.04021937842778794,0.13740919961871678,1.0,6/12,14.96%,VTN;FBLN1;TGFB1;EFEMP1;FBLN5;LTBP4
303,prerank,Defective CHST6 Causes MCDC1 R-HSA-3656225,0.5465180111301315,1.5080192911737549,0.07050092764378478,0.1403728915028115,1.0,3/5,7.83%,LUM;OGN;FMOD
304,prerank,Defective ST3GAL3 Causes MCT12 And EIEE15 R-HSA-3656243,0.5465180111301315,1.5080192911737549,0.07050092764378478,0.1403728915028115,1.0,3/5,7.83%,LUM;OGN;FMOD
305,prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,0.4145780404095155,1.5077055184300499,0.06115107913669065,0.14002120576715918,1.0,6/9,28.23%,LUM;OGN;FMOD;B4GAT1;B4GALT1;OMD
306,prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.2259406596903538,1.5026584492095545,0.08247422680412371,0.14264243043220495,1.0,25/35,50.56%,ALB;APOB;APOE;APOA1;RPS27A;ANGPTL8;APOC3;CLTC;APOC2;PLTP;P4HB;LCAT;PCSK6;AP2M1;LPL;LDLR;AP2B1;AP2A1;APOA4;APOA5;APOC1;CLTA;ANGPTL4;ANGPTL3;PCSK5
307,prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.4027209116257572,1.501928839132096,0.06148282097649186,0.14266874845630007,1.0,5/9,17.83%,GSN;SPTBN1;MYH9;EZR;SPTAN1
308,prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.1476246146920397,-1.5002186519467924,0.05307262569832402,0.4986360639867822,1.0,50/73,53.36%,CSTF2;SRSF10;DDX42;POLR2H;SNRNP70;PRPF8;CPSF1;DDX23;CTNNBL1;PABPN1;FUS;HNRNPUL1;NCBP1;HNRNPM;HNRNPA3;PRPF40A;SNRNP40;LSM6;CDC5L;SRRT;SF3B2;SF3A3;NUDT21;EFTUD2;TRA2B;SNRPB;HNRNPA0;DHX15;SF3A1;MTREX;SNRPF;HNRNPL;ELAVL1;ALYREF;SNRPE;CPSF6;U2AF2;SNRPA;SNU13;HNRNPH1;SNRPA1;RBMX;LSM3;PTBP1;CSTF3;HNRNPR;SNRNP200;MAGOH;PCBP2;PCBP1
309,prerank,mRNA Splicing R-HSA-72172,-0.1476246146920397,-1.5002186519467924,0.05307262569832402,0.4986360639867822,1.0,50/73,53.36%,CSTF2;SRSF10;DDX42;POLR2H;SNRNP70;PRPF8;CPSF1;DDX23;CTNNBL1;PABPN1;FUS;HNRNPUL1;NCBP1;HNRNPM;HNRNPA3;PRPF40A;SNRNP40;LSM6;CDC5L;SRRT;SF3B2;SF3A3;NUDT21;EFTUD2;TRA2B;SNRPB;HNRNPA0;DHX15;SF3A1;MTREX;SNRPF;HNRNPL;ELAVL1;ALYREF;SNRPE;CPSF6;U2AF2;SNRPA;SNU13;HNRNPH1;SNRPA1;RBMX;LSM3;PTBP1;CSTF3;HNRNPR;SNRNP200;MAGOH;PCBP2;PCBP1
310,prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,0.4425617042625116,1.5001974583068336,0.07222222222222222,0.14325298074424783,1.0,4/8,8.65%,H2BC11;H2BC12;H2AZ1;RAN
311,prerank,SARS-CoV-2 Infection R-HSA-9694516,0.15433166902505654,1.4861387176451157,0.08306709265175719,0.15239316317988635,1.0,60/79,62.36%,GPC3;VCP;HSP90AB1;HSP90AA1;SDC1;AGRN;RPS27A;SDC4;RPSA;GANAB;HSPG2;RPS10;SNRPD3;YWHAZ;MASP1;RPS9;RPS16;RPS3;RPS25;SEC23A;RPS13;YWHAQ;HLA-A;YWHAE;MAN2A1;RPS14;RPS2;YWHAG;RPS4X;SNRPD2;RPS5;RPS11;RPS3A;UBE2V1;YWHAB;TKFC;SEC24C;GPC6;NRP1;RPS15A;RPS7;DDX5;TPR;RPS8;UBE2N;YWHAH;RPS23;MASP2;RPS6;RPS17;RPS27;RPS20;SEC24A;RPS12;RPS19;SNRPE;TUFM;PRMT1;HLA-C;SNRPF
312,prerank,Terminal Pathway Of Complement R-HSA-166665,0.548457147466066,1.4858161363846147,0.07495429616087751,0.15205678471966663,1.0,4/5,27.76%,C5;CLU;C8B;PSMA7
313,prerank,Scavenging By Class F Receptors R-HSA-3000484,0.5406249313103296,1.4857572216433144,0.07366482504604052,0.1515489418563593,1.0,3/5,8.36%,APOB;HSP90AA1;HYOU1
314,prerank,Plasma Lipoprotein Assembly R-HSA-8963898,0.40718695092218693,1.4841812298182857,0.0724907063197026,0.1519803496561778,1.0,6/10,21.45%,APOB;APOE;APOA1;APOC3;APOC2;P4HB
315,prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.3511263039726451,-1.4784249067649167,0.06904231625835189,0.5340708172435954,1.0,6/11,18.12%,SRGAP2;GOPC;OBSCN;ARHGAP17;SLC1A5;ARHGAP1
316,prerank,Keratan Sulfate Degradation R-HSA-2022857,0.4068693875235099,1.4779559352673617,0.0625,0.15558961146647712,1.0,6/9,28.23%,LUM;OGN;FMOD;HEXB;GLB1;OMD
317,prerank,GPER1 Signaling R-HSA-9634597,-0.41682028059223936,-1.471443777623919,0.07641921397379912,0.5360890313623297,1.0,6/8,32.73%,GNAI2;GNB4;SRC;GNB2;PRKAR1A;ITGB1
318,prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.2765687925303215,-1.4708336238701418,0.08545034642032333,0.5237057606282798,1.0,17/20,56.98%,DYNC1LI2;PPP2R5D;PPP1CC;SMC1A;CDK1;RANGAP1;DYNC1LI1;CKAP5;SEC13;DYNC1I2;BUB3;MAPRE1;NUDC;RPS27;RCC2;XPO1;PAFAH1B1
319,prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.27827832140872627,1.4700920106511963,0.07904411764705882,0.16036017760821095,1.0,8/21,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;PEBP1;VWF
320,prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.2554848643138181,1.4685382058954641,0.07259528130671507,0.16091002659855994,1.0,9/25,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;PEBP1;LMNA;VWF
321,prerank,Cardiac Conduction R-HSA-5576891,-0.5201904960687184,-1.4674265273009037,0.07249466950959488,0.5174559911838501,1.0,4/5,27.00%,SRI;CES1;SCN1A;ASPH
322,prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.15984869628255374,1.4649669765611821,0.08878504672897196,0.1629634076566021,1.0,55/71,63.18%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;FBL;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;NOP56;NOP58;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;SNU13;RRP9;RPL23;RPS19;RPL35A;RPL7A;MTREX;RPL18A
323,prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,0.3284609399737437,1.4580964492441242,0.09666080843585237,0.16709592085521846,1.0,7/14,18.94%,HSP90AB1;HSP90AA1;DDX39B;ACTN1;HNRNPC;CCT7;CCT2
324,prerank,Glycogen Metabolism R-HSA-8982491,0.40246768507638075,1.457610676583164,0.0807899461400359,0.1667979624089333,1.0,9/9,59.96%,RPS27A;PYGB;UGP2;PYGL;CALM1;PGM1;AGL;GAA;GYS1
325,prerank,Protein-protein Interactions At Synapses R-HSA-6794362,-0.40181099868771625,-1.4562056791187137,0.08185840707964602,0.5298700203181853,1.0,4/8,7.66%,FLOT1;MPP2;PDLIM5;NRXN1
326,prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.5213246377435459,-1.4554403862179375,0.07882882882882883,0.5192299734846865,1.0,4/5,27.35%,GNB4;SRC;MAPK14;GNB2
327,prerank,Transmission Across Chemical Synapses R-HSA-112315,-0.2343298322268902,-1.4546055659682182,0.08735632183908046,0.5091356008327405,1.0,25/27,69.26%,MPP2;GNAI2;GNB4;PRKAA1;SRC;AP2A2;PRKAG1;COMT;MAPK1;RPS6KA3;GNB2;NRAS;PRKAR1A;MAPK3;GNB1;ACHE;ABAT;CACNA2D1;PRKAR2A;ALDH5A1;ALDH2;AP2A1;AP2B1;NSF;AP2M1
328,prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.12961097083221212,1.4532604763397106,0.0890302066772655,0.1694261421158849,1.0,62/110,45.65%,FN1;FGB;FGA;NPM1;VCP;TLN1;HSP90AA1;CLSTN1;TGFB1;RAP1B;RPS27A;EEF1G;FGG;ATIC;PSMD14;PPP2CA;PEBP1;LMNA;VWF;CLTC;EML4;SPTBN1;MYH9;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RRBP1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;SND1;IQGAP1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;MSN;PSMA3;PSMA2;PSMD3;KIF5B;PSMB1;HDAC1;PSMD6;SEC31A;CDC37;PSMD2;DCTN1;PSMA5;TPR;AP3B1;PSMB4
329,prerank,RAC2 GTPase Cycle R-HSA-9013404,-0.3318348500460627,-1.4518422339069532,0.0963302752293578,0.503801676909974,1.0,8/12,32.73%,ARHGDIA;ARHGAP17;ABI1;ESYT1;ARHGAP1;TMPO;NCKAP1;ITGB1
330,prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.26588596631428457,-1.4481313803998577,0.07710280373831775,0.5005813492520212,1.0,12/20,32.50%,MPP2;GNAI2;GNB4;PRKAA1;SRC;AP2A2;PRKAG1;MAPK1;RPS6KA3;GNB2;NRAS;PRKAR1A
331,prerank,MAPK3 (ERK1) Activation R-HSA-110056,-0.5205158264947245,-1.446776349516955,0.09846827133479212,0.49269013419883523,1.0,5/5,48.16%,JAK2;CDK1;PTPN11;MAP2K1;MAPK3
332,prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.39665181547552286,1.4436497437385825,0.09392265193370165,0.17593098706925006,1.0,4/9,7.25%,H2BC11;H2BC12;H2AZ1;RPS27A
333,prerank,Nucleotide Catabolism R-HSA-8956319,-0.5134818288393903,-1.440432190235294,0.1047008547008547,0.49566698060211933,1.0,5/5,48.86%,ITPA;DPYS;SAMHD1;NT5C2;DPYD
334,prerank,Death Receptor Signaling R-HSA-73887,0.423188246564419,1.4363320436170874,0.0842911877394636,0.18064085722882825,1.0,5/8,22.27%,RPS27A;RACK1;FASN;YWHAE;RTN4
335,prerank,HSF1-dependent Transactivation R-HSA-3371571,0.4061362627098867,1.4359866144420386,0.09351145038167939,0.17974927271200858,1.0,6/9,27.82%,HSPA1A;HSP90AB1;HSP90AA1;HSPA8;SERPINH1;PTGES3
336,prerank,Attenuation Phase R-HSA-3371568,0.4061362627098867,1.4359866144420386,0.09351145038167939,0.17974927271200858,1.0,6/9,27.82%,HSPA1A;HSP90AB1;HSP90AA1;HSPA8;SERPINH1;PTGES3
337,prerank,Meiosis R-HSA-1500620,0.4149969986580331,1.4358143411914226,0.08043875685557587,0.17924785906930457,1.0,4/8,11.28%,H2BC11;H2BC12;H2AZ1;LMNA
338,prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,0.1892184214104546,1.432237757423845,0.10606060606060606,0.18140691664576175,1.0,19/44,26.24%,GLUD1;HSP90AA1;TUBB4B;TUBA4A;ATP5F1B;TUBB;CCT3;TCP1;CCT4;CCT8;DYNC1H1;CCT2;CCT5;YWHAE;HSPA9;YWHAG;ARF4;CALM1;PPP2R1A
339,prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.23244962467676739,1.4319623840798525,0.10218978102189781,0.18106412603311237,1.0,14/28,28.58%,PPIB;PLOD1;COL6A1;PLOD2;COL6A3;COL18A1;COL1A1;P4HB;PLOD3;COL2A1;P4HA1;COL6A2;SERPINH1;PCOLCE
340,prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.46443096061806277,1.4299197019588974,0.1036468330134357,0.18213769047367015,1.0,4/6,23.44%,H2BC11;H2BC12;H2AZ1;NOTCH3
341,prerank,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.37075684683523846,1.4214823118366733,0.10408921933085502,0.18865245236732553,1.0,5/11,10.46%,GPC3;SDC1;AGRN;SDC4;HSPG2
342,prerank,Cellular Senescence R-HSA-2559583,0.24979801363954582,1.419418651373127,0.10745233968804159,0.1897543681344094,1.0,8/23,12.04%,H2BC11;H2BC12;H1-2;H1-1;H2AZ1;RPS27A;H1-0;H1-5
343,prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.5053658978715468,-1.4171440012898668,0.1050328227571116,0.5341749294094177,1.0,4/5,28.93%,NUP93;CDK1;NEK9;SEC13
344,prerank,Sema4D In Semaphorin Signaling R-HSA-400685,0.44399911773822076,1.4169250044634876,0.09706959706959707,0.19087734667636577,1.0,6/7,42.84%,MYH9;MYL6;ROCK2;MYH10;RHOC;MYH14
345,prerank,Semaphorin Interactions R-HSA-373755,0.29625824523446787,1.4163973278971298,0.12087912087912088,0.1905815240518811,1.0,12/17,42.84%,HSP90AB1;TLN1;HSP90AA1;DPYSL5;DPYSL2;MYH9;MYL6;ROCK2;MYH10;RHOC;NRP1;MYH14
346,prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.4442488262910798,-1.4145283748761164,0.11182795698924732,0.5180929608912829,1.0,7/7,55.82%,CPSF1;NUP93;NCBP1;SEC13;ALYREF;EIF4E;TPR
347,prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.4442488262910798,-1.4145283748761164,0.11182795698924732,0.5180929608912829,1.0,7/7,55.82%,CPSF1;NUP93;NCBP1;SEC13;ALYREF;EIF4E;TPR
348,prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.3305435732168738,1.3993040661281586,0.10740740740740741,0.20431270672893273,1.0,8/12,35.48%,YWHAZ;MYH9;YWHAQ;YWHAE;YWHAG;CALM1;RAB14;YWHAB
349,prerank,Glycogen Breakdown (Glycogenolysis) R-HSA-70221,0.4609970674486805,1.3928633617870676,0.11970534069981584,0.20960163720405067,1.0,6/6,54.06%,PYGB;PYGL;CALM1;PGM1;AGL;GAA
350,prerank,Cell-extracellular Matrix Interactions R-HSA-446353,0.3880789807103965,1.392053123324687,0.1198501872659176,0.2096360050786336,1.0,6/9,29.34%,FLNA;ACTN1;PARVB;RSU1;LIMS1;ILK
351,prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,0.37798438609535623,1.3887149435669628,0.1295238095238095,0.2118790529060582,1.0,8/9,51.96%,PGK1;ENO1;RPS27A;KPNB1;CORO1A;RAB7A;RAB5A;MAPK3
352,prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.5023407939650666,-1.3862493117756494,0.10752688172043011,0.5705821195499354,1.0,4/5,28.93%,SUMO2;NUP93;UBE2I;SEC13
353,prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,0.3316817889238878,1.385543463234703,0.122040072859745,0.21408735295038978,1.0,9/12,43.19%,TLN1;PDIA6;HYOU1;LMNA;DNAJB11;ACADVL;GFPT1;SEC31A;DCTN1
354,prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.3892191089461566,-1.3767206284859141,0.13125,0.5812943552028387,1.0,7/9,38.11%,HLA-G;STAT1;SAMHD1;IFITM1;ABCE1;PTPN11;HLA-C
355,prerank,Sensory Processing Of Sound R-HSA-9659379,0.32601456878593077,1.3724414429651386,0.13513513513513514,0.22534087332096514,1.0,8/12,36.29%,GSN;SPTBN1;MYH9;EZR;SPTAN1;CAPZA1;CAPZB;MSN
356,prerank,Cell Cycle R-HSA-1640170,0.11826593673965548,1.3702029978949173,0.11674347158218126,0.2266743251536759,1.0,88/123,61.72%,H2BC11;H2BC12;NPM1;TUBA1C;HSP90AB1;HSP90AA1;TUBB4B;TUBA4A;H2AZ1;RPS27A;RAN;PSMD14;PPP2CA;LMNA;YWHAZ;TUBB;EML4;FEN1;PSMC5;DYNC1H1;PSMC3;USO1;PSMC4;YWHAQ;PSMD13;PSMC1;TUBB3;RBBP4;YWHAE;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PCNA;YWHAG;PPP2R1A;TUBA8;PSMA7;RUVBL1;PSMD12;RUVBL2;PSMD11;ACTR1A;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;LMNB1;PSMD2;PAFAH1B1;DCTN1;PSMA5;TPR;RAB1B;TUBB2A;PSMB4;UBE2N;XPO1;YWHAH;PSMD5;RCC2;MAPK3;RPS27;PSMD7;NUDC;MAPRE1;PPP1CB;PSME3;RAB1A;BUB3;RAB2A;PSMB5;TNPO1;NUMA1;PSMB6;RBX1;PSMB9;PSME1
357,prerank,rRNA Processing R-HSA-72312,0.14875602713154953,1.36469322864546,0.12558869701726844,0.2310795429518149,1.0,55/72,63.18%,RPS27A;RPSA;RPS10;RPL22;RPLP1;RPS9;RPS16;RPS3;RPS25;RPLP0;RPS13;RPL10A;RPL30;RPS14;RPS2;RPL12;RPL27A;RPS4X;RPLP2;FBL;RPS5;RPL18;RPS11;RPL11;RPS3A;RPL5;RPS15A;RPS7;RPL14;RPL9;RPS8;RPL15;RPL27;RPL4;NOP56;NOP58;RPS23;RPL7;RPL29;RPL28;RPL26;RPL8;RPS6;RPS17;RPS27;RPS20;RPS12;SNU13;RRP9;RPL23;RPS19;RPL35A;RPL7A;MTREX;RPL18A
358,prerank,Retrograde Neurotrophin Signaling R-HSA-177504,0.41857629178067884,1.3582809281944501,0.12407407407407407,0.23639687877520477,1.0,6/7,44.71%,CLTC;AP2M1;AP2B1;AP2A1;DNM2;CLTA
359,prerank,Biological Oxidations R-HSA-211859,0.18846098345531564,1.3534945947694117,0.13725490196078433,0.23991010224735218,1.0,26/40,47.87%,AHCY;HSP90AB1;GSTA5;UGDH;ALDH1A1;UGP2;GSTO1;AKR1A1;ADH5;ESD;FDXR;CYB5R3;PTGES3;MAT2A;MAT1A;GSTP1;CNDP2;EPHX1;AKR7A2;ALDH2;GSTM3;GSTA1;GSTM2;SULT1A1;NNMT;CBR3
360,prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.4571803596900633,1.3523387659604333,0.1317365269461078,0.2395707916605488,1.0,3/6,7.07%,H2BC11;H2BC12;H2AZ1
361,prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.4571803596900633,1.3523387659604333,0.1317365269461078,0.2395707916605488,1.0,3/6,7.07%,H2BC11;H2BC12;H2AZ1
362,prerank,"Cell Cycle, Mitotic R-HSA-69278",0.12268199485060169,1.3519301513567865,0.1267387944358578,0.2392551109586273,1.0,80/111,61.72%,H2BC11;H2BC12;TUBA1C;HSP90AB1;HSP90AA1;TUBB4B;TUBA4A;H2AZ1;RPS27A;RAN;PSMD14;PPP2CA;LMNA;TUBB;EML4;FEN1;PSMC5;DYNC1H1;PSMC3;USO1;PSMC4;PSMD13;PSMC1;TUBB3;RBBP4;YWHAE;PSMC2;PSMC6;KPNB1;PSME2;PSMB2;PSMA6;PCNA;YWHAG;PPP2R1A;TUBA8;PSMA7;PSMD12;PSMD11;ACTR1A;PSMA1;PSMA4;PSMD8;PSMB3;RCC1;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;LMNB1;PSMD2;PAFAH1B1;DCTN1;PSMA5;TPR;RAB1B;TUBB2A;PSMB4;XPO1;PSMD5;RCC2;MAPK3;RPS27;PSMD7;NUDC;MAPRE1;PPP1CB;PSME3;RAB1A;BUB3;RAB2A;PSMB5;TNPO1;NUMA1;PSMB6;RBX1;PSMB9;PSME1
363,prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.3009742151920908,-1.351862968689693,0.12418300653594772,0.6301158447047724,1.0,11/13,53.83%,GNAI2;MMP2;GNB4;SRC;MAPK1;GNB2;NRAS;PRMT1;MAPK3;XPO1;GNB1
364,prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.44340175953079175,1.350085791383086,0.12454873646209386,0.2401305834439369,1.0,6/6,55.82%,PPA2;QARS1;GARS1;KARS1;DTD1;IARS2
365,prerank,MET Promotes Cell Motility R-HSA-8875878,0.3742730130623813,1.3500316695116852,0.12181818181818181,0.2394135862278799,1.0,4/9,9.00%,LAMB1;LAMC1;RAP1B;LAMA5
366,prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.4130747982237298,-1.3485854480436779,0.13232104121475055,0.6265220561467943,1.0,5/7,28.93%,SUMO2;NUP93;UBE2I;SMC1A;SEC13
367,prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.39102903967836633,1.3484406101621478,0.1336996336996337,0.2400135677037858,1.0,4/8,13.21%,H2BC11;H2BC12;XRCC5;XRCC6
368,prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.33280248978286014,1.346920408226951,0.13944954128440368,0.240732507674394,1.0,5/12,10.46%,GPC3;SDC1;AGRN;SDC4;HSPG2
369,prerank,Signal Transduction By L1 R-HSA-445144,-0.39178332895032875,-1.3464780734834414,0.13725490196078433,0.6206235757199089,1.0,7/8,48.16%,ITGB3;MAPK1;CSNK2B;NCAM1;ITGB1;MAP2K1;MAPK3
370,prerank,Oncogenic MAPK Signaling R-HSA-6802957,0.22825883560602586,1.345611314831527,0.1412639405204461,0.2412786257240595,1.0,9/27,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;PEBP1;LMNA;VWF
371,prerank,Estrogen-dependent Gene Expression R-HSA-9018519,0.29090768909684644,1.345326348499505,0.14210526315789473,0.24076910567639684,1.0,6/15,13.38%,H2BC11;H2BC12;HSP90AB1;HSP90AA1;H2AZ1;CTSD
372,prerank,Adaptive Immune System R-HSA-1280218,0.10810616744508969,1.3446728753439772,0.13282442748091602,0.24067702324276738,1.0,76/140,45.65%,C3;FGB;FGA;CLSTN1;IGLL5;PPIA;HSPA5;RAP1B;RPS27A;UBA1;FGG;PSMD14;CTSB;PPP2CA;YWHAZ;PDIA3;CTSD;CLTC;PSMC5;DYNC1H1;PSMC3;SEC23A;AP1B1;PSMC4;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;PSME2;CD74;PSMB2;PSMA6;CAPZA1;CALM1;PPP2R1A;MRC2;PSMA7;CAPZB;CTSH;PSMD12;HUWE1;AP2M1;PSMD11;ACTR1A;PSMA1;PSMA4;AP2B1;PSMD8;RAB7A;UBE2V1;AP2A1;YWHAB;PSMB3;SEC24C;PSMA3;PSMA2;PSMD3;KIF5B;DNM2;PSMB1;AP1M1;PSMD6;SEC31A;VASP;PSMD2;DCTN1;CDC42;PSMA5;AP1G1;NPEPPS;CLTA;ICOSLG;ELOB;CD81;PSMB4
373,prerank,Interleukin-12 Family Signaling R-HSA-447115,0.24509806990072447,1.3446087653360608,0.1386861313868613,0.2400134711842862,1.0,16/23,46.70%,PPIA;RAP1B;GSTO1;TCP1;CRLF1;RPLP0;P4HB;HSPA9;PSME2;CAPZA1;HNRNPA2B1;MSN;LMNB1;CDC42;HNRNPF;TALDO1
374,prerank,Sialic Acid Metabolism R-HSA-4085001,-0.3775701146720734,-1.344452783309579,0.12391304347826088,0.614311784982621,1.0,6/8,36.00%,ST3GAL1;ST3GAL6;CMAS;GNE;ST6GAL1;CTSA
375,prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.13688562558233744,1.3382429484285474,0.1435483870967742,0.2450679889559296,1.0,59/80,61.89%,FN1;FGB;FGA;TLN1;RAP1B;RPS27A;FGG;PSMD14;PPP2CA;PEBP1;VWF;SPTBN1;PSMC5;PSMC3;SPTAN1;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;IQGAP1;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;YWHAB;SEPTIN7;PSMB3;PSMA3;PSMA2;HSPB1;PSMD3;PSMB1;PSMD6;PSMD2;CDC42;PSMA5;PSMB4;XPO1;PSMD5;VCL;MAPK3;PSMD7;PPP1CB;PSME3;LYPLA1;PSMB5;PSMB6;RBX1;PSMB9;PSME1;MAP2K1
376,prerank,tRNA Aminoacylation R-HSA-379724,0.22804327915440317,1.337478718314641,0.13250883392226148,0.24509890726654393,1.0,21/27,56.05%,VARS1;RARS1;AARS1;HARS1;PPA2;DARS1;PPA1;SARS1;TARS1;IARS1;NARS1;QARS1;GARS1;FARSB;KARS1;DTD1;EPRS1;WARS1;MARS1;IARS2;LARS1
377,prerank,Ion Channel Transport R-HSA-983712,-0.35666256970215915,-1.3368889337384506,0.1416490486257928,0.6217207484217068,1.0,7/9,40.97%,SRI;CUTC;ATP6AP1;ASPH;STOM;ATP6V1B2;ATP6V1A
378,prerank,Glutathione Conjugation R-HSA-156590,0.3317097377015592,1.334484741039448,0.140625,0.24748657707015778,1.0,9/12,42.90%,GSTA5;GSTO1;AKR1A1;ESD;GSTP1;CNDP2;GSTM3;GSTA1;GSTM2
379,prerank,G Alpha (Q) Signaling Events R-HSA-416476,-0.3476146031641062,-1.3333799854246347,0.15051546391752577,0.6191722090063317,1.0,8/9,53.83%,GNB4;MAPK1;RPS6KA3;GNB2;NRAS;MAPK3;KNG1;GNB1
380,prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2591160775274136,-1.333076932526077,0.1515837104072398,0.5991883042147181,1.0,15/18,56.98%,DYNC1LI2;PPP2R5D;PPP1CC;RANGAP1;DYNC1LI1;CKAP5;SEC13;DYNC1I2;BUB3;MAPRE1;NUDC;RPS27;RCC2;XPO1;PAFAH1B1
381,prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.2591160775274136,-1.333076932526077,0.1515837104072398,0.5991883042147181,1.0,15/18,56.98%,DYNC1LI2;PPP2R5D;PPP1CC;RANGAP1;DYNC1LI1;CKAP5;SEC13;DYNC1I2;BUB3;MAPRE1;NUDC;RPS27;RCC2;XPO1;PAFAH1B1
382,prerank,Cell-Cell Communication R-HSA-1500931,0.23401915227374326,1.3309953998167978,0.14586994727592267,0.24992306762085761,1.0,13/25,30.45%,PARD3;FLNA;ANG;SPTBN1;ACTN1;SPTAN1;PARVB;RSU1;LIMS1;ACTN4;IQGAP1;ILK;CDH11
383,prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.3498559282533002,1.3283822749066738,0.15384615384615385,0.2516768610759354,1.0,6/10,26.83%,TUBA1C;TUBB4B;TUBA4A;TUBB;TUBB3;TUBA8
384,prerank,RAB Geranylgeranylation R-HSA-8873719,-0.2783018867924528,-1.322280219471252,0.13973799126637554,0.6135077412535664,1.0,15/15,72.47%,RAB9A;RAB4A;RAB8B;RABGGTA;RAB21;RAB5B;RAB2A;RAB1A;RAB6A;RAB5A;RAB1B;RAB5C;RAB7A;RAB18;RAB14
385,prerank,HATs Acetylate Histones R-HSA-3214847,0.32391393898129744,1.3211834184492304,0.13204225352112675,0.25780763395244183,1.0,4/11,6.66%,H2AC21;H2BC11;H2BC12;H2AC11
386,prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.41072642699585826,1.3194371430745708,0.16111111111111112,0.2587665380186913,1.0,6/7,45.70%,TUBA1C;TUBB4B;TUBB;TUBB3;TUBB2A;TTLL12
387,prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.4439882697947214,-1.3146595952157547,0.163135593220339,0.611363814069083,1.0,6/6,55.82%,NUP93;NCBP1;SEC13;ALYREF;EIF4E;TPR
388,prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.4439882697947214,-1.3146595952157547,0.163135593220339,0.611363814069083,1.0,6/6,55.82%,NUP93;NCBP1;SEC13;ALYREF;EIF4E;TPR
389,prerank,NCAM1 Interactions R-HSA-419037,0.43306887596020394,1.3138086655206622,0.1751412429378531,0.26367398481598125,1.0,4/6,25.07%,AGRN;COL6A1;COL6A3;COL6A2
390,prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.19090858686933304,-1.3130832775816739,0.14691943127962084,0.6052804644879497,1.0,32/34,75.22%,KLC4;UBE2Z;RAB3GAP2;DYNC1LI2;DCTN4;DCTN3;GALNT2;COPZ1;DYNC1LI1;DCTN2;DYNC1I2;KLC1;COPE;PAFAH1B3;CAPZA2;RAB1A;RAB6A;RAB1B;DCTN1;PAFAH1B1;COPG1;KIF5B;ARCN1;COPB2;RAB18;ACTR1A;NSF;CAPZB;ARF5;ARF4;CAPZA1;COPB1
391,prerank,Reproduction R-HSA-1474165,0.3561639349558667,1.2958483398941654,0.1705989110707804,0.2809717574986166,1.0,4/9,11.28%,H2BC11;H2BC12;H2AZ1;LMNA
392,prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.32004121236838223,-1.2945517030863516,0.1761904761904762,0.6383584413882736,1.0,10/11,58.45%,CSTF2;CPSF1;NUP93;RPP30;FAM98B;SEC13;XPOT;RTCB;TPR;DDX1
393,prerank,Signaling By ERBB4 R-HSA-1236394,-0.39381176118452577,-1.287784802993561,0.1870967741935484,0.6446464332573717,1.0,4/7,14.96%,SPARC;COPS2;NEDD4;SRC
394,prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.3485750033308686,1.284590502156833,0.16195856873822975,0.2917472232705708,1.0,5/9,23.61%,H2BC11;H2BC12;H2AZ1;NOTCH3;B4GALT1
395,prerank,Metabolism Of Lipids R-HSA-556833,-0.1242959729000503,-1.2809044882942748,0.15625,0.6524634183546737,1.0,38/75,37.23%,SUMO2;HMGCL;ACAA1;RAB4A;GPD1L;PIP4K2A;ACSL4;SMPD1;ACSL1;PCCA;PTGR2;UBE2I;CPNE1;PPP1CC;STARD10;ESYT1;ACAA2;PPT1;PCCB;HADHB;MED6;PLD3;PCYT1A;CSNK2B;PLA1A;ACOT1;CARM1;BDH2;CPNE3;SAR1B;PCYT2;HEXA;GGT1;MBTPS1;FABP1;CTSA;HADHA;HADH
396,prerank,Signaling By EGFR R-HSA-177929,-0.33572673334893066,-1.2804315211037438,0.16274089935760172,0.64404595914051,1.0,7/10,35.24%,PTPRK;CSK;EPS15L1;SRC;NRAS;SH3GL1;PTPN11
397,prerank,CDC42 GTPase Cycle R-HSA-9013148,-0.2927143510790633,-1.2797517364238469,0.16052060737527116,0.6361784407154203,1.0,7/12,27.82%,SRGAP2;IQGAP2;ARHGDIA;ARHGAP17;ARHGAP1;TMPO;STOM
398,prerank,Degradation Of Extracellular Matrix R-HSA-1474228,0.2195472975695986,1.2704130607818642,0.19499105545617174,0.306720080021128,1.0,9/25,16.07%,PLG;LAMB1;LAMC1;LAMA5;CTSB;HSPG2;NID1;CTSD;COL18A1
399,prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.3858028444392241,1.2694661345640794,0.19600725952813067,0.30602626447358183,1.0,3/7,7.25%,H2BC11;H2BC12;RPS27A
400,prerank,DNA Double Strand Break Response R-HSA-5693606,0.3858028444392241,1.2694661345640794,0.19600725952813067,0.30602626447358183,1.0,3/7,7.25%,H2BC11;H2BC12;RPS27A
401,prerank,Apoptotic Execution Phase R-HSA-75153,0.2667418446044051,1.2690277708182527,0.17406749555950266,0.30562260153664833,1.0,8/17,22.62%,GSN;H1-2;H1-1;H1-0;LMNA;H1-5;SPTAN1;KPNB1
402,prerank,Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,-0.4597425140448287,-1.2672751681684957,0.19294605809128632,0.6569991548860411,1.0,4/5,33.55%,UAP1;GNPNAT1;NAGK;PGM3
403,prerank,O-linked Glycosylation R-HSA-5173105,-0.28386377993203926,-1.2666217390733867,0.18092909535452323,0.6493246128243809,1.0,10/13,47.34%,ST3GAL1;ADAMTSL2;ADAMTSL4;GALNT2;ST6GAL1;THBS2;SPON1;MUC6;SPON2;DAG1
404,prerank,MTOR Signaling R-HSA-165159,-0.3890945634376749,-1.2663938533568406,0.17729083665338646,0.6407106406351106,1.0,6/7,46.52%,PRKAA1;FKBP1A;PRKAG1;EIF4B;EIF4E;RPS6
405,prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.14842523695046508,1.2662605499717716,0.19639934533551553,0.3077143321064022,1.0,47/58,67.62%,CLSTN1;RPS27A;PSMD14;PPP2CA;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;CALM1;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PRKAR2A;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;MAPK3;USP7;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1;PDGFA;PTPN11;IL1RAP;PRKAR1A
406,prerank,Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,0.3206903654861034,1.265850129925934,0.19318181818181818,0.30727557301878455,1.0,9/11,50.56%,ANGPTL8;APOC2;PCSK6;LPL;APOA4;APOA5;ANGPTL4;ANGPTL3;PCSK5
407,prerank,Signaling By RAF1 Mutants R-HSA-9656223,0.24701124616441292,1.265833179619675,0.19172932330827067,0.30637904596403326,1.0,7/20,12.86%,FN1;FGB;FGA;TLN1;RAP1B;FGG;VWF
408,prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.4558987244537885,1.2654420860599485,0.16326530612244897,0.3050273831229935,1.0,4/5,35.42%,AP2M1;NSF;AP2B1;AP2A1
409,prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.4558987244537885,1.2654420860599485,0.16326530612244897,0.3050273831229935,1.0,4/5,35.42%,AP2M1;NSF;AP2B1;AP2A1
410,prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.31810399001373524,1.2632993359204012,0.15749525616698293,0.30671214004664427,1.0,4/11,7.25%,H2BC11;H2BC12;H2AZ1;RPS27A
411,prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.31454056129915736,1.2631953296349345,0.1853932584269663,0.3059202319649147,1.0,9/11,51.96%,LTF;PGK1;ENO1;RPS27A;KPNB1;CORO1A;RAB7A;RAB5A;MAPK3
412,prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.22966981254207564,1.2605171093309944,0.18971631205673758,0.3079716949455422,1.0,11/23,26.83%,TUBA1C;TUBB4B;TUBA4A;RAN;PPP2CA;LMNA;TUBB;TUBB3;KPNB1;PPP2R1A;TUBA8
413,prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,0.15720041611436186,1.260355548823001,0.1834710743801653,0.307191335842871,1.0,28/48,44.36%,MAN1A1;F5;SERPINA1;SPTBN1;COPA;DYNC1H1;SPTAN1;SEC23A;USO1;MAN2A1;LMAN2;B4GALT1;COPB1;CAPZA1;ARF4;ARF5;CAPZB;NSF;ACTR1A;COPB2;SEC24C;ARCN1;CTSZ;COPG1;FUCA1;SEC31A;DCTN1;RAB1B
414,prerank,Collagen Formation R-HSA-1474290,0.18678828482552925,1.2501790590962834,0.21565217391304348,0.317587953991801,1.0,15/33,28.58%,PPIB;PLOD1;COL6A1;CTSB;PLOD2;COL6A3;COL18A1;COL1A1;P4HB;PLOD3;COL2A1;P4HA1;COL6A2;SERPINH1;PCOLCE
415,prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.3847598493258144,1.2440438971041683,0.19444444444444445,0.32395435612634504,1.0,3/7,7.07%,H2BC11;H2BC12;H2AZ1
416,prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.41055718475073316,-1.2420157595552364,0.189873417721519,0.6897222671559238,1.0,6/6,59.15%,SUMO2;NUP93;UBE2I;SEC13;TPR;HDAC1
417,prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.3821933545409229,1.2376368110298408,0.21482889733840305,0.33050803644435855,1.0,3/7,7.07%,H2BC11;H2BC12;H2AZ1
418,prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.3609590681475532,-1.2370004222698325,0.21521739130434783,0.6934165364867665,1.0,5/8,24.96%,RAD50;PRKAA1;MAPK14;PRKAG1;CSNK2B
419,prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.2511396324968167,-1.2369911041852872,0.20634920634920634,0.6841903950770741,1.0,9/16,30.16%,CTNNA1;ITGB3;SRC;MAPK14;ABI1;VEGFA;NCKAP1;CTNNB1;NRAS
420,prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.3821847373766695,1.235977645336494,0.21442495126705652,0.3314808169214193,1.0,3/7,7.07%,H2BC11;H2BC12;H2AZ1
421,prerank,EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.41516966844499037,1.2358882195797534,0.2140221402214022,0.33065440065192053,1.0,5/6,42.84%,MYH9;MYL6;ROCK2;MYH10;MYH14
422,prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,0.3855691018942665,1.2351626975111003,0.22682445759368836,0.33064187094202097,1.0,3/7,7.07%,H2BC11;H2BC12;H2AZ1
423,prerank,Phase II - Conjugation Of Compounds R-HSA-156580,0.21289381095171503,1.2349853833963322,0.21926910299003322,0.3299126256987533,1.0,23/25,71.36%,AHCY;GSTA5;UGDH;UGP2;GSTO1;AKR1A1;ESD;MAT2A;MAT1A;GSTP1;CNDP2;GSTM3;GSTA1;GSTM2;SULT1A1;NNMT;MAT2B;SULT2A1;GCLC;GGT1;SULT1E1;GSTM1;PAPSS1
424,prerank,Calnexin/calreticulin Cycle R-HSA-901042,0.412316715542522,1.2326721585342129,0.20265151515151514,0.33146987957880303,1.0,6/6,58.91%,RPS27A;GANAB;PDIA3;UGGT1;OS9;CALR
425,prerank,Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.3824233446749731,1.2321961095302172,0.2230347349177331,0.3310695165340379,1.0,6/7,48.39%,YWHAZ;YWHAQ;YWHAE;YWHAG;YWHAB;YWHAH
426,prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.3472204277169157,-1.2275684135617493,0.20956719817767655,0.6986647733812122,1.0,4/8,12.45%,SUMO2;BABAM2;RAD50;UBE2I
427,prerank,PIP3 Activates AKT Signaling R-HSA-1257604,0.14795491986638334,1.2271265329775751,0.2288961038961039,0.33615429461332924,1.0,43/55,64.87%,CLSTN1;RPS27A;PSMD14;PPP2CA;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;RBBP4;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PPP2R1A;PSMA7;PSMD12;PSMD11;PSMA1;PSMA4;PSMD8;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;HDAC1;PSMD6;PSMD2;PSMA5;PSMB4;PSMD5;MAPK3;USP7;PSMD7;PSME3;PSMB5;PSMB6;PSMB9;PSME1;PDGFA;PTPN11
428,prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.2490419374318793,1.2256104030746826,0.19859402460456943,0.33719791835030544,1.0,6/18,10.46%,GPC3;SDC1;AGRN;EXT1;SDC4;HSPG2
429,prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.1430964967598754,1.2227962059047324,0.2224,0.33956362655209743,1.0,44/59,61.72%,RPS27A;UBA1;PSMD14;PSMC5;PSMC3;PSMC4;PSMD13;PSMC1;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;PSMA7;PSMD12;HUWE1;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;PSMD2;PSMA5;NPEPPS;ELOB;PSMB4;UBE2N;PSMD5;FBXO2;PSMD7;PSME3;FBXO22;PSMB5;UFL1;PSMB6;RBX1;PSMB9;PSME1
430,prerank,Fructose Metabolism R-HSA-5652084,0.44576413153904076,1.2180569922087305,0.21764705882352942,0.3445406570185731,1.0,4/5,36.18%,ALDH1A1;SORD;AKR1B1;TKFC
431,prerank,SARS-CoV Infections R-HSA-9679506,0.11293393663323402,1.2140655028115468,0.22570532915360503,0.34855619702111007,1.0,49/101,39.33%,GPC3;VCP;HSP90AB1;HSP90AA1;SDC1;IGLL5;AGRN;RPS27A;SDC4;RPSA;GANAB;HSPG2;RPS10;SNRPD3;YWHAZ;TUBB;MASP1;RPS9;RPS16;RPS3;RPS25;SEC23A;RPS13;YWHAQ;HLA-A;RBBP4;YWHAE;MAN2A1;RPS14;RPS2;YWHAG;RPS4X;PTGES3;SNRPD2;RPS5;AP2M1;RPS11;ROCK2;RPS3A;AP2B1;UBE2V1;AP2A1;YWHAB;TKFC;SEC24C;GPC6;NRP1;RPS15A;RPS7
432,prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.2241263010679319,-1.211782646753253,0.21577726218097448,0.7301492760628869,1.0,16/20,56.98%,DYNC1LI2;PPP2R5D;PPP1CC;NEK9;RANGAP1;DYNC1LI1;CKAP5;SEC13;DYNC1I2;BUB3;MAPRE1;NUDC;RPS27;RCC2;XPO1;PAFAH1B1
433,prerank,Signaling To ERKs R-HSA-187687,-0.37263691831091506,-1.2050523685207564,0.22717149220489977,0.7373915983041734,1.0,6/7,48.16%,SRC;MAPK14;MAPK1;NRAS;MAP2K1;MAPK3
434,prerank,Interleukin-6 Family Signaling R-HSA-6783589,-0.4378819683307926,-1.2037380395652193,0.2386117136659436,0.7313011200184616,1.0,4/5,35.24%,JAK2;STAT1;STAT3;PTPN11
435,prerank,PERK Regulates Gene Expression R-HSA-381042,-0.32755946235652633,-1.2001618627514867,0.23829787234042554,0.7314960120157448,1.0,6/9,32.67%,EXOSC6;ASNS;EIF2S2;EXOSC4;KHSRP;IGFBP1
436,prerank,TBC/RABGAPs R-HSA-8854214,-0.3487962419260129,-1.1993205835708889,0.23157894736842105,0.7241907446198127,1.0,8/8,65.34%,RAB4A;RAB8B;ARF6;RAB5B;RAB6A;RAB5A;RAB5C;RAB7A
437,prerank,FLT3 Signaling R-HSA-9607240,-0.4343211438728226,-1.1977798007459781,0.24130879345603273,0.7196825543198461,1.0,4/5,35.24%,CSK;STAT5B;NRAS;PTPN11
438,prerank,Toll-like Receptor Cascades R-HSA-168898,0.19026562866625227,1.196635277289222,0.2392086330935252,0.36898411670514863,1.0,8/29,10.64%,APOB;FGB;FGA;HSP90B1;RPS27A;FGG;CTSB;PPP2CA
439,prerank,RND2 GTPase Cycle R-HSA-9696270,-0.39824046920821116,-1.1956840681980274,0.2288888888888889,0.7159495658207722,1.0,6/6,60.37%,ARHGAP1;NUDC;RBMX;TFRC;TXNL1;KTN1
440,prerank,Cytokine Signaling In Immune System R-HSA-1280215,0.10036883138035527,1.1934530741318956,0.2453125,0.37193337169298324,1.0,71/129,47.17%,FN1;F13A1;HSP90AA1;CLSTN1;SDC1;PPIA;TGFB1;FLNA;RAP1B;HSP90B1;RPS27A;LAMA5;PSMD14;PPP2CA;YWHAZ;GSTO1;HSPA8;TCP1;EIF4A1;PSMC5;PSMC3;CRLF1;FLNB;RPLP0;APP;PSMC4;PSMD13;PSMC1;HLA-A;P4HB;HSPA9;PSMC2;PSMC6;KPNB1;LBP;PSME2;PSMB2;PSMA6;CAPZA1;PPP2R1A;PSMA7;EIF4A3;FSCN1;PSMD12;CCL20;PSMD11;HNRNPA2B1;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;MSN;PSMA3;PSMA2;PSMD3;TIMP1;PSMB1;EIF4A2;PSMD6;LMNB1;PSMD2;CDC42;PSMA5;HNRNPF;TPR;ELOB;PSMB4;TALDO1;UBE2N;COL1A2
441,prerank,Neddylation R-HSA-8951664,-0.12320242337212145,-1.1932579206921776,0.24867724867724866,0.713345408542995,1.0,61/64,83.23%,COPS2;CUL4A;PSMD4;WDR5;PSMB10;SKP1;CUL5;CUL3;NAE1;NPLOC4;CUL4B;CUL1;CUL2;UBE2D2;UBE2M;RBBP7;UCHL3;COPS5;COPS4;PSME1;PSMB9;RBX1;PSMB6;PSMB5;FBXO22;PSME3;COPS6;PSMD7;FBXO2;COPS3;PSMD5;PSMB4;ELOB;PSMA5;GPS1;PSMD2;PSMD6;COPS8;PSMB1;PSMD3;PSMA2;PSMA3;PSMB3;PSMD8;PSMA4;PSMA1;DDB1;PSMD11;PSMD12;PSMA7;PSMA6;PSMB2;PSME2;PSMC6;PSMC2;PSMC1;PSMD13;CAND1;PSMC4;PSMC3;PSMC5
442,prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.43611040663547895,1.192482309228526,0.24242424242424243,0.3720688129710404,1.0,3/5,18.70%,APOE;APOC2;PLTP
443,prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.12126285176440921,1.1917590534444662,0.24572317262830481,0.3719282331447569,1.0,58/80,62.01%,FGB;FGA;HSPA5;RPS27A;UBA1;FGG;PSMD14;PDIA3;PSMC5;PSMC3;SEC23A;PSMC4;PSMD13;PSMC1;HLA-A;PSMC2;PSMC6;PSME2;PSMB2;PSMA6;MRC2;PSMA7;PSMD12;HUWE1;PSMD11;PSMA1;PSMA4;PSMD8;UBE2V1;PSMB3;SEC24C;PSMA3;PSMA2;PSMD3;PSMB1;PSMD6;SEC31A;PSMD2;PSMA5;NPEPPS;ELOB;PSMB4;UBE2N;PSMD5;CTSV;FBXO2;PSMD7;SEC24A;PSME3;CALR;FBXO22;PSMB5;UFL1;PSMB6;RBX1;PSMB9;PSME1;HLA-C
444,prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.29458697929425637,1.1913502865037924,0.2447418738049713,0.37139006349365533,1.0,7/11,36.29%,SPTBN1;MYH9;EZR;SPTAN1;CAPZA1;CAPZB;MSN
445,prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.23088672152209033,1.190742673451744,0.26,0.3710918927169723,1.0,6/20,9.00%,FN1;F13A1;HSP90AA1;TGFB1;HSP90B1;LAMA5
446,prerank,Elastic Fibre Formation R-HSA-1566948,0.25036247931102196,1.1902289910975437,0.2328042328042328,0.37069215981713455,1.0,6/16,14.96%,VTN;FBLN1;TGFB1;EFEMP1;FBLN5;LTBP4
447,prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.31384395441401636,1.1830933139464532,0.26992753623188404,0.3782726923406504,1.0,5/10,20.51%,VCP;RPS27A;GANAB;PDIA3;PSMC1
448,prerank,G2/M DNA Damage Checkpoint R-HSA-69473,0.28315201101503706,1.1818566566570725,0.23674911660777384,0.378842139250314,1.0,9/12,48.39%,H2BC11;H2BC12;YWHAZ;YWHAQ;YWHAE;YWHAG;YWHAB;UBE2N;YWHAH
449,prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.387683284457478,-1.18161259966335,0.24835164835164836,0.7349195903760303,1.0,6/6,61.43%,GNAI2;GNB4;GNB2;PRKAR1A;GNB1;PRKAR2A
450,prerank,Protein Ubiquitination R-HSA-8852135,0.25221930974180284,1.1811505778679976,0.26629422718808193,0.3785829986601504,1.0,5/16,8.01%,H2BC11;H2BC12;VCP;RPS27A;UBA1
451,prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.26356132075471705,1.1769289944934174,0.25092250922509224,0.3828694806447789,1.0,15/15,73.87%,GPC3;SDC1;AGRN;SDC4;HSPG2;HEXB;VCAN;GPC6;CHPF;XYLT2;HEXA;BGN;GPC1;B3GAT3;CSPG4
452,prerank,Gluconeogenesis R-HSA-70263,0.2856518468012084,1.1757092026494504,0.24906367041198502,0.3833626828085904,1.0,6/12,23.20%,PGK1;ENO1;ALDOC;TPI1;MDH2;PCK2
453,prerank,Autophagy R-HSA-9612973,0.23807917248541172,1.1687861511955504,0.2546816479400749,0.39116314198673546,1.0,7/18,17.36%,VCP;HSP90AB1;HSP90AA1;EEF1A1;RPS27A;HSPA8;DYNC1H1
454,prerank,Myogenesis R-HSA-525793,-0.4091441969519343,-1.1620419501773125,0.24568965517241378,0.7773400550520893,1.0,5/5,59.26%,CTNNA1;MAPK14;CTNNB1;CDC42;NEO1
455,prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.2766093733255882,1.1528497840098832,0.275,0.41137221692953674,1.0,10/12,56.58%,RPS9;RPS14;RPS2;FBL;RPS7;NOP56;NOP58;RPS6;SNU13;RRP9
456,prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.32429061687111926,-1.152283998072384,0.2532467532467532,0.7939508395331601,1.0,5/8,28.93%,NUP93;CDK1;NEK9;TMPO;SEC13
457,prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.3485915492957747,-1.148064846210534,0.2890792291220557,0.7957819729300463,1.0,7/7,65.34%,SLC1A5;ARHGAP1;TMPO;STOM;TFRC;CDC42;RAB7A
458,prerank,Signaling By VEGF R-HSA-194138,-0.21902626173334927,-1.146082912493362,0.2880184331797235,0.7916255434280797,1.0,16/18,66.63%,CTNNA1;ITGB3;SRC;MAPK14;ABI1;VEGFA;NCKAP1;CTNNB1;NRAS;CYFIP2;CDH5;NRP2;CDC42;NRP1;HSPB1;ROCK2
459,prerank,Homology Directed Repair R-HSA-5693538,0.2856188901622163,1.1417823704289014,0.2974910394265233,0.425622052228582,1.0,6/11,28.70%,H2BC11;H2BC12;RPS27A;FEN1;PCNA;PARP1
460,prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.21217494089834515,-1.1390236985079396,0.27610208816705334,0.8001714571072696,1.0,19/19,79.08%,RAB9A;RAB4A;RAB3GAP2;GAPVD1;GDI1;RAB8B;ARF6;RAB21;RAB5B;RAB1A;RAB6A;RAB5A;RAB1B;RAB5C;RAB7A;RAB18;RAB14;YWHAE;GDI2
461,prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.3453344706255561,1.1343041131161549,0.29300567107750475,0.4344415059606262,1.0,6/7,51.96%,RPS27A;SERPINE1;YBX1;HDAC1;COL1A2;MAPK3
462,prerank,HCMV Late Events R-HSA-9610379,0.2658851007191555,1.1325638993811538,0.2977624784853701,0.43589789250844246,1.0,4/13,6.66%,H2AC21;H2BC11;H2BC12;H2AC11
463,prerank,Heme Degradation R-HSA-189483,0.37618595497791724,1.132552681256154,0.28,0.43474208394444513,1.0,3/6,15.08%,ALB;BLVRB;BLVRA
464,prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.37986636583279076,1.1316516091066053,0.30357142857142855,0.43365097892159843,1.0,4/6,30.74%,C3;C5;APP;CCL20
465,prerank,Peptide Ligand-Binding Receptors R-HSA-375276,0.37986636583279076,1.1316516091066053,0.30357142857142855,0.43365097892159843,1.0,4/6,30.74%,C3;C5;APP;CCL20
466,prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.3346148179671985,1.1306177306025293,0.299625468164794,0.4339624469222262,1.0,4/8,18.70%,APOE;FASN;APOC2;PLTP
467,prerank,RHOA GTPase Cycle R-HSA-8980692,-0.24572775486152032,-1.1286354315123788,0.30701754385964913,0.8175131212732207,1.0,14/14,75.69%,FLOT1;OBSCN;ARHGDIA;ATP6AP1;ARHGAP1;TMPO;STOM;SCFD1;TFRC;KTN1;DIAPH1;ROCK2;IQGAP1;C1QBP
468,prerank,RHO GTPases Activate ROCKs R-HSA-5627117,0.33424111457060746,1.124304705570844,0.2886405959031657,0.4414848811218029,1.0,6/8,42.84%,MYH9;MYL6;ROCK2;MYH10;RHOC;MYH14
469,prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.2683606307417794,1.1219629759654453,0.2885662431941924,0.44337792409236965,1.0,6/12,25.07%,AGRN;COL6A1;COL6A3;SPTBN1;SPTAN1;COL6A2
470,prerank,Cytosolic tRNA Aminoacylation R-HSA-379716,0.20032435313489905,1.1177936875063754,0.3100358422939068,0.44795149857283195,1.0,18/24,56.05%,VARS1;RARS1;AARS1;HARS1;DARS1;PPA1;SARS1;TARS1;IARS1;NARS1;QARS1;GARS1;FARSB;KARS1;EPRS1;WARS1;MARS1;LARS1
471,prerank,Recycling Pathway Of L1 R-HSA-437239,0.25923005442459246,1.116716408589634,0.30654205607476637,0.44836489820586756,1.0,9/13,44.71%,CLTC;DPYSL2;EZR;AP2M1;AP2B1;AP2A1;MSN;DNM2;CLTA
472,prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.3223848334838226,-1.1143544052788337,0.30151843817787416,0.8462439288262781,1.0,5/8,28.93%,SUMO2;NUP93;UBE2I;RANGAP1;SEC13
473,prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.2938458144207548,-1.1141366461405626,0.2975391498881432,0.8376533247495977,1.0,4/9,12.45%,SUMO2;BABAM2;RAD50;UBE2I
474,prerank,Platelet Homeostasis R-HSA-418346,-0.24553943102874173,-1.10993763594527,0.30257510729613735,0.8398552076798113,1.0,8/13,35.24%,SRI;GNB4;PPP2R5D;MAPK14;PDE5A;GNB2;PDE2A;PTPN11
475,prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.21192443919716647,-1.1093668397291974,0.3004484304932735,0.8325165340670232,1.0,17/17,79.08%,RAB9A;RAB3GAP2;GAPVD1;GDI1;RAB8B;RAB21;RAB5B;RAB1A;RAB6A;RAB5A;RAB1B;RAB5C;RAB7A;RAB18;RAB14;YWHAE;GDI2
476,prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.39404928130695,-1.109048354672421,0.32426778242677823,0.8245724522170814,1.0,3/5,18.41%,ACSL4;ACSL1;PPT1
477,prerank,COPI-mediated Anterograde Transport R-HSA-6807878,0.1795547155537796,1.1074303817777371,0.328042328042328,0.46021888718377596,1.0,17/28,44.36%,SPTBN1;COPA;DYNC1H1;SPTAN1;USO1;COPB1;CAPZA1;ARF4;ARF5;CAPZB;NSF;ACTR1A;COPB2;ARCN1;COPG1;DCTN1;RAB1B
478,prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,0.34053762399769727,1.1068874173210976,0.32897196261682243,0.4598124178286392,1.0,3/7,10.81%,HSP90AA1;RPS27A;FASN
479,prerank,Regulation Of Insulin Secretion R-HSA-422356,-0.2862232105241002,-1.1054499410804481,0.34505494505494505,0.8254451976532349,1.0,4/10,9.94%,MARCKS;ACSL4;GNAI2;GNB4
480,prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.2929167415161984,-1.1028479011226775,0.3143507972665148,0.8152991659569244,1.0,8/9,58.68%,ACSL1;MED6;CARM1;FABP1;SULT2A1;HMGCS1;ANGPTL4;APOA5
481,prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.2929167415161984,-1.1028479011226775,0.3143507972665148,0.8152991659569244,1.0,8/9,58.68%,ACSL1;MED6;CARM1;FABP1;SULT2A1;HMGCS1;ANGPTL4;APOA5
482,prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.35506337952877776,-1.0997063283854678,0.3162217659137577,0.8160200722786181,1.0,4/6,30.16%,MPP2;MAPK1;RPS6KA3;NRAS
483,prerank,FGFR2 Alternative Splicing R-HSA-6803529,-0.31139196493082644,-1.0922654954606605,0.346072186836518,0.8268461427663379,1.0,7/8,55.99%,POLR2H;TIAL1;NCBP1;HNRNPM;HNRNPH1;PTBP1;HNRNPF
484,prerank,Drug ADME R-HSA-9748784,-0.23525723890370942,-1.091880707556699,0.335632183908046,0.8198745775961559,1.0,14/15,68.97%,CES1;PCK1;GSTM1;SULT1E1;GGT1;NT5C2;SULT2A1;BSG;IMPDH2;SULT1A1;GSTA1;GMPS;CNDP2;GSTP1
485,prerank,SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,-0.38766615128871823,-1.090864496195862,0.3246445497630332,0.8065856409548143,1.0,4/5,40.33%,NCBP1;SNRPB;SNRPF;SNRPE
486,prerank,SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,-0.38766615128871823,-1.090864496195862,0.3246445497630332,0.8065856409548143,1.0,4/5,40.33%,NCBP1;SNRPB;SNRPF;SNRPE
487,prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.2215903159825292,-1.087945358860644,0.36384976525821594,0.8061280627160056,1.0,15/16,71.42%,COPS2;CUL4A;RAD23B;CUL4B;COPS5;ACTL6A;COPS4;RBX1;COPS6;COPS3;GPS1;COPS8;DDB1;RUVBL1;PARP1
488,prerank,RHO GTPases Activate Formins R-HSA-5663220,-0.1761715335997972,-1.0862945714273848,0.3357487922705314,0.8022796570565899,1.0,22/26,66.45%,SRGAP2;DYNC1LI2;PPP2R5D;PPP1CC;SRC;RANGAP1;DYNC1LI1;CKAP5;SEC13;DYNC1I2;ITGB1;BUB3;MAPRE1;NUDC;RPS27;RCC2;XPO1;CDC42;PAFAH1B1;PFN2;RHOC;DIAPH1
489,prerank,ER To Golgi Anterograde Transport R-HSA-199977,0.14435430825407408,1.0814603549938826,0.33793103448275863,0.49638680029962473,1.0,24/42,44.36%,F5;SERPINA1;SPTBN1;COPA;DYNC1H1;SPTAN1;SEC23A;USO1;LMAN2;COPB1;CAPZA1;ARF4;ARF5;CAPZB;NSF;ACTR1A;COPB2;SEC24C;ARCN1;CTSZ;COPG1;SEC31A;DCTN1;RAB1B
490,prerank,Membrane Trafficking R-HSA-199991,-0.07813986943369024,-1.0783015152571618,0.3253012048192771,0.8154300801501418,1.0,123/132,85.56%,COG2;RAB9A;COPS2;RAB4A;AP1G2;ASPSCR1;TXNDC5;KLC4;UBE2Z;EPS15L1;ACBD3;ARPC1A;SCARB2;RAB3GAP2;DYNC1LI2;COL7A1;SRC;AP1S1;GAPVD1;VPS36;AP2A2;TFG;AP1S2;TOR1B;ARRB1;PRKAG1;TSG101;GNS;DCTN4;DCTN3;CLTB;GALNT2;GDI1;COPZ1;DYNC1LI1;RAB8B;SEC13;ARF6;DCTN2;SAR1B;COPS5;DYNC1I2;VPS25;SH3GL1;KLC1;ACTR2;SCFD1;COPE;COPS4;RAB21;PAFAH1B3;CAPZA2;RAB5B;RAB1A;LRP2;SNX5;AKR1B10;SEC24A;COPS6;TFRC;RAB6A;CTSC;COPS3;PACSIN2;ARPC3;FTL;YWHAH;RAB5A;AP3B1;CLTA;RAB1B;AP1G1;GPS1;DCTN1;PAFAH1B1;SEC31A;AP1M1;COPS8;COPG1;DNM2;KIF5B;CTSZ;ARCN1;SEC24C;COPB2;ARPC5;YWHAB;AP2A1;RAB5C;RAB7A;AP2B1;RAB18;ACTR1A;LDLR;SNX2;NSF;ARPC2;AP2M1;CAPZB;RAB14;ARF5;CALM1;ARF4;CAPZA1;YWHAG;COPB1;ACTR3;LMAN2;MAN2A1;YWHAE;FTH1;GDI2;YWHAQ;USO1;AP1B1;APP;SEC23A;SPTAN1;DYNC1H1;COPA;MYH9;SPTBN1;HSPA8
491,prerank,Metabolism Of Steroids R-HSA-8957322,0.20948020917180712,1.0763656140111066,0.3397548161120841,0.5030798389007344,1.0,9/20,26.07%,ALB;GC;RAN;AKR1C3;FASN;SEC23A;KPNB1;HSD17B4;FDXR
492,prerank,Signaling By MET R-HSA-6806834,0.22269784066526885,1.0745658476961695,0.34341637010676157,0.5043531881254442,1.0,5/17,9.00%,LAMB1;LAMC1;RAP1B;RPS27A;LAMA5
493,prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.34637621946598185,-1.073293493730171,0.3346456692913386,0.8209225146871891,1.0,4/6,30.74%,MTA2;POLR2H;RBBP7;POLR1D
494,prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.38745603751465413,-1.073118008676356,0.35667396061269147,0.7992207299489255,1.0,5/5,61.43%,GNB4;GNB2;PRKAR1A;GNB1;PRKAR2A
495,prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.38745603751465413,-1.073118008676356,0.35667396061269147,0.7992207299489255,1.0,5/5,61.43%,GNB4;GNB2;PRKAR1A;GNB1;PRKAR2A
496,prerank,Aquaporin-mediated Transport R-HSA-445717,-0.38745603751465413,-1.073118008676356,0.35667396061269147,0.7992207299489255,1.0,5/5,61.43%,GNB4;GNB2;PRKAR1A;GNB1;PRKAR2A
497,prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.37599601753790535,1.0706493858191417,0.362453531598513,0.5091673780564803,1.0,3/5,24.61%,VCP;RPS27A;PCNA
498,prerank,GPCR Downstream Signaling R-HSA-388396,-0.16004896493338444,-1.067190073961245,0.3780487804878049,0.7991642593825008,1.0,15/30,32.73%,OBSCN;GNAI2;GNB4;PPP2R5D;SRC;ARRB1;MAPK1;PPP3CA;RPS6KA3;GNB2;PDE2A;NRAS;HEBP1;PRKAR1A;ITGB1
499,prerank,Signaling By GPCR R-HSA-372790,-0.16004896493338444,-1.067190073961245,0.3780487804878049,0.7991642593825008,1.0,15/30,32.73%,OBSCN;GNAI2;GNB4;PPP2R5D;SRC;ARRB1;MAPK1;PPP3CA;RPS6KA3;GNB2;PDE2A;NRAS;HEBP1;PRKAR1A;ITGB1
500,prerank,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,0.3757327080890975,1.0667898089140995,0.36380597014925375,0.513673316534968,1.0,5/5,62.54%,HSP90AA1;CALM1;DNM2;LYPLA1;DDAH2
501,prerank,Interferon Signaling R-HSA-913531,-0.16318624366951195,-1.0658925042184089,0.34725274725274724,0.7953085632272334,1.0,19/29,48.16%,B2M;CD44;HLA-G;NUP93;JAK2;NEDD4;TRIM25;STAT1;SAMHD1;NCAM1;IFITM1;SEC13;ABCE1;PTPN11;HLA-C;ICAM1;EIF4E;VCAM1;MAPK3
502,prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.28065489800138416,1.0616544474911644,0.38095238095238093,0.5202593071217052,1.0,7/10,43.31%,FLNA;MYH9;MYL6;CALM1;MYH10;MYH14;CDC42
503,prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.2650587127315494,-1.0608122681737497,0.3484848484848485,0.7938462468061598,1.0,7/11,35.77%,PIP4K2A;PPP2R5D;SRC;MAPK1;IL1RAP;PTPN11;PDGFA
504,prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.2650587127315494,-1.0608122681737497,0.3484848484848485,0.7938462468061598,1.0,7/11,35.77%,PIP4K2A;PPP2R5D;SRC;MAPK1;IL1RAP;PTPN11;PDGFA
505,prerank,RHO GTPases Activate KTN1 R-HSA-5625970,-0.3798358733880422,-1.060363831729428,0.3784355179704017,0.7881749609617161,1.0,5/5,62.19%,KLC4;KLC1;CDC42;KTN1;KIF5B
506,prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.19405908567046243,-1.055386052858284,0.38004750593824227,0.7931367890206414,1.0,19/20,75.51%,SUMO2;COPS2;CUL4A;RAD23B;UBE2I;CUL4B;COPS5;ACTL6A;COPS4;RBX1;COPS6;COPS3;UBE2N;GPS1;COPS8;DDB1;RUVBL1;PARP1;PCNA
507,prerank,Metabolism Of Nucleotides R-HSA-15869,-0.17303934360724063,-1.0549574931124104,0.39285714285714285,0.7875667807348062,1.0,19/25,58.15%,AK1;RRM2B;ADSS2;ITPA;DPYS;SAMHD1;CMPK1;ADSS1;CTPS1;NT5C2;RRM1;AK4;DPYD;PFAS;GSR;GART;AMPD2;IMPDH2;ADSL
508,prerank,Signaling By PDGF R-HSA-186797,0.21775094281209648,1.0546129247892326,0.37213403880070545,0.5300310820872904,1.0,7/18,19.35%,PLG;THBS4;COL6A1;THBS1;GRB7;COL6A3;THBS3
509,prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.2792475014697236,1.0544798741832397,0.38010657193605685,0.5289938546190885,1.0,10/10,72.24%,RAN;FASN;SEC23A;KPNB1;SEC24C;HMGCS1;SEC24A;MBTPS1;SAR1B;CARM1
510,prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.2885787802248646,1.052375271147684,0.3680297397769517,0.5307858548839246,1.0,8/9,60.61%,PRDX1;PRDX2;P4HB;GPX3;GSTP1;GSR;PRDX3;ERO1A
511,prerank,Signaling By Nuclear Receptors R-HSA-9006931,0.15000356144678995,1.0510604877223304,0.38971807628524047,0.5315662676996338,1.0,12/38,18.70%,APOE;H2BC11;H2BC12;HSP90AB1;HSP90AA1;H2AZ1;AKR1C3;FASN;ALDH1A1;CTSD;APOC2;PLTP
512,prerank,Cell Junction Organization R-HSA-446728,0.21235899390702628,1.043115582865183,0.38204225352112675,0.5428327142413719,1.0,9/18,30.45%,PARD3;FLNA;ANG;ACTN1;PARVB;RSU1;LIMS1;ILK;CDH11
513,prerank,Muscle Contraction R-HSA-397014,-0.19140604274935835,-1.0384269968613986,0.37264150943396224,0.8203987840388555,1.0,11/20,34.60%,ANXA2;SRI;CES1;VIM;PDE5A;SCN1A;TPM3;ASPH;TPM4;MYL12A;MYLK
514,prerank,MET Activates PTK2 Signaling R-HSA-8874081,0.30346014698852236,1.0364960343148264,0.4036697247706422,0.5517566802847241,1.0,3/8,9.00%,LAMB1;LAMC1;LAMA5
515,prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.23616018845700823,-1.0360943592802707,0.41333333333333333,0.819340075710492,1.0,13/13,76.62%,ARPC1A;ABI1;MAPK1;NCKAP1;ACTR2;CYFIP2;ARPC1B;MAPK3;ARPC3;CDC42;ARPC5;ARPC2;ACTR3
516,prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.3430471069179419,1.0350658750017483,0.4117647058823529,0.5525606217426372,1.0,5/6,49.80%,RPS27A;APP;UBE2V1;UBE2N;USP14
517,prerank,SARS-CoV-1 Infection R-HSA-9678108,0.2969662748740913,1.0318965837057146,0.4111310592459605,0.5562158525129858,1.0,3/8,10.17%,VCP;RPS27A;GANAB
518,prerank,Paracetamol ADME R-HSA-9753281,-0.31220657276995306,-1.0315712365116874,0.3930885529157667,0.8232572415409225,1.0,7/7,68.97%,GSTM1;SULT1E1;GGT1;SULT2A1;SULT1A1;CNDP2;GSTP1
519,prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.31299447741300557,-1.0305750954492294,0.39215686274509803,0.8124504588140337,1.0,4/7,24.43%,NELFB;POLR2H;NCBP1;SUPT6H
520,prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.31299447741300557,-1.0305750954492294,0.39215686274509803,0.8124504588140337,1.0,4/7,24.43%,NELFB;POLR2H;NCBP1;SUPT6H
521,prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.19883150980673925,-1.0295467354772538,0.3927765237020316,0.8086763575259536,1.0,17/18,74.58%,RAB3GAP2;DYNC1LI2;DCTN4;DCTN3;GALNT2;DYNC1LI1;DCTN2;DYNC1I2;PAFAH1B3;CAPZA2;RAB6A;DCTN1;PAFAH1B1;RAB18;ACTR1A;CAPZB;CAPZA1
522,prerank,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.371880138636611,1.0286967424619897,0.4181184668989547,0.5598557517129418,1.0,2/5,5.03%,HSP90AB1;HSP90AA1
523,prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.2590979676563882,-1.026800336837787,0.4175824175824176,0.8085442144769884,1.0,4/10,12.45%,SUMO2;CUL4A;RAD23B;UBE2I
524,prerank,RHOC GTPase Cycle R-HSA-9013106,-0.2452941176470588,-1.0226949947101913,0.40131578947368424,0.8120769073639982,1.0,11/11,75.69%,FLOT1;ARHGDIA;ARHGAP1;TMPO;STOM;TFRC;RHOC;DIAPH1;ROCK2;IQGAP1;C1QBP
525,prerank,Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,0.2838533641526797,1.0200117085578282,0.4072727272727273,0.570757802300554,1.0,7/9,50.32%,ATIC;PAICS;GMPS;ADSL;IMPDH2;GART;PFAS
526,prerank,Nucleotide Biosynthesis R-HSA-8956320,0.2838533641526797,1.0200117085578282,0.4072727272727273,0.570757802300554,1.0,7/9,50.32%,ATIC;PAICS;GMPS;ADSL;IMPDH2;GART;PFAS
527,prerank,G Alpha (12/13) Signaling Events R-HSA-416482,-0.33548387096774196,-1.0187685073511483,0.4337078651685393,0.8151961064642175,1.0,6/6,66.63%,OBSCN;GNB4;GNB2;GNB1;RHOC;ROCK2
528,prerank,RHO GTPase Cycle R-HSA-9012999,-0.101035085460956,-1.0176986628026383,0.4177545691906005,0.8113597394929147,1.0,27/67,29.05%,SRGAP2;FLOT1;COPS2;GOPC;FERMT2;OBSCN;IQGAP2;ARHGDIA;VIM;TWF1;CSK;PLXNA1;ATP6AP1;ARHGAP17;SRC;ABI1;SLC1A5;ESYT1;ARHGAP1;PDE5A;CUL3;TPM3;TMPO;NCKAP1;STOM;TPM4;FAM169A
529,prerank,LDL Clearance R-HSA-8964038,0.26683656753050555,1.0102815511896106,0.4251824817518248,0.5851202636294132,1.0,7/10,44.71%,APOB;CLTC;AP2M1;LDLR;AP2B1;AP2A1;CLTA
530,prerank,Protein Localization R-HSA-9609507,0.18902257584251334,1.0070124058310599,0.43875685557586835,0.5891510743098312,1.0,9/21,25.83%,RPS27A;ATP5F1B;CS;APP;IDH1;HSPD1;HSPA9;HSD17B4;ACO2
531,prerank,FOXO-mediated Transcription R-HSA-9614085,0.3159862598292172,1.0063698926796256,0.4091778202676864,0.5887537174658534,1.0,5/7,40.97%,YWHAZ;YWHAQ;YWHAG;YWHAB;HDAC1
532,prerank,RHOB GTPase Cycle R-HSA-9013026,-0.33548387096774196,-1.0059834044324916,0.45652173913043476,0.8336155554847288,1.0,6/6,66.63%,FLOT1;ARHGAP1;STOM;TFRC;DIAPH1;ROCK2
533,prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.35325227578465046,1.0029588677454446,0.455743879472693,0.5928243804850476,1.0,3/5,25.95%,ALG1;B4GALT1;GLB1
534,prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.28081589551014474,1.0019238657345224,0.4264705882352941,0.5929391219195155,1.0,4/9,18.29%,HSP90AB1;HSP90AA1;RPS27A;APP
535,prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,0.19220076568742644,1.0010337111839445,0.4328097731239092,0.5929223280585507,1.0,15/20,57.22%,IGF2R;CLTC;HSPA8;AP1B1;FTH1;SNX2;RAB5C;DNM2;AP1M1;AP1G1;CLTA;AP3B1;FTL;TFRC;SNX5
536,prerank,Gap Junction Trafficking R-HSA-190828,0.3615422849860692,1.0008030545757363,0.4495049504950495,0.588978066541868,1.0,4/5,44.71%,CLTC;AP2M1;DNM2;CLTA
537,prerank,Formation Of Annular Gap Junctions R-HSA-196025,0.3615422849860692,1.0008030545757363,0.4495049504950495,0.588978066541868,1.0,4/5,44.71%,CLTC;AP2M1;DNM2;CLTA
538,prerank,Gap Junction Degradation R-HSA-190873,0.3615422849860692,1.0008030545757363,0.4495049504950495,0.588978066541868,1.0,4/5,44.71%,CLTC;AP2M1;DNM2;CLTA
539,prerank,mTORC1-mediated Signaling R-HSA-166208,-0.35521688159437276,-0.9974465035584881,0.4268774703557312,0.847701792451388,1.0,5/5,64.64%,FKBP1A;EIF4B;EIF4E;RPS6;YWHAB
540,prerank,HCMV Early Events R-HSA-9609690,0.2077428031533157,0.995939141292102,0.4565972222222222,0.59566498935869,1.0,7/17,22.79%,H2AC21;H2BC11;H2BC12;H2AC11;DYNC1H1;RBBP4;HSD17B4
541,prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.28675165231451105,-0.9955506594955079,0.4426605504587156,0.8457303247934075,1.0,7/8,57.69%,SUMO2;CTBP1;UBE2I;PARK7;TRIM28;DDX17;DDX5
542,prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.28597197871364155,0.9843667379937203,0.45940959409594095,0.6134104889265258,1.0,3/8,10.81%,HSP90AA1;RPS27A;FASN
543,prerank,Phase I - Functionalization Of Compounds R-HSA-211945,0.21976603759357485,0.9838761681988888,0.48717948717948717,0.6127136043941965,1.0,8/14,37.00%,HSP90AB1;ALDH1A1;ADH5;FDXR;CYB5R3;PTGES3;EPHX1;ALDH2
544,prerank,Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,-0.2954494604743334,-0.9797134390835731,0.483402489626556,0.8774993211223626,1.0,6/7,55.76%,CDK1;MAPK1;RAB2A;RAB1A;MAPK3;RAB1B
545,prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.2248381400824014,-0.9782604914804365,0.47417840375586856,0.8746341062452394,1.0,12/12,77.73%,PCCA;ACAA2;PCCB;HADHB;ACOT1;HADHA;HADH;ACOT7;DECR1;ECHS1;ACADVL;ACOT13
546,prerank,SUMOylation R-HSA-2990846,-0.1728584685407487,-0.9750316407221336,0.4604651162790698,0.8757962754089863,1.0,17/22,59.15%,SUMO2;CTBP1;NUP93;UBE2I;SMC1A;PARK7;RANGAP1;SAE1;SEC13;TRIM28;UBA2;NOP58;TPR;DDX17;DDX5;TOP1;HDAC1
547,prerank,Regulation Of TP53 Degradation R-HSA-6804757,0.3540185903856839,0.9749557691820168,0.4819734345351044,0.6248627609204466,1.0,3/5,26.24%,RPS27A;PPP2CA;PPP2R1A
548,prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.3540185903856839,0.9749557691820168,0.4819734345351044,0.6248627609204466,1.0,3/5,26.24%,RPS27A;PPP2CA;PPP2R1A
549,prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.2655200110643685,-0.9727249352846925,0.4853932584269663,0.8749073329352458,1.0,6/9,38.34%,ST3GAL1;SRPK1;UBE2I;ST6GAL1;MOGS;PRMT1
550,prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.18660027941098634,0.9715020688878295,0.48201438848920863,0.6292160916344536,1.0,12/20,43.19%,HSP90AA1;TUBB4B;TUBA4A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A;ACTR1A;SEPTIN2;PAFAH1B1;DCTN1
551,prerank,Cargo Concentration In ER R-HSA-5694530,0.2519386698444638,0.9694902843451525,0.47302158273381295,0.631108259507156,1.0,8/10,55.87%,F5;SERPINA1;SEC23A;LMAN2;SEC24C;CTSZ;CTSC;SEC24A
552,prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.12527421546366316,-0.969216818870039,0.4725,0.8771026377209435,1.0,33/40,69.26%,COPS2;EPS15L1;ARPC1A;SCARB2;GAPVD1;AP2A2;TOR1B;ARRB1;CLTB;ARF6;COPS5;SH3GL1;ACTR2;COPS4;RAB5B;LRP2;COPS6;TFRC;COPS3;PACSIN2;ARPC3;RAB5A;CLTA;GPS1;COPS8;DNM2;ARPC5;AP2A1;RAB5C;AP2B1;LDLR;ARPC2;AP2M1
553,prerank,Signaling By FGFR2 R-HSA-5654738,-0.19529059911580393,-0.9682685926394793,0.46238938053097345,0.866671589184008,1.0,11/16,48.16%,POLR2H;SRC;TIAL1;NCBP1;MAPK1;HNRNPM;NRAS;PTPN11;HNRNPH1;PTBP1;MAPK3
554,prerank,Signaling By FGFR R-HSA-190236,-0.19529059911580393,-0.9682685926394793,0.46238938053097345,0.866671589184008,1.0,11/16,48.16%,POLR2H;SRC;TIAL1;NCBP1;MAPK1;HNRNPM;NRAS;PTPN11;HNRNPH1;PTBP1;MAPK3
555,prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.17637383863210004,0.9673073844772987,0.488135593220339,0.6332840576274029,1.0,5/22,7.07%,H2AC21;H2BC11;H2BC12;H2AC11;H2AZ1
556,prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,0.3506875167081551,0.967272273997315,0.4860335195530726,0.631847084777004,1.0,2/5,7.25%,VCP;RPS27A
557,prerank,Glycolysis R-HSA-70171,0.1898546798424435,0.9644897429124707,0.484629294755877,0.6352971049220797,1.0,6/18,16.19%,PKM;PGK1;ENO1;PPP2CA;ALDOC;TPI1
558,prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.34232121922626024,0.9615555190629665,0.5,0.638454468622776,1.0,5/5,65.87%,AHCY;FDXR;MAT1A;GCLC;GGT1
559,prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.1837167962090656,0.9587889799438809,0.4973637961335677,0.641757583102496,1.0,9/19,30.68%,HSPA1A;HSPA5;HSPA8;HSPA13;YWHAE;HSPA9;HSPA4;SERPINH1;ST13
560,prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.22690350987941366,-0.9586270746591932,0.49327354260089684,0.8829336100506081,1.0,7/12,34.25%,GNAI2;GNB4;SRC;MAPK14;GNB2;PRKAR1A;GGT1
561,prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.28893919629015075,-0.9545951886910311,0.4758909853249476,0.8803100784806902,1.0,4/7,26.94%,PPP2R5D;MAPK14;MAPK1;RPS6KA3
562,prerank,ERK/MAPK Targets R-HSA-198753,-0.28893919629015075,-0.9545951886910311,0.4758909853249476,0.8803100784806902,1.0,4/7,26.94%,PPP2R5D;MAPK14;MAPK1;RPS6KA3
563,prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.25250252078684954,-0.9540837105050926,0.5031712473572939,0.8753249173541281,1.0,7/9,51.32%,UBE2Z;UBA6;UBE2D2;UCHL3;USP9X;USP7;USP5
564,prerank,Regulation Of TP53 Activity R-HSA-5633007,-0.18750930653229927,-0.9509311698236915,0.49330357142857145,0.8771780615468033,1.0,9/18,29.81%,MTA2;PIP4K2A;RAD50;PRKAA1;MAPK14;CDK1;PRKAG1;CSNK2B;RBBP7
565,prerank,Peroxisomal Protein Import R-HSA-9033241,-0.25235578276205095,-0.9464477080048148,0.4959349593495935,0.8813150525420944,1.0,5/9,28.52%,HMGCL;ACAA1;ECH1;IDE;UBE2D2
566,prerank,SLC Transporter Disorders R-HSA-5619102,-0.2934249765520519,-0.9434914498489675,0.4820627802690583,0.8822641240813424,1.0,6/7,55.82%,NUP93;SEC13;CP;SLC3A2;BSG;TPR
567,prerank,RNA Polymerase I Transcription R-HSA-73864,0.252055871830303,0.9433506759542063,0.492156862745098,0.6647273708082161,1.0,3/10,7.07%,H2BC11;H2BC12;H2AZ1
568,prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,0.252055871830303,0.9433506759542063,0.492156862745098,0.6647273708082161,1.0,3/10,7.07%,H2BC11;H2BC12;H2AZ1
569,prerank,RHO GTPases Activate CIT R-HSA-5625900,0.29935052263299033,0.9405753493733113,0.514018691588785,0.6677513343226327,1.0,5/7,42.84%,MYH9;MYL6;MYH10;RHOC;MYH14
570,prerank,Aggrephagy R-HSA-9646399,0.24638417105661098,0.9401248587817671,0.48987108655616945,0.6668853479785055,1.0,4/10,17.36%,VCP;HSP90AA1;RPS27A;DYNC1H1
571,prerank,MHC Class II Antigen Presentation R-HSA-2132295,0.12820761068535955,0.9391052680863667,0.5272108843537415,0.6670390182739285,1.0,23/41,44.71%,CTSB;CTSD;CLTC;DYNC1H1;SEC23A;AP1B1;CD74;CAPZA1;CAPZB;CTSH;AP2M1;ACTR1A;AP2B1;RAB7A;AP2A1;SEC24C;KIF5B;DNM2;AP1M1;SEC31A;DCTN1;AP1G1;CLTA
572,prerank,COPII-mediated Vesicle Transport R-HSA-204005,0.1842150717604369,0.935944592413962,0.5371024734982333,0.6707778355387016,1.0,16/18,71.19%,F5;SERPINA1;SEC23A;USO1;LMAN2;NSF;SEC24C;CTSZ;SEC31A;RAB1B;CTSC;SEC24A;RAB1A;SCFD1;SAR1B;SEC13
573,prerank,RHOBTB GTPase Cycle R-HSA-9706574,0.17812139128783985,0.9338055014335059,0.5298245614035088,0.672757026658317,1.0,7/20,18.94%,HSP90AB1;HSP90AA1;DDX39B;ACTN1;HNRNPC;CCT7;CCT2
574,prerank,Striated Muscle Contraction R-HSA-390522,-0.30381231671554254,-0.9337528369347794,0.5361050328227571,0.8994433201312659,1.0,6/6,69.78%,VIM;TPM3;TPM4;TTR;TPM1;TMOD2
575,prerank,MyD88-independent TLR4 Cascade R-HSA-166166,-0.1821858789937954,-0.9323090435653552,0.510158013544018,0.8968287546402836,1.0,13/18,53.07%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1;UBE2D2;PTPN11;MAP2K1;MAPK3;USP14;UBE2N
576,prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.12333784415088789,-0.9312599167637416,0.542654028436019,0.8932477208815005,1.0,36/40,77.38%,COG2;RAB9A;KLC4;UBE2Z;RAB3GAP2;DYNC1LI2;DCTN4;DCTN3;GALNT2;COPZ1;DYNC1LI1;DCTN2;DYNC1I2;KLC1;COPE;PAFAH1B3;CAPZA2;RAB1A;AKR1B10;RAB6A;RAB1B;DCTN1;PAFAH1B1;COPG1;KIF5B;ARCN1;COPB2;RAB18;ACTR1A;NSF;CAPZB;ARF5;ARF4;CAPZA1;COPB1;MAN2A1
577,prerank,Fatty Acid Metabolism R-HSA-8978868,-0.15544767476738786,-0.9306528698916764,0.5288461538461539,0.8885448365290918,1.0,13/24,37.23%,ACAA1;ACSL4;ACSL1;PCCA;PTGR2;ACAA2;PPT1;PCCB;HADHB;ACOT1;GGT1;HADHA;HADH
578,prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.0825956551045508,-0.930028870203968,0.5235602094240838,0.8841356482491407,1.0,42/93,35.77%,SPARC;PTPRK;COPS2;RAB4A;PDGFC;NELFB;POLR2H;CSK;EPS15L1;JAK2;ATP6AP1;CTNNA1;NEDD4;PPP2R5D;ITGB3;SRC;MEMO1;STAT5B;MAPK14;ABI1;TIAL1;AP2A2;NCBP1;STAT1;VEGFA;STAT3;CUL5;MAPK1;HNRNPM;RPS6KA3;NCKAP1;ITGA2;ARF6;CTNNB1;NRAS;COL9A1;ATP6V1B2;ITGB1;SH3GL1;THBS2;PTPN11;PDGFA
579,prerank,HCMV Infection R-HSA-9609646,0.17578235589387461,0.9297963905937902,0.5198618307426598,0.6777130194881862,1.0,8/21,22.79%,H2AC21;H2BC11;H2BC12;H2AC11;DYNC1H1;HNRNPK;RBBP4;HSD17B4
580,prerank,Nuclear Import Of Rev Protein R-HSA-180746,0.2878791361945663,0.9227459384014604,0.5373406193078324,0.6881909929160072,1.0,5/7,44.30%,NPM1;RAN;KPNB1;RCC1;TPR
581,prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.34194836449625743,0.9217064975250243,0.550185873605948,0.6883102710599969,1.0,4/5,47.05%,HSP90AB1;APP;UBE2V1;UBE2N
582,prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.30172513599065176,-0.9213189724719062,0.5462184873949579,0.8870163613404757,1.0,3/6,18.18%,NELFB;POLR2H;NCBP1
583,prerank,Transcription Of HIV Genome R-HSA-167172,-0.30172513599065176,-0.9213189724719062,0.5462184873949579,0.8870163613404757,1.0,3/6,18.18%,NELFB;POLR2H;NCBP1
584,prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.30172513599065176,-0.9213189724719062,0.5462184873949579,0.8870163613404757,1.0,3/6,18.18%,NELFB;POLR2H;NCBP1
585,prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.2218065536634991,-0.9205463020966986,0.54627539503386,0.8830783644568002,1.0,10/12,60.67%,EXOSC6;DCPS;EXOSC4;EIF4B;LSM6;LSM3;EIF4E;PABPC1;DDX6;EIF4A2
586,prerank,mRNA Splicing - Minor Pathway R-HSA-72165,-0.1675379793694437,-0.9205245135806305,0.5587529976019184,0.8774596037129703,1.0,18/20,72.94%,DDX42;POLR2H;PRPF8;DDX23;NCBP1;SNRNP40;SF3B2;EFTUD2;SNRPB;SNRPF;SNRPE;SNRNP200;SF3B3;SRSF2;YBX1;SRSF7;SNRPD2;SF3B1
587,prerank,Signaling By ERBB2 R-HSA-1227986,0.2552078842197648,0.9169591890992604,0.5532710280373832,0.6947400343959217,1.0,3/9,9.70%,HSP90AA1;RPS27A;GRB7
588,prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.33092167756828156,-0.9167351409293341,0.5553235908141962,0.8690716252641898,1.0,2/5,5.08%,NELFB;POLR2H
589,prerank,HIV Elongation Arrest And Recovery R-HSA-167287,-0.33092167756828156,-0.9167351409293341,0.5553235908141962,0.8690716252641898,1.0,2/5,5.08%,NELFB;POLR2H
590,prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.33092167756828156,-0.9167351409293341,0.5553235908141962,0.8690716252641898,1.0,2/5,5.08%,NELFB;POLR2H
591,prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.2959573714940895,-0.9159771449672292,0.5418410041841004,0.8651777544713762,1.0,2/6,1.11%,COG2;RAB9A
592,prerank,Basigin Interactions R-HSA-210991,-0.33016109103792013,-0.9150247521908038,0.5726681127982647,0.8619155313530703,1.0,4/5,45.94%,ITGB1;SLC16A3;SLC3A2;BSG
593,prerank,Methylation R-HSA-156581,0.2836435649679916,0.9135622294068118,0.5459558823529411,0.6989547577657224,1.0,4/7,30.22%,AHCY;GSTO1;MAT2A;MAT1A
594,prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.2676571115442374,-0.9128649863754993,0.5337690631808278,0.8609403893224072,1.0,5/8,34.02%,JAK2;SKP1;SRC;CUL1;PPP2R2A
595,prerank,Generic Transcription Pathway R-HSA-212436,0.07888704922992772,0.9105625852635343,0.5613207547169812,0.7020807896329055,1.0,53/118,38.98%,APOE;H2BC11;H2BC12;NPM1;TGFB1;H2AZ1;RPS27A;THBS1;PSMD14;PPP2CA;FASN;CCN2;YWHAZ;PRDX1;PRDX2;PSMC5;PSMC3;PSMC4;YWHAQ;PSMD13;SERPINE1;PSMC1;COL1A1;HSPD1;RBBP4;YWHAE;PSMC2;PSMC6;NOTCH3;PSME2;PSMB2;PSMA6;PCNA;YWHAG;CALM1;PPP2R1A;SSRP1;PSMA7;PARP1;PSMD12;YBX1;PSMD11;PRMT5;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;SUPT16H;PSMB1
596,prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.19488247337183165,0.9089070680533148,0.5706422018348624,0.7033227520180138,1.0,10/16,44.36%,COPA;COPB1;ARF4;ARF5;NSF;COPB2;ARCN1;KIF5B;COPG1;RAB1B
597,prerank,RHOD GTPase Cycle R-HSA-9013405,-0.23235061880323582,-0.908899617600064,0.5754923413566739,0.8639966529726774,1.0,5/10,25.42%,PLXNA1;ARHGAP17;ESYT1;ARHGAP1;TMPO
598,prerank,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.2789942201442074,0.9076375548521715,0.5403377110694184,0.7020894682663739,1.0,5/7,44.71%,CLTC;AP2M1;AP2B1;AP2A1;CLTA
599,prerank,"WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",0.2789942201442074,0.9076375548521715,0.5403377110694184,0.7020894682663739,1.0,5/7,44.71%,CLTC;AP2M1;AP2B1;AP2A1;CLTA
600,prerank,SLC-mediated Transmembrane Transport R-HSA-425407,-0.23118688798057718,-0.9059352087333732,0.5831533477321814,0.8650536896398588,1.0,7/10,45.94%,SRI;SLC1A5;CP;SLC16A3;LCN15;SLC3A2;BSG
601,prerank,Opioid Signaling R-HSA-111885,-0.20169827362919118,-0.9051579169888663,0.548936170212766,0.8614080519301153,1.0,7/13,32.50%,GNAI2;GNB4;PPP2R5D;MAPK1;PPP3CA;GNB2;PRKAR1A
602,prerank,Plasma Lipoprotein Clearance R-HSA-8964043,0.18283383122878405,0.9041442481530393,0.5617391304347826,0.7065841893869491,1.0,11/18,44.71%,APOB;APOE;APOA1;RPS27A;CLTC;AP2M1;LDLR;AP2B1;AP2A1;APOC1;CLTA
603,prerank,Selective Autophagy R-HSA-9663891,0.20347563533290736,0.9038137324408089,0.5686274509803921,0.7055610130095576,1.0,5/14,17.36%,VCP;HSP90AA1;RPS27A;HSPA8;DYNC1H1
604,prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.23319386278814663,0.9033700567634287,0.564638783269962,0.7047320016615826,1.0,8/10,57.63%,RPS27A;SERPINE1;PARP1;YBX1;HDAC1;COL1A2;MAPK3;USP9X
605,prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.29731284878619246,0.9021291987916066,0.6007604562737643,0.7054440891184226,1.0,3/6,22.27%,RPS27A;YWHAE;RTN4
606,prerank,Translation Of Structural Proteins R-HSA-9683701,-0.2942152779178908,-0.9018636763301539,0.5418502202643172,0.8636125192712013,1.0,4/6,35.18%,ST3GAL1;UBE2I;ST6GAL1;MOGS
607,prerank,EPHB-mediated Forward Signaling R-HSA-3928662,-0.23574368018812464,-0.9017875877403778,0.5736263736263736,0.8585850362668076,1.0,10/10,76.62%,ARPC1A;SRC;ACTR2;ARPC1B;ARPC3;CDC42;ARPC5;ROCK2;ARPC2;ACTR3
608,prerank,AURKA Activation By TPX2 R-HSA-8854518,0.17690971594418847,0.9017634180254828,0.573943661971831,0.702908499941418,1.0,8/19,26.24%,HSP90AA1;TUBB4B;TUBA4A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A
609,prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.17690971594418847,0.9017634180254828,0.573943661971831,0.702908499941418,1.0,8/19,26.24%,HSP90AA1;TUBB4B;TUBA4A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A
610,prerank,Deadenylation Of mRNA R-HSA-429947,0.2946686785256649,0.9017224803805681,0.5638095238095238,0.7013852531477174,1.0,5/6,54.53%,EIF4A1;EIF4A3;EIF4A2;PABPC1;EIF4E
611,prerank,EPH-Ephrin Signaling R-HSA-2682334,0.15805023150364625,0.9015149791833971,0.5743589743589743,0.70019473911025,1.0,16/25,49.50%,CLTC;MYH9;MYL6;ACTR3;AP2M1;ARPC2;ROCK2;MYH10;AP2B1;AP2A1;ARPC5;MYH14;CDC42;CLTA;ARPC3;ADAM10
612,prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.3209914813681164,-0.9011620568407307,0.55863539445629,0.8547483504657992,1.0,4/5,46.58%,ATP6AP1;ATP6V1B2;ATP6V1A;TFRC
613,prerank,Sphingolipid Metabolism R-HSA-428157,-0.293835185796962,-0.8979942901163898,0.6079295154185022,0.8514197440594912,1.0,4/6,36.00%,SMPD1;ESYT1;HEXA;CTSA
614,prerank,Glycosphingolipid Metabolism R-HSA-1660662,-0.293835185796962,-0.8979942901163898,0.6079295154185022,0.8514197440594912,1.0,4/6,36.00%,SMPD1;ESYT1;HEXA;CTSA
615,prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.3145899208127177,-0.8922258974125975,0.5708418891170431,0.8534293666814949,1.0,2/5,6.25%,RAB4A;PIP4K2A
616,prerank,PI Metabolism R-HSA-1483255,-0.3145899208127177,-0.8922258974125975,0.5708418891170431,0.8534293666814949,1.0,2/5,6.25%,RAB4A;PIP4K2A
617,prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.2765701277147922,0.8904370527240341,0.5878003696857671,0.7177791946985171,1.0,2/7,3.45%,APOE;NPM1
618,prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.14608076009501167,0.888401615641873,0.6041308089500861,0.7195312606687475,1.0,27/27,85.62%,FN1;NPM1;EEF1G;ATIC;CLTC;EML4;MYH9;RRBP1;MSN;KIF5B;SEC31A;DCTN1;TPR;VCL;MAPK3;RPS6;RBX1;KLC1;PRKAR1A;TPM4;CUL1;TPM3;MAPK1;STAT3;CARS1;TFG;SKP1
619,prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,0.22317698068009478,0.8873265628269787,0.5932203389830508,0.7182049088931184,1.0,3/11,7.07%,H2BC11;H2BC12;H2AZ1
620,prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.22317698068009478,0.8873265628269787,0.5932203389830508,0.7182049088931184,1.0,3/11,7.07%,H2BC11;H2BC12;H2AZ1
621,prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.21155405256468351,0.8871124617317717,0.5776614310645725,0.7169553336548149,1.0,4/12,14.32%,FN1;NPM1;CLTC;EML4
622,prerank,Macroautophagy R-HSA-1632852,-0.1903560192533032,-0.8853808731754473,0.5743243243243243,0.8628367461502607,1.0,8/15,32.61%,DYNC1LI2;PRKAA1;SRC;PRKAG1;PARK7;CSNK2B;DYNC1LI1;DYNC1I2
623,prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.17479169419746676,-0.8815153346235218,0.5912087912087912,0.8660110447273888,1.0,8/17,28.52%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1;UBE2D2
624,prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.3214767933891329,-0.8806986036379104,0.597872340425532,0.8628428055152728,1.0,2/5,6.25%,MTA2;PIP4K2A
625,prerank,Transcriptional Regulation By TP53 R-HSA-3700989,-0.11718395477253832,-0.8779512406205348,0.610126582278481,0.8635282510991414,1.0,18/42,29.81%,MOV10;MTA2;NELFB;POLR2H;PIP4K2A;LRPPRC;RAD50;PRKAA1;RRM2B;MAPK14;CDK1;NDRG1;PRKAG1;CASP6;CSNK2B;CYCS;CARM1;RBBP7
626,prerank,RHOV GTPase Cycle R-HSA-9013424,0.24265569917743834,0.8748436056361497,0.6348920863309353,0.7361137222475317,1.0,9/9,75.86%,CLTC;SPTBN1;SPTAN1;IQGAP1;CDC42;TXNL1;USP9X;TPM4;TPM3
627,prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.1852630054975939,0.8727160406645817,0.6157989228007181,0.7381427256175034,1.0,10/16,45.35%,HBE1;EHD3;CAPZA1;CAPZB;EHD1;KIF5B;PRKAR2A;HDAC1;CDC42;RAB5A
628,prerank,Signaling By NOTCH3 R-HSA-9012852,0.31580693674790294,0.8724063672128526,0.6075471698113207,0.7370361529755135,1.0,4/5,49.50%,RPS27A;NOTCH3;YBX1;ADAM10
629,prerank,Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,-0.30128956623681125,-0.8703143096722464,0.6483050847457628,0.874146586129939,1.0,5/5,70.02%,HADHB;HADHA;HADH;ECHS1;ACADVL
630,prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.29149560117302054,-0.8688161985266551,0.6164079822616408,0.8724297005995457,1.0,6/6,71.01%,GNB4;GNB2;PRKAR1A;GNB1;PRKAR2A;IQGAP1
631,prerank,Cytoprotection By HMOX1 R-HSA-9707564,0.25351152840955893,0.8670377256715166,0.6068840579710145,0.7445323488782848,1.0,3/8,15.08%,ALB;BLVRB;BLVRA
632,prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.1628292854026176,0.8652138843573796,0.6061151079136691,0.7458893669754261,1.0,5/20,10.64%,FGB;FGA;RPS27A;FGG;PPP2CA
633,prerank,Unfolded Protein Response (UPR) R-HSA-381119,0.1533153473321264,0.8648706199780452,0.6060070671378092,0.7448207899781918,1.0,6/24,11.28%,TLN1;PDIA6;HSPA5;HSP90B1;HYOU1;LMNA
634,prerank,Vesicle-mediated Transport R-HSA-5653656,0.06731820332632525,0.8646863477498632,0.6052631578947368,0.7435056702767338,1.0,76/152,45.35%,ALB;APOB;APOE;APOA1;MAN1A1;F5;IGF2R;TF;HSP90AA1;IGLL5;HSP90B1;RPS27A;HYOU1;SERPINA1;AMBP;YWHAZ;CLTC;MASP1;JCHAIN;HSPA8;SPTBN1;MYH9;COPA;DYNC1H1;SPTAN1;SEC23A;APP;AP1B1;USO1;YWHAQ;COL1A1;GDI2;FTH1;YWHAE;MAN2A1;LMAN2;ACTR3;COPB1;YWHAG;CAPZA1;ARF4;CALM1;ARF5;RAB14;CAPZB;AP2M1;ARPC2;NSF;SNX2;LDLR;ACTR1A;RAB18;AP2B1;RAB7A;RAB5C;AP2A1;YWHAB;ARPC5;COPB2;SEC24C;ARCN1;CTSZ;KIF5B;DNM2;COPG1;COPS8;AP1M1;SEC31A;PAFAH1B1;DCTN1;GPS1;AP1G1;RAB1B;CLTA;AP3B1;RAB5A
635,prerank,RND1 GTPase Cycle R-HSA-9696273,0.29517225735091046,0.8643371194974443,0.6114180478821363,0.7425208460161332,1.0,5/6,54.82%,GRB7;STIP1;TXNL1;TFRC;RBMX
636,prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.2871869927909896,0.8636096953341182,0.625,0.7421880038765365,1.0,2/6,6.78%,LAMB1;LAMC1
637,prerank,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.31053900656363764,-0.8600302419331123,0.6161825726141079,0.8853929768886142,1.0,2/5,7.07%,NOTCH4;ST3GAL6
638,prerank,Glucose Metabolism R-HSA-70326,0.1525435701558929,0.8598649395207218,0.6322241681260946,0.7468797509523,1.0,15/23,51.61%,PKM;PGK1;ENO1;PPP2CA;ALDOC;TPI1;MDH2;PCK2;PPP2R1A;BPGM;PKLR;TPR;PFKL;FBP1;ENO3
639,prerank,Asparagine N-linked Glycosylation R-HSA-446203,0.08809264630986981,0.8585933860065842,0.6490939044481054,0.7472545581196952,1.0,65/76,77.91%,MAN1A1;F5;VCP;RPS27A;SERPINA1;GANAB;ALG1;PDIA3;SPTBN1;NANS;COPA;DYNC1H1;SPTAN1;SEC23A;USO1;PSMC1;MAN2A1;LMAN2;B4GALT1;COPB1;CAPZA1;ARF4;GLB1;ARF5;CAPZB;NSF;ACTR1A;GFPT1;COPB2;SEC24C;ARCN1;CTSZ;COPG1;FUCA1;SEC31A;DCTN1;RAB1B;GMDS;PMM2;UGGT1;CTSC;SEC24A;OS9;RAB1A;CALR;CAPZA2;CTSA;COPE;SCFD1;MOGS;FUT3;PGM3;DYNC1I2;SAR1B;DCTN2;SEC13;ST6GAL1;GMPPB;DYNC1LI1;COPZ1;NAGK;GNPNAT1;UAP1;DCTN3;DCTN4
640,prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.16812085015776024,0.8574972107076297,0.6166077738515902,0.7473609318242536,1.0,8/19,27.12%,MOCS3;SHMT2;FASN;GSTO1;SLC2A1;ALDH1L1;CYB5R3;MTHFD1
641,prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.25273189950854247,0.8566311821774746,0.6284658040665434,0.7471092563468216,1.0,4/8,26.24%,PPP2CA;LMNA;KPNB1;PPP2R1A
642,prerank,HIV Life Cycle R-HSA-162587,0.1565189935339361,0.8559062422993606,0.6306620209059234,0.7467258352405253,1.0,14/23,47.11%,PPIA;RPS27A;RAN;XRCC5;XRCC6;FEN1;HMGA1;SSRP1;PDCD6IP;RCC1;SUPT16H;TPR;ELOB;XPO1
643,prerank,Metabolism Of Porphyrins R-HSA-189445,0.24926312161141997,0.8556774398985403,0.6427221172022685,0.7455176075695646,1.0,3/8,15.08%,ALB;BLVRB;BLVRA
644,prerank,Stimuli-sensing Channels R-HSA-2672351,-0.303785444271391,-0.8553393594512592,0.6387755102040816,0.8902288631079806,1.0,3/5,27.82%,SRI;ASPH;STOM
645,prerank,Dual Incision In GG-NER R-HSA-5696400,0.25693723466996066,0.8470127279608308,0.6584905660377358,0.7579296013767343,1.0,4/7,33.20%,RPS27A;PCNA;PARP1;DDB1
646,prerank,Lysosome Vesicle Biogenesis R-HSA-432720,-0.17426828995147278,-0.8443366698712285,0.6345291479820628,0.9081348005000011,1.0,7/16,24.90%,AP1G2;TXNDC5;AP1S1;AP1S2;ARRB1;GNS;CLTB
647,prerank,Endosomal/Vacuolar Pathway R-HSA-1236977,-0.306357808149911,-0.843564707703324,0.6466942148760331,0.9046369778967666,1.0,2/5,7.77%,B2M;HLA-G
648,prerank,Mitotic Prometaphase R-HSA-68877,-0.11777423826746589,-0.842077986004459,0.6426735218508998,0.9027407183509979,1.0,21/36,45.35%,TUBG1;DYNC1LI2;PPP2R5D;PPP1CC;SMC1A;CDK1;SFI1;NEK9;DCTN3;RANGAP1;CSNK2B;DYNC1LI1;CKAP5;SEC13;DCTN2;DYNC1I2;NUMA1;BUB3;MAPRE1;NUDC;RPS27
649,prerank,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.29847335439910316,0.8417836845444369,0.6609848484848485,0.7645978953018406,1.0,4/5,51.20%,GALK1;PGM1;GFPT1;PMM2
650,prerank,VLDLR Internalisation And Degradation R-HSA-8866427,0.2323125021909614,0.8405264579669126,0.6504672897196262,0.7649860467620074,1.0,6/9,44.71%,RPS27A;CLTC;AP2M1;AP2B1;AP2A1;CLTA
651,prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.30118747922245714,0.8400333956293506,0.6666666666666666,0.7641846604808075,1.0,2/5,12.22%,CLSTN1;YWHAZ
652,prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.21041232864806314,0.8391166538626436,0.660482374768089,0.762440713869031,1.0,7/11,44.24%,AP1B1;HLA-A;AP2M1;AP2B1;AP2A1;AP1M1;AP1G1
653,prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.21041232864806314,0.8391166538626436,0.660482374768089,0.762440713869031,1.0,7/11,44.24%,AP1B1;HLA-A;AP2M1;AP2B1;AP2A1;AP1M1;AP1G1
654,prerank,Circadian Clock R-HSA-400253,-0.21745284584158464,-0.8385290074252391,0.6349557522123894,0.9049677882512718,1.0,7/10,47.11%,SKP1;PPP1CC;CUL1;CARM1;NAMPT;PPP1CB;PPP1CA
655,prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.16517453600543916,-0.8369643140657439,0.6572052401746725,0.9031177852806194,1.0,12/17,53.07%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1;EEA1;MAP2K1;MAPK3;USP14;UBE2N
656,prerank,Metabolism Of Non-Coding RNA R-HSA-194441,-0.20319769909257257,-0.833716067539821,0.6751152073732719,0.9045322086857602,1.0,10/11,70.31%,NUP93;NCBP1;SEC13;SNRPB;SNRPF;SNRPE;TPR;WDR77;PRMT5;SNRPD2
657,prerank,Gene Expression (Transcription) R-HSA-74160,0.06493910003201257,0.8313025363933462,0.6661631419939577,0.7730614006838031,1.0,65/152,38.22%,APOE;H2BC11;H2BC12;POLR3B;NPM1;HSP90AA1;TGFB1;H2AZ1;RPS27A;THBS1;RAN;ANG;PSMD14;PPP2CA;FASN;CCN2;DDX39B;SNRPD3;SRSF1;YWHAZ;SRSF3;PRDX1;PRDX2;PSMC5;PSMC3;PSMC4;YWHAQ;PSMD13;SERPINE1;PSMC1;COL1A1;HSPD1;RBBP4;YWHAE;PSMC2;PSMC6;NOTCH3;PSME2;PSMB2;PSMA6;PCNA;YWHAG;CALM1;PPP2R1A;SSRP1;SF3B1;PSMA7;EIF4A3;PARP1;SRSF7;PSMD12;YBX1;PSMD11;PRMT5;SRSF2;PSMA1;PSMA4;PSMD8;YWHAB;SSB;PSMB3;PSMA3;PSMA2;PSMD3;SUPT16H
658,prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.29793803860256796,-0.8309818112219075,0.6897321428571429,0.9051607176949918,1.0,3/5,28.93%,NUP93;PABPN1;SEC13
659,prerank,Glutamate And Glutamine Metabolism R-HSA-8964539,0.27682265069392864,0.8292124915452656,0.6685714285714286,0.7748736637088052,1.0,3/6,24.78%,GLUD1;OAT;PYCR1
660,prerank,Mitochondrial Biogenesis R-HSA-1592230,-0.17425689153081375,-0.8231918157307464,0.6601731601731602,0.9150447382508065,1.0,7/15,27.88%,MAPK14;HCFC1;PRKAG1;ATP5PO;CYCS;ACSS2;CARM1
661,prerank,Signaling By NTRKs R-HSA-166520,-0.13698777900460257,-0.8214182366422302,0.6823529411764706,0.9139277953097211,1.0,22/25,73.87%,NELFB;PPP2R5D;SRC;MAPK14;AP2A2;STAT3;MAPK1;RPS6KA3;NRAS;PTPN11;MAP2K1;MAPK3;PCSK5;CLTA;DNM2;YWHAB;AP2A1;PTPRS;AP2B1;AP2M1;PCSK6;PPP2R1A
662,prerank,RAF Activation R-HSA-5673000,-0.20301206592609883,-0.8196828558564188,0.6860215053763441,0.9124049874184806,1.0,4/11,14.96%,JAK2;PPP2R5D;PPP1CC;SRC
663,prerank,GPCR Ligand Binding R-HSA-500792,0.23223083336576522,0.8181011372227274,0.6871609403254972,0.7908054514511859,1.0,2/9,1.46%,C3;C5
664,prerank,ESR-mediated Signaling R-HSA-8939211,-0.12560924686492211,-0.8137808574149835,0.6635294117647059,0.9185817806880123,1.0,13/28,32.32%,MOV10;POLR2H;GNAI2;MMP2;GNB4;SMC1A;SRC;FKBP5;MAPK1;GNB2;CARM1;NRAS;FKBP4
665,prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.15947079777032364,0.8136431544937495,0.6953405017921147,0.7959794160960781,1.0,16/19,69.32%,COL6A1;CTSB;COL6A3;COL18A1;COL1A1;COL2A1;COL6A2;PCOLCE;PLEC;COL15A1;COL1A2;CTSV;LOX;COL5A1;COL3A1;COL9A1
666,prerank,Integration Of Energy Metabolism R-HSA-163685,0.16382173762149582,0.8122208246293309,0.7129629629629629,0.7964804530894606,1.0,11/18,46.70%,PPP2CA;FASN;TKT;ACLY;SLC2A1;PPP2R1A;IQGAP1;PRKAR2A;PKLR;GNB1;TALDO1
667,prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.2338587340054466,-0.8114062545462547,0.7036247334754797,0.9183207438003055,1.0,7/8,63.47%,NUP93;RANBP1;RANGAP1;SEC13;XPO1;TPR;RCC1
668,prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.23364782194238576,-0.8112918947504717,0.7139830508474576,0.9138115467602774,1.0,3/8,12.45%,SUMO2;NUP93;UBE2I
669,prerank,RHO GTPases Activate IQGAPs R-HSA-5626467,-0.26217008797653957,-0.8109246812121058,0.6919642857142857,0.909795371752677,1.0,6/6,73.93%,IQGAP2;CTNNA1;CTNNB1;CDC42;IQGAP1;CALM1
670,prerank,Centrosome Maturation R-HSA-380287,0.15531230930066825,0.8107597329569894,0.686411149825784,0.7970680630479787,1.0,8/20,26.24%,HSP90AA1;TUBB4B;TUBA4A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A
671,prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,0.1965862271924662,0.8094393570092022,0.7030411449016101,0.7975445002649296,1.0,12/12,80.48%,YWHAZ;YWHAQ;YWHAE;C1QBP;YWHAG;YWHAB;YWHAH;MAPK3;NMT1;CYCS;MAPK1;STAT3
672,prerank,SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,-0.2870756676058782,-0.8080647878736468,0.7066666666666667,0.9103561725739062,1.0,2/5,9.06%,RRAS;PLXNA1
673,prerank,Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,-0.2647528137467585,-0.8076139952636988,0.7118279569892473,0.9065211740037497,1.0,3/6,21.39%,VIM;ADD1;CASP6
674,prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.1552667705157103,0.8075726624230629,0.7087033747779752,0.7989776719388002,1.0,8/20,26.24%,HSP90AA1;TUBB4B;TUBA4A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A
675,prerank,Platelet Sensitization By LDL R-HSA-432142,0.2633327759881252,0.8069607084159561,0.7091932457786116,0.798272379238559,1.0,3/6,26.24%,APOB;PPP2CA;PPP2R1A
676,prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.1846743457100581,0.8033948271526118,0.6913123844731978,0.802253257238967,1.0,11/14,61.19%,DDX39B;SRSF1;SRSF3;EIF4A3;SRSF7;SRSF2;SRSF4;TPR;MAGOH;U2AF2;ALYREF
677,prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,0.20748650321443515,0.8028758558586457,0.6923076923076923,0.8014638631099235,1.0,3/10,10.70%,RPS27A;PPP2CA;PEBP1
678,prerank,L1CAM Interactions R-HSA-373760,0.12647181874446817,0.802746442847628,0.6893542757417103,0.800004682693459,1.0,9/31,17.83%,LAMB1;LAMC1;CNTN1;CLTC;HSPA8;SPTBN1;DPYSL2;EZR;SPTAN1
679,prerank,EGFR Downregulation R-HSA-182971,-0.2914650727820081,-0.801798336755965,0.7215189873417721,0.9122403929485291,1.0,2/5,8.65%,PTPRK;EPS15L1
680,prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.14863769260711987,-0.8009069913222826,0.6964705882352941,0.9094934742075823,1.0,15/20,59.15%,SUMO2;CTBP1;NUP93;UBE2I;SMC1A;PARK7;RANGAP1;SEC13;TRIM28;NOP58;TPR;DDX17;DDX5;TOP1;HDAC1
681,prerank,Regulated Necrosis R-HSA-5218859,0.20962453853955065,0.800077430167304,0.692167577413479,0.8026938785061853,1.0,3/10,10.81%,HSP90AA1;RPS27A;FASN
682,prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.267343758083751,0.7965196814030467,0.7333333333333333,0.8066253327935159,1.0,2/6,8.65%,HSPA1A;RAN
683,prerank,RHOH GTPase Cycle R-HSA-9013407,-0.21486094031405992,-0.79607654182998,0.6722689075630253,0.9136587398007926,1.0,8/9,66.63%,ARHGDIA;CSK;SLC1A5;STOM;NSFL1C;TFRC;RAB7A;ROCK2
684,prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.20420582430524614,-0.795019942840485,0.7268722466960352,0.9108812409363994,1.0,9/10,69.26%,MMP2;SRC;AP2A2;CLTB;ADAM10;CLTA;AP2A1;AP2B1;AP2M1
685,prerank,Mitotic Prophase R-HSA-68875,0.15381214077193728,0.7932963971940561,0.725177304964539,0.8103043795121234,1.0,5/20,11.28%,H2BC11;H2BC12;H2AZ1;PPP2CA;LMNA
686,prerank,Arachidonic Acid Metabolism R-HSA-2142753,0.2792365989853414,0.7918839257170334,0.7175572519083969,0.8108019074244458,1.0,3/5,33.72%,AKR1C3;PTGES3;CBR1
687,prerank,MAP Kinase Activation R-HSA-450294,-0.180314272275615,-0.7907185455174633,0.7408256880733946,0.9099999703720112,1.0,6/13,26.94%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3
688,prerank,Interleukin-17 Signaling R-HSA-448424,-0.180314272275615,-0.7907185455174633,0.7408256880733946,0.9099999703720112,1.0,6/13,26.94%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3
689,prerank,RHOU GTPase Cycle R-HSA-9013420,0.21850841386897257,0.7892704632843078,0.7163375224416517,0.8130630889558716,1.0,7/9,57.63%,CLTC;SPTBN1;SPTAN1;IQGAP1;CDC42;TXNL1;USP9X
690,prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.2364570333046224,-0.7861726531899295,0.7018348623853211,0.9091466849958453,1.0,5/7,46.23%,ADAMTSL2;ADAMTSL4;THBS2;SPON1;SPON2
691,prerank,Defective B3GALTL Causes PpS R-HSA-5083635,-0.2364570333046224,-0.7861726531899295,0.7018348623853211,0.9091466849958453,1.0,5/7,46.23%,ADAMTSL2;ADAMTSL4;THBS2;SPON1;SPON2
692,prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.17817190195775368,-0.7778931425832774,0.7447795823665894,0.9195055000581082,1.0,10/13,57.92%,USP15;ITGB3;PPP1CC;FKBP1A;UBE2M;ITGB1;PPP1CB;PPP1CA;XPO1;LTBP3
693,prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,0.16671051259786335,0.7754563871628048,0.7368421052631579,0.832187017745974,1.0,6/15,25.01%,YWHAZ;PRDX1;PRDX2;YWHAQ;YWHAE;YWHAG
694,prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.18595287220406698,-0.7725078391831627,0.7707865168539326,0.9240425016241571,1.0,9/12,54.53%,B2M;HLA-G;LAIR1;IFITM1;ITGB1;HLA-C;ICAM1;VCAM1;CD81
695,prerank,RMTs Methylate Histone Arginines R-HSA-3214858,0.17961485371864128,0.7688703881427489,0.7335640138408305,0.8400111362423662,1.0,3/13,7.07%,H2AC21;H2AC11;H2AZ1
696,prerank,RHOF GTPase Cycle R-HSA-9035034,-0.19466799972113968,-0.7673773523765665,0.7809734513274337,0.9279659553898211,1.0,5/10,29.05%,SRGAP2;ESYT1;ARHGAP1;TMPO;FAM169A
697,prerank,Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,0.2355636629306252,0.7614169711659637,0.7666068222621185,0.8496345891119003,1.0,3/7,21.27%,CTSD;KCTD11;CPB2
698,prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.15528037649984047,-0.7606833989030936,0.750561797752809,0.9215144690875106,1.0,7/16,27.12%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1
699,prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.15528037649984047,-0.7606833989030936,0.750561797752809,0.9215144690875106,1.0,7/16,27.12%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1
700,prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.15528037649984047,-0.7606833989030936,0.750561797752809,0.9215144690875106,1.0,7/16,27.12%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1
701,prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.15528037649984047,-0.7606833989030936,0.750561797752809,0.9215144690875106,1.0,7/16,27.12%,PPP2R5D;SKP1;MAPK14;MAPK1;CUL1;RPS6KA3;HMGB1
702,prerank,Respiratory Electron Transport R-HSA-611105,-0.20681551116333724,-0.7595650314150006,0.7556053811659192,0.9190013513695455,1.0,9/9,79.49%,LRPPRC;CYCS;SDHB;NDUFV1;SDHA;NDUFS1;ETFA;NDUFA9;ETFB
703,prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.13138953806297488,0.7570534920360917,0.7657342657342657,0.8544758190251532,1.0,9/24,26.24%,HSP90AA1;TUBB4B;TUBA4A;RPS27A;TUBB;DYNC1H1;YWHAE;YWHAG;PPP2R1A
704,prerank,DNA Repair R-HSA-73894,0.10584786362870738,0.7550570006266104,0.7582781456953642,0.8555738670307061,1.0,17/39,35.01%,H2BC11;H2BC12;VCP;H2AZ1;RPS27A;XRCC5;XRCC6;FEN1;PRPF19;PPIE;PCNA;PARP1;RUVBL1;MSH3;PRKDC;DDB1;APEX1
705,prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.17848001178618936,-0.7549556663868305,0.7715617715617715,0.9218160670087479,1.0,8/12,47.34%,NOTCH4;ADAMTSL2;ADAMTSL4;THBS2;SPON1;MUC6;SPON2;DAG1
706,prerank,Collagen Chain Trimerization R-HSA-8948216,0.16469684195804007,0.7547750859067013,0.7680608365019012,0.8541942104163194,1.0,6/15,25.07%,COL6A1;COL6A3;COL18A1;COL1A1;COL2A1;COL6A2
707,prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.1515353658487743,-0.7547128535170056,0.7612612612612613,0.9177806518843792,1.0,13/16,65.52%,ATP6AP2;CES1;ACE;CTNNB1;DPP4;ERO1A;INHBE;GNB1;ACHE;CPE;KIF5B;CTSZ;PLA2G7
708,prerank,FLT3 Signaling In Disease R-HSA-9682385,0.2712894913863364,0.753432994554885,0.7669172932330827,0.8543362419936994,1.0,2/5,14.79%,RPS27A;SPTBN1
709,prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.13040901007705993,0.7509732100542588,0.7845303867403315,0.8560833444308997,1.0,24/24,87.14%,FGB;FGA;RPS27A;FGG;PPP2CA;APP;LBP;PPP2R1A;UBE2V1;DNM2;UBE2N;USP14;MAPK3;MAP2K1;PTPN11;UBE2D2;HMGB1;RPS6KA3;CUL1;S100A1;MAPK1;MAPK14;SKP1;PPP2R5D
710,prerank,RHOG GTPase Cycle R-HSA-9013408,-0.17279426855791186,-0.7507726613464,0.7835990888382688,0.9200229624597642,1.0,10/12,65.34%,IQGAP2;ARHGDIA;ESYT1;ARHGAP1;TMPO;ITGB1;TFRC;CDC42;KTN1;RAB7A
711,prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.23143700648483717,0.7503406668351325,0.7883895131086143,0.8552605282731994,1.0,2/7,7.25%,TGFB1;RPS27A
712,prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.12372146249441339,0.7495476877744374,0.7766990291262136,0.8546497127850169,1.0,25/28,77.73%,LDHA;ATP5F1B;CS;LDHB;MDH2;ETFB;NDUFA9;ACO2;ATP5F1A;LDLR;ETFA;DLST;NDUFS1;IDH2;SDHA;GLO1;BSG;NDUFV1;SLC16A3;SDHB;PDHA1;OGDH;CYCS;PDPR;ATP5PO
713,prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.2702227432590857,0.748211809211052,0.8037037037037037,0.8546710230029234,1.0,5/5,73.06%,MAN2A1;B4GALT1;FUCA1;FUT3;ST6GAL1
714,prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.21543585121877784,-0.7448278956607683,0.7894736842105263,0.9249912321253648,1.0,5/8,39.57%,NUP93;UBE2I;RANGAP1;SEC13;TNPO1
715,prerank,CRMPs In Sema3A Signaling R-HSA-399956,0.26599142971965223,0.7377054161013917,0.7955390334572491,0.8677536784164286,1.0,2/5,15.02%,DPYSL5;DPYSL2
716,prerank,CS/DS Degradation R-HSA-2024101,-0.26393919859308856,-0.7375311856347253,0.8047722342733189,0.9319298734683967,1.0,3/5,32.55%,CSPG4;BGN;HEXA
717,prerank,Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.22289057288354158,-0.7338987819881576,0.7838427947598253,0.9330846525247573,1.0,3/7,18.99%,B2M;AP1S1;AP1S2
718,prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,0.19236162306683158,0.7314159184520385,0.8064516129032258,0.8745004081671174,1.0,7/11,45.88%,CS;MDH2;ACO2;LDLR;DLST;IDH2;SDHA
719,prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.18669104409831894,0.7290478989727104,0.8045540796963947,0.8741922691998042,1.0,5/10,33.20%,RPS27A;PRPF19;PPIE;PCNA;DDB1
720,prerank,Dual Incision In TC-NER R-HSA-6782135,0.18669104409831894,0.7290478989727104,0.8045540796963947,0.8741922691998042,1.0,5/10,33.20%,RPS27A;PRPF19;PPIE;PCNA;DDB1
721,prerank,G-protein Mediated Events R-HSA-112040,-0.26299617654694174,-0.7259805742504873,0.8041666666666667,0.9404082812759321,1.0,3/5,32.50%,GNAI2;MAPK1;PRKAR1A
722,prerank,Costimulation By CD28 Family R-HSA-388841,-0.2122976717377682,-0.7256500349077836,0.8212058212058212,0.9366730543470755,1.0,3/8,14.96%,CSK;PPP2R5D;SRC
723,prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.23580467439565386,-0.7218273940920817,0.8033126293995859,0.9380344484263615,1.0,5/6,59.15%,MTA2;MAPK1;RBBP7;MAPK3;HDAC1
724,prerank,Netrin-1 Signaling R-HSA-373752,-0.23435205550713264,-0.7212819636242764,0.7982456140350878,0.9345435916546336,1.0,5/6,59.26%,SRC;MAPK14;PTPN11;CDC42;NEO1
725,prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,0.12417614569607899,0.7167263712657933,0.8284734133790738,0.8891057594779677,1.0,15/25,49.21%,IGF2R;CLTC;HSPA8;APP;AP1B1;FTH1;SNX2;RAB5C;CTSZ;DNM2;AP1M1;AP1G1;CLTA;AP3B1;FTL
726,prerank,Pentose Phosphate Pathway R-HSA-71336,-0.22784227815171876,-0.7157887246048753,0.8663883089770354,0.9379556444716126,1.0,2/6,8.83%,SHPK;DERA
727,prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.1619552414605418,-0.7152389440149383,0.8378995433789954,0.9344475601855963,1.0,13/13,83.99%,COPS2;VIM;PDE5A;CUL3;TRA2B;COPS4;RBMX;TXNL1;GPS1;ROCK2;CCT2;CCT7;HNRNPC
728,prerank,Hyaluronan Metabolism R-HSA-2142845,-0.2531005187856822,-0.7146420461297232,0.8562231759656652,0.9313039052449315,1.0,3/5,32.55%,CD44;GUSB;HEXA
729,prerank,Pyruvate Metabolism R-HSA-70268,0.22476525821596244,0.7092197112721218,0.8248587570621468,0.8969915886475914,1.0,7/7,77.62%,LDHA;LDHB;GLO1;BSG;SLC16A3;PDHA1;PDPR
730,prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.2329750593104051,-0.7078872008976325,0.8311688311688312,0.9362214581246631,1.0,5/6,59.15%,SKP1;CUL1;RBX1;ADAM10;HDAC1
731,prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.14495061656513275,-0.7076073795982816,0.8418604651162791,0.9325268585774604,1.0,12/16,59.56%,COPS2;CUL4A;POLR2H;CUL4B;COPS5;COPS4;RBX1;COPS6;COPS3;USP7;GPS1;COPS8
732,prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.15042700907232642,0.7064258791801854,0.8201834862385321,0.8987201742527795,1.0,12/16,61.19%,DDX39B;SRSF1;SRSF3;EIF4A3;SRSF7;SRSF2;SRSF4;TPR;MAGOH;EIF4E;U2AF2;ALYREF
733,prerank,Gap Junction Trafficking And Regulation R-HSA-157858,0.2325905020989404,0.7016606436330086,0.8355899419729207,0.9032903696716383,1.0,4/6,44.71%,CLTC;AP2M1;DNM2;CLTA
734,prerank,Nucleotide Excision Repair R-HSA-5696398,-0.11517964157851299,-0.6967097195281711,0.8544600938967136,0.9430376428924209,1.0,21/24,75.51%,SUMO2;COPS2;CUL4A;POLR2H;RAD23B;UBE2I;CUL4B;COPS5;ACTL6A;COPS4;RBX1;COPS6;COPS3;USP7;UBE2N;GPS1;COPS8;DDB1;RUVBL1;PARP1;PCNA
735,prerank,Iron Uptake And Transport R-HSA-917937,0.1593138063987639,0.6961926480382672,0.8278985507246377,0.908518188362371,1.0,5/14,21.39%,TF;RPS27A;ACO1;CAND1;FTH1
736,prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.12299500159303939,0.6915559626935094,0.8628158844765343,0.9124219987440357,1.0,21/23,79.60%,HSPA1A;HSP90AB1;HSP90AA1;HSPA8;DYNC1H1;CAPZA1;PTGES3;CAPZB;ACTR1A;DCTN1;STIP1;DNAJA2;CAPZA2;DNAJB1;DYNC1I2;FKBP4;DCTN2;DYNC1LI1;DCTN3;DCTN4;FKBP5
737,prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.15551803277912096,0.6911185496155269,0.8178506375227687,0.9111732050358691,1.0,12/14,71.19%,HSPA5;PDIA3;SEC23A;HLA-A;SEC24C;SEC31A;SEC24A;CALR;HLA-C;TAPBP;SAR1B;SEC13
738,prerank,DNA Damage Bypass R-HSA-73893,-0.18569092238697774,-0.6890828780554902,0.8720173535791758,0.9486914766696751,1.0,4/9,24.20%,CUL4A;TRIM25;NPLOC4;CUL4B
739,prerank,Potential Therapeutics For SARS R-HSA-9679191,-0.11580139461553408,-0.6869465389079034,0.8615751789976134,0.9473266694289069,1.0,11/24,32.73%,BRD4;MTA2;JAK2;AP2A2;FKBP1A;VEGFA;COMT;CUL3;RBBP7;FKBP4;ITGB1
740,prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,0.13010053222945006,0.6853261040770674,0.8717047451669596,0.9165157232808628,1.0,20/20,87.14%,TF;PPP2CA;CLTC;PPP2R1A;AP2M1;AP2B1;AP2A1;YWHAB;DNM2;CLTA;MAPK3;MAP2K1;NRAS;RPS6KA3;MAPK1;STAT3;AP2A2;MAPK14;SRC;PPP2R5D
741,prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.22853440461342855,0.6820360639713865,0.8436293436293436,0.9185352499746392,1.0,2/6,12.22%,RPS27A;YWHAZ
742,prerank,Collagen Degradation R-HSA-1442490,0.18880805068953932,0.6816971548947235,0.8613678373382625,0.9171758340175308,1.0,6/9,49.50%,CTSB;CTSD;COL18A1;COL12A1;COL15A1;ADAM10
743,prerank,Ethanol Oxidation R-HSA-71384,0.2459002690097911,0.6813316847951039,0.8606403013182674,0.915781737887267,1.0,3/5,37.00%,ALDH1A1;ADH5;ALDH2
744,prerank,RNA Polymerase II Transcription R-HSA-73857,0.05421550657024838,0.6786201079219446,0.8539156626506024,0.9173004871668649,1.0,59/141,38.22%,APOE;H2BC11;H2BC12;NPM1;TGFB1;H2AZ1;RPS27A;THBS1;PSMD14;PPP2CA;FASN;CCN2;DDX39B;SNRPD3;SRSF1;YWHAZ;SRSF3;PRDX1;PRDX2;PSMC5;PSMC3;PSMC4;YWHAQ;PSMD13;SERPINE1;PSMC1;COL1A1;HSPD1;RBBP4;YWHAE;PSMC2;PSMC6;NOTCH3;PSME2;PSMB2;PSMA6;PCNA;YWHAG;CALM1;PPP2R1A;SSRP1;PSMA7;EIF4A3;PARP1;SRSF7;PSMD12;YBX1;PSMD11;PRMT5;SRSF2;PSMA1;PSMA4;PSMD8;YWHAB;PSMB3;PSMA3;PSMA2;PSMD3;SUPT16H
745,prerank,Adherens Junctions Interactions R-HSA-418990,-0.2196653983108428,-0.676068979795961,0.8706140350877193,0.9567797102497746,1.0,4/6,43.48%,CTNNA1;CTNNB1;CDH6;CDH5
746,prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.1362707780736906,0.6706235879437479,0.8771929824561403,0.9244764207441544,1.0,3/17,5.26%,HSP90AB1;HSP90AA1;IGLL5
747,prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.17283950617283936,0.6576440772616895,0.8876190476190476,0.936671294609985,1.0,10/10,82.82%,GLUD1;ATP5F1B;CALM1;SSBP1;IDH2;TFAM;CARM1;ACSS2;CYCS;HCFC1
748,prerank,RNA Polymerase II Transcription Termination R-HSA-73856,0.12325792526327597,0.6542839579119103,0.8760757314974182,0.9382948990364043,1.0,17/21,69.78%,DDX39B;SNRPD3;SRSF1;SRSF3;EIF4A3;SRSF7;SRSF2;SRSF4;MAGOH;CSTF3;U2AF2;CPSF6;SNRPE;ALYREF;SNRPF;SNRPB;NUDT21
749,prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,0.21530950807423765,0.6532814069042868,0.9059500959692899,0.9376372928399721,1.0,3/6,30.22%,AHCY;BHMT;MAT1A
750,prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.1967876426219157,-0.6516703245374015,0.9117647058823529,0.9800547705395972,1.0,5/7,50.50%,CTBP1;PPP2R5D;CTNNB1;DKK1;DKK4
751,prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.1035099431340331,-0.6486992841808943,0.8875878220140515,0.9790322038082757,1.0,21/26,69.26%,COPS2;EPS15L1;SCARB2;AP2A2;TOR1B;ARRB1;CLTB;COPS5;SH3GL1;COPS4;LRP2;COPS6;TFRC;COPS3;CLTA;GPS1;COPS8;AP2A1;AP2B1;LDLR;AP2M1
752,prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.11435123315035224,-0.6482070918497592,0.9123222748815166,0.9753616144231433,1.0,17/22,64.82%,B2M;HLA-G;NUP93;G3BP1;TRIM25;STAT1;SEC13;SAR1B;PTPN11;HLA-C;SEC24A;MASP2;UBE2N;TPR;SEC24C;TKFC;UBE2V1
753,prerank,CTLA4 Inhibitory Signaling R-HSA-389513,-0.23646810340049537,-0.6445529753390463,0.9071729957805907,0.9749872662686886,1.0,2/5,14.96%,PPP2R5D;SRC
754,prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.18731650029359953,0.6437117548059932,0.9118236472945892,0.9455183846180988,1.0,8/8,81.36%,RPS27A;SERPINE1;PARP1;HDAC1;MAPK3;USP9X;MAPK1;STAT1
755,prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.23141786657750874,-0.63784593971565,0.8937093275488069,0.9775125290805758,1.0,4/5,55.82%,NUP93;SEC13;XPO1;TPR
756,prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.1939561044416607,0.6376601821882112,0.9191729323308271,0.9425214017719575,1.0,2/7,10.64%,RPS27A;PPP2CA
757,prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.1939561044416607,0.6376601821882112,0.9191729323308271,0.9425214017719575,1.0,2/7,10.64%,RPS27A;PPP2CA
758,prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.1939561044416607,0.6376601821882112,0.9191729323308271,0.9425214017719575,1.0,2/7,10.64%,RPS27A;PPP2CA
759,prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.1939561044416607,0.6376601821882112,0.9191729323308271,0.9425214017719575,1.0,2/7,10.64%,RPS27A;PPP2CA
760,prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.1939561044416607,0.6376601821882112,0.9191729323308271,0.9425214017719575,1.0,2/7,10.64%,RPS27A;PPP2CA
761,prerank,Signal Transduction R-HSA-162582,0.03689814092591283,0.6342022887856371,0.8990318118948825,0.9440609427580969,1.0,148/323,44.18%,C3;FN1;FGB;APOE;FGA;C5;PARD3;H2BC11;H2BC12;PFN1;PLG;THBS4;VCP;HSP90AB1;TLN1;TF;HSP90AA1;CLSTN1;LAMB1;TGFB1;FLNA;COL6A1;LAMC1;RAP1B;H2AZ1;RPS27A;RACK1;THBS1;NOTUM;FGG;AKR1C3;CNTN1;LAMA5;PSMD14;GRB7;SHMT2;PPP2CA;PEBP1;FASN;DDX39B;IGF2;YWHAZ;VWF;ALDH1A1;CTSD;CLTC;COL6A3;SPTBN1;LTBP4;MYH9;ACTN1;HNRNPC;PSMC5;CCT7;DYNC1H1;PSMC3;SPTAN1;APP;APOC2;HSPE1;PLTP;CCT2;PSMC4;THBS3;YWHAQ;PSMD13;SERPINE1;PSMC1;P4HB;VPS35;RBBP4;YWHAE;PSMC2;MYL6;PSMC6;RTN4;NOTCH3;ACTR3;PSME2;B4GALT1;PSMB2;PSMA6;C1QBP;HNRNPA1;YWHAG;COL6A2;CALM1;PPP2R1A;CKB;PCSK6;PSMA7;PTGES3;CAPZB;PARP1;IQGAP1;RUVBL1;HGFAC;PSMD12;CCL20;AP2M1;YBX1;ARPC2;PSMD11;KHDRBS1;ROCK2;DIAPH1;PSMA1;MYH10;PSMA4;AP2B1;PSMD8;RAB7A;RHOC;PTPRS;AP2A1;YWHAB;LMNB2;CCT6A;ARPC5;SEPTIN7;PSMB3;PSMA3;PSMA2;HSPB1;PSMD3;NRP1;KIF5B;PFN2;DNM2;PRKAR2A;PSMB1;KTN1;HDAC1;PSMD6;LTBP3;DDX5;CDC37;LMNB1;APOC1;MYH14;PSMD2;PAFAH1B1;CDC42;GPS1;NRP2;PSMA5;HNRNPF;STIP1
762,prerank,Smooth Muscle Contraction R-HSA-445355,-0.13943507362848961,-0.6321125230977971,0.931350114416476,0.9787172016758755,1.0,12/13,77.97%,ANXA2;PDE5A;TPM3;TPM4;MYL12A;MYLK;VCL;ALDH2;TPM1;ANXA6;CALM1;MYL6
763,prerank,Leishmania Infection R-HSA-9658195,-0.0988324708728779,-0.6298922416993084,0.9137931034482759,0.976801075378014,1.0,13/27,36.88%,GNAI2;ARPC1A;GNB4;SRC;MAPK14;ABI1;MAPK1;NCKAP1;GNB2;PRKAR1A;GGT1;ACTR2;CYFIP2
764,prerank,Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.2099706744868036,0.6298229375429047,0.9011627906976745,0.9464775085638731,1.0,6/6,79.08%,APP;CAPZA1;MAPK3;CAPZA2;HMGB1;MAPK1
765,prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.22927911115484445,0.6280150458182634,0.8862815884476535,0.9462825333091687,1.0,3/5,38.69%,IGLL5;CALM1;PRKAR2A
766,prerank,Signaling By TGFB Family Members R-HSA-9006936,-0.10558851918701613,-0.6247586665433382,0.9235955056179775,0.9774016512956862,1.0,17/24,59.15%,USP15;ITGB3;PPP1CC;FKBP1A;STAT1;MAPK1;UBE2M;ITGB1;USP9X;PPP1CB;DRAP1;PPP1CA;MAPK3;COL1A2;XPO1;LTBP3;HDAC1
767,prerank,Cell-cell Junction Organization R-HSA-421270,0.18221292161262145,0.6230763192483352,0.9212454212454212,0.948934772837071,1.0,7/8,70.08%,PARD3;ANG;CDH11;SDK1;CDH5;CDH6;CTNNB1
768,prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.17413828746432103,0.6222206227569025,0.9256505576208178,0.9478717079662573,1.0,3/9,17.83%,GSN;LMNA;SPTAN1
769,prerank,ISG15 Antiviral Mechanism R-HSA-1169408,0.13577684535488335,0.6187638677214,0.9308510638297872,0.9491841223953293,1.0,10/15,54.53%,RPS27A;EIF4A1;FLNB;KPNB1;EIF4A3;EIF4A2;TPR;UBE2N;MAPK3;EIF4E
770,prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.21114369501466257,0.6169062886072176,0.9236499068901304,0.9490718466803189,1.0,6/6,78.96%,TGFB1;LPL;ANGPTL4;CARM1;PCK1;MED6
771,prerank,RHO GTPase Effectors R-HSA-195258,-0.06229200994894932,-0.6166392958725072,0.9489247311827957,0.9805784663236886,1.0,57/67,78.26%,SRGAP2;GOPC;PPP1R12A;KLC4;IQGAP2;ARPC1A;DYNC1LI2;CTNNA1;PPP2R5D;PPP1CC;SRC;MAPK14;ABI1;MAPK1;RANGAP1;DYNC1LI1;NCKAP1;CKAP5;SEC13;CTNNB1;DYNC1I2;ITGB1;KLC1;ACTR2;MYLK;CYFIP2;ARPC1B;BUB3;PPP1CB;MAPRE1;NUDC;RPS27;MAPK3;ARPC3;RCC2;YWHAH;XPO1;CDC42;PAFAH1B1;MYH14;KTN1;PFN2;KIF5B;ARPC5;YWHAB;RHOC;MYH10;DIAPH1;ROCK2;ARPC2;IQGAP1;PPP2R1A;CALM1;YWHAG;ACTR3;MYL6;YWHAE
772,prerank,Late Phase Of HIV Life Cycle R-HSA-162599,-0.11741228287990418,-0.6159190941864143,0.9260143198090692,0.9771077554477593,1.0,8/19,28.93%,NELFB;POLR2H;NUP93;RANBP1;NCBP1;TSG101;RANGAP1;SEC13
773,prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.11722970163477409,0.6081837965845278,0.9113043478260869,0.9545399358774105,1.0,3/19,5.26%,HSP90AB1;HSP90AA1;IGLL5
774,prerank,Signaling By NOTCH1 R-HSA-1980143,0.17545929581598613,0.5987952860363626,0.9572490706319703,0.9601912245291988,1.0,2/8,8.94%,RPS27A;CNTN1
775,prerank,G Alpha (I) Signaling Events R-HSA-418594,-0.10861862955014799,-0.595715124900009,0.9471264367816092,0.988516823507501,1.0,9/20,32.50%,GNAI2;GNB4;PPP2R5D;SRC;MAPK1;PPP3CA;GNB2;HEBP1;PRKAR1A
776,prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.14552233430228018,0.5950988572276003,0.9289520426287744,0.9612087702272095,1.0,11/12,77.73%,ATP5F1B;ETFB;NDUFA9;ATP5F1A;ETFA;NDUFS1;SDHA;NDUFV1;SDHB;CYCS;ATP5PO
777,prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.15996252935916563,-0.5879536240907448,0.9454148471615721,0.9901557421299125,1.0,4/9,26.94%,PPP2R5D;MAPK14;MAPK1;RPS6KA3
778,prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.11590149953404921,-0.5860133265714186,0.9439252336448598,0.9874731040070218,1.0,3/17,5.08%,COPS2;CUL4A;POLR2H
779,prerank,mRNA 3-End Processing R-HSA-72187,-0.11629279811097992,-0.5854996388293197,0.9604395604395605,0.9837783570026312,1.0,17/17,88.54%,CSTF2;CPSF1;PABPN1;NCBP1;NUDT21;ALYREF;CPSF6;U2AF2;CSTF3;MAGOH;SRSF4;SRSF2;SRSF7;EIF4A3;SRSF3;SRSF1;DDX39B
780,prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.1941847939364888,0.5834609220255755,0.9436363636363636,0.9674014678381143,1.0,5/6,65.05%,PLG;COL18A1;TIMP1;CTSV;TIMP2
781,prerank,"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.04468642991297307,-0.580207465446046,0.9602446483180428,0.9832060218520147,1.0,51/120,36.88%,SRGAP2;RAB9A;FLOT1;COPS2;GOPC;PPP1R12A;FERMT2;OBSCN;KLC4;IQGAP2;ARHGDIA;VIM;TWF1;CSK;PLXNA1;ARPC1A;DYNC1LI2;ATP6AP1;CTNNA1;ARHGAP17;PPP2R5D;PPP1CC;SRC;MAPK14;ABI1;SLC1A5;ESYT1;ARHGAP1;PDE5A;CUL3;MAPK1;TPM3;RANGAP1;TMPO;DYNC1LI1;NCKAP1;STOM;CKAP5;SEC13;TPM4;FAM169A;CTNNB1;TRA2B;DYNC1I2;ITGB1;KLC1;ACTR2;MYLK;SCFD1;COPS4;CYFIP2
782,prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.12013907312414636,0.5784034025891668,0.9530434782608695,0.969063431866645,1.0,16/18,77.62%,LDHA;CS;LDHB;MDH2;ACO2;LDLR;DLST;IDH2;SDHA;GLO1;BSG;SLC16A3;SDHB;PDHA1;OGDH;PDPR
783,prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.11710842083933523,-0.5742187735446254,0.9523809523809523,0.9827974713200908,1.0,13/16,68.79%,ARPC1A;SRC;ABI1;MAPK1;NCKAP1;ACTR2;CYFIP2;ARPC1B;MAPK3;ARPC3;CDC42;ARPC5;ARPC2
784,prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.18630539291137868,0.5726771743388949,0.9553072625698324,0.9711774579080658,1.0,3/6,33.20%,RPS27A;PCNA;DDB1
785,prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.11649173528783832,0.5613516282328782,0.9501779359430605,0.976563844549146,1.0,11/17,54.53%,FLNA;RPS27A;EIF4A1;FLNB;KPNB1;EIF4A3;EIF4A2;TPR;UBE2N;MAPK3;EIF4E
786,prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.10113352172196045,0.560864473010959,0.9596330275229358,0.9750396134640692,1.0,22/23,85.97%,PARD3;TGFB1;RPS27A;LTBP4;SERPINE1;PARP1;YBX1;HDAC1;LTBP3;XPO1;COL1A2;MAPK3;PPP1CA;PPP1CB;USP9X;ITGB1;UBE2M;MAPK1;STAT1;FKBP1A;PPP1CC;ITGB3
787,prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.19859187283891472,-0.5570496465940602,0.9777777777777777,0.9884008652791607,1.0,3/5,38.34%,CDK1;CARM1;PRMT1
788,prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.15120487228865387,0.5534815889595329,0.9776119402985075,0.9773676549802996,1.0,7/9,63.65%,RPS27A;DCXR;GLB1;TALDO1;GAA;GYS1;ALDOB
789,prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.19917809345157308,-0.5532346202759839,0.9715536105032823,0.986197211561066,1.0,3/5,38.69%,SKP1;CUL1;RBX1
790,prerank,Signaling By FGFR1 R-HSA-5654736,0.15733923221994295,0.5522311110175581,0.9758364312267658,0.9727019691384545,1.0,2/8,10.64%,RPS27A;PPP2CA
791,prerank,Signaling By FGFR4 R-HSA-5654743,0.15733923221994295,0.5522311110175581,0.9758364312267658,0.9727019691384545,1.0,2/8,10.64%,RPS27A;PPP2CA
792,prerank,Signaling By FGFR3 R-HSA-5654741,0.15733923221994295,0.5522311110175581,0.9758364312267658,0.9727019691384545,1.0,2/8,10.64%,RPS27A;PPP2CA
793,prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.14624532213517874,0.546429580659055,0.9783783783783784,0.9739018486848728,1.0,6/10,47.11%,NPM1;RAN;KPNB1;RCC1;TPR;XPO1
794,prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.17953079611848766,0.5271919288757645,0.9784172661870504,0.9806484489717262,1.0,5/6,66.10%,PPP2CA;PPP2R1A;XPO1;PPME1;PPP2R2A
795,prerank,Signaling By Rho GTPases R-HSA-194315,-0.03976673095882517,-0.5223930402530559,0.9881656804733728,0.9946307460350344,1.0,50/119,36.88%,SRGAP2;FLOT1;COPS2;GOPC;PPP1R12A;FERMT2;OBSCN;KLC4;IQGAP2;ARHGDIA;VIM;TWF1;CSK;PLXNA1;ARPC1A;DYNC1LI2;ATP6AP1;CTNNA1;ARHGAP17;PPP2R5D;PPP1CC;SRC;MAPK14;ABI1;SLC1A5;ESYT1;ARHGAP1;PDE5A;CUL3;MAPK1;TPM3;RANGAP1;TMPO;DYNC1LI1;NCKAP1;STOM;CKAP5;SEC13;TPM4;FAM169A;CTNNB1;TRA2B;DYNC1I2;ITGB1;KLC1;ACTR2;MYLK;SCFD1;COPS4;CYFIP2
796,prerank,Oncogene Induced Senescence R-HSA-2559585,-0.18053120916159618,-0.5049223921499597,0.9854166666666667,0.9958073353067026,1.0,4/5,60.72%,MOV10;MAPK1;MAPK3;ETF1
797,prerank,ERKs Are Inactivated R-HSA-202670,-0.17554640115675677,-0.4864267255214811,0.9959432048681541,0.9959057485104547,1.0,2/5,21.04%,PPP2R5D;MAPK1
798,prerank,Phenylalanine And Tyrosine Metabolism R-HSA-8963691,-0.16934084804606095,-0.48127663033676793,0.993421052631579,0.9929188822134751,1.0,4/5,62.01%,PAH;FAH;HPD;QDPR
799,prerank,DARPP-32 Events R-HSA-180024,0.13519960652833518,0.46644280298578616,0.9922630560928434,0.9951052012359017,1.0,7/8,74.63%,PPP2CA;CALM1;PPP2R1A;PRKAR2A;PPP1CA;PRKAR1A;PPP3CA
800,prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.16356119826732135,0.44984949307737526,0.9942857142857143,0.9956996930242406,1.0,1/5,5.03%,HSP90AA1
